p.value	odds_ratio	overlap	adj_p.value	genes
DNA Double Strand Break Response R-HSA-5693606	1.80674832923737e-11	13.9130086815979	15/61	2.39755503289799e-08	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;SMARCA5;BAZ1B;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1;EYA4
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks R-HSA-5693565	1.39213465672837e-11	14.2243032578193	15/60	2.39755503289799e-08	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;SMARCA5;BAZ1B;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1;EYA4
Nonhomologous End-Joining (NHEJ) R-HSA-5693571	2.97053975789099e-09	13.0732458139007	12/50	2.62793750581423e-06	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1
DNA Double-Strand Break Repair R-HSA-5693532	2.79450289956142e-08	7.463427057278	15/100	1.79899055510042e-05	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;SMARCA5;BAZ1B;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1;EYA4
G2/M DNA damage checkpoint R-HSA-69473	4.06704722328655e-08	9.91306653064484	12/62	1.79899055510042e-05	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1
Processing of DNA double-strand break ends R-HSA-5693607	4.06704722328655e-08	9.91306653064484	12/62	1.79899055510042e-05	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1
Sensory perception of salty taste R-HSA-9730628	4.46442653190233e-07	Inf	4/4	0.000169265543080983	SCNN1A;SCNN1B;SCNN1G;SCNN1D
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) R-HSA-5693567	6.64845103070073e-07	7.36755967705415	12/79	0.000220562362943497	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1
Homology Directed Repair R-HSA-5693538	8.78888183491436e-07	7.15092649159247	12/81	0.000259174359887363	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1
Neurexins and neuroligins R-HSA-6794361	1.82170801866833e-06	23.4940669692911	6/16	0.000483481308154575	NRXN1;DLGAP4;DLGAP2;NRXN2;DLGAP3;SHANK2
Intrinsic Pathway of Fibrin Clot Formation R-HSA-140837	7.70491801680946e-06	27.6855378258264	5/12	0.00179016736096448	SERPINC1;SERPINE2;VWF;GP1BA;F11
Protein-protein interactions at synapses R-HSA-6794362	8.09420057708128e-06	16.7740360241453	6/20	0.00179016736096448	NRXN1;DLGAP4;DLGAP2;NRXN2;DLGAP3;SHANK2
Sensory perception of taste R-HSA-9717189	1.46982713502368e-05	51.118346474106	4/7	0.00278637229739489	SCNN1A;SCNN1B;SCNN1G;SCNN1D
Transcriptional regulation of testis differentiation R-HSA-9690406	1.46982713502368e-05	51.118346474106	4/7	0.00278637229739489	SRY;SOX9;WT1;DMRT1
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer R-HSA-2173793	4.27122875578852e-05	7.38621559375524	8/51	0.00755722741190849	EP300;NCOR1;FURIN;E2F5;SMAD3;JUNB;SMAD2;TRIM33
DCC mediated attractive signaling R-HSA-418885	5.0802691629508e-05	30.7215030345276	4/9	0.00756313543313827	SRC;CDC42;ABLIM2;NTN1
DNA Repair R-HSA-73894	4.80807478834307e-05	3.81551304598507	15/178	0.00756313543313827	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;SMARCA5;BAZ1B;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1;EYA4
G2/M Checkpoints R-HSA-69481	5.12948145427614e-05	4.5671135073197	12/119	0.00756313543313827	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1
Netrin-1 signaling R-HSA-373752	7.34961712923438e-05	14.9054282862097	5/18	0.0102662546636779	SRC;CDC42;UNC5B;ABLIM2;NTN1
B-WICH complex positively regulates rRNA expression R-HSA-5250924	0.000123349090187781	5.43789840682187	9/75	0.0161455845119893	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;SMARCA5;DDX21;BAZ1B
Germ layer formation at gastrulation R-HSA-9754189	0.000127753306236539	21.9495758254887	4/11	0.0161455845119893	NANOG;SMAD3;SMAD2;TRIM33
Netrin mediated repulsion signals R-HSA-418886	0.00016852387910384	56.9916785789207	3/5	0.0203301079609814	SRC;UNC5B;NTN1
Formation of Fibrin Clot (Clotting Cascade) R-HSA-140877	0.000207751334985597	11.3959498960529	5/22	0.0239726975239902	SERPINC1;SERPINE2;VWF;GP1BA;F11
Sensory Perception R-HSA-9709957	0.000223835883968798	5.65419996837525	8/64	0.0247525181688829	GSN;SCNN1A;SCNN1B;SCNN1G;SCNN1D;SYP;PCLO;BSN
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription R-HSA-2173796	0.000289127909745149	7.80604618911961	6/36	0.030693818898545	EP300;FURIN;E2F5;SMAD3;JUNB;SMAD2
DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586	0.000309048344284382	5.361837188711	8/67	0.0315467040665673	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4;KAT5;NBN
Signaling by TGF-beta Receptor Complex R-HSA-170834	0.000387706569509469	4.5876796383579	9/87	0.0381101198325234	EP300;NCOR1;FURIN;E2F5;SMAD3;JUNB;SMAD2;TRIM33;PMEPA1
Positive epigenetic regulation of rRNA expression R-HSA-5250913	0.000422559873234064	4.52869239335264	9/88	0.0400526394129716	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;SMARCA5;DDX21;BAZ1B
Ion channel transport R-HSA-983712	0.000462208816953508	5.0162921611923	8/71	0.0423000758687797	ATP1A1;FXYD2;SCNN1A;SCNN1B;TRPM7;SCNN1G;SCNN1D;WNK2
Cleavage of the damaged purine R-HSA-110331	0.000600111348182381	6.68291404040591	6/41	0.0482635005477588	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Depurination R-HSA-73927	0.000600111348182381	6.68291404040591	6/41	0.0482635005477588	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Packaging Of Telomere Ends R-HSA-171306	0.000600111348182381	6.68291404040591	6/41	0.0482635005477588	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Recognition and association of DNA glycosylase with site containing an affected purine R-HSA-110330	0.000600111348182381	6.68291404040591	6/41	0.0482635005477588	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Base-Excision Repair, AP Site Formation R-HSA-73929	0.000779820114450399	6.3188625809936	6/43	0.051741064593784	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Cell Cycle Checkpoints R-HSA-69620	0.000731243767861722	3.15496692901861	13/180	0.051741064593784	AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBE2V2;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1
Cleavage of the damaged pyrimidine  R-HSA-110329	0.000779820114450399	6.3188625809936	6/43	0.051741064593784	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Defective F9 activation R-HSA-9673221	0.000680738441575027	Inf	2/2	0.051741064593784	GP1BA;F11
Depyrimidination R-HSA-73928	0.000779820114450399	6.3188625809936	6/43	0.051741064593784	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Recognition and association of DNA glycosylase with site containing an affected pyrimidine R-HSA-110328	0.000779820114450399	6.3188625809936	6/43	0.051741064593784	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Stimuli-sensing channels R-HSA-2672351	0.000685411920234934	6.49583665796329	6/42	0.051741064593784	SCNN1A;SCNN1B;TRPM7;SCNN1G;SCNN1D;WNK2
Signaling by TGFB family members R-HSA-9006936	0.00100733111468754	3.96448901222711	9/99	0.0652062628873349	EP300;NCOR1;FURIN;E2F5;SMAD3;JUNB;SMAD2;TRIM33;PMEPA1
Formation of the beta-catenin:TCF transactivating complex R-HSA-201722	0.0011250694975607	4.31894321159554	8/81	0.0710936772982404	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;H3-4;KAT5
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) R-HSA-9651496	0.00131081723246532	19.0311607058504	3/9	0.0790661121582491	VWF;GP1BA;F11
GP1b-IX-V activation signalling R-HSA-430116	0.00131081723246532	19.0311607058504	3/9	0.0790661121582491	SRC;VWF;GP1BA
Deposition of new CENPA-containing nucleosomes at the centromere R-HSA-606279	0.00141169765255614	5.55959362898206	6/48	0.0797158631890212	H2BC21;H2BC12;H4C9;H2AX;H2BC14;SMARCA5
Nucleosome assembly R-HSA-774815	0.00141169765255614	5.55959362898206	6/48	0.0797158631890212	H2BC21;H2BC12;H4C9;H2AX;H2BC14;SMARCA5
Signaling by PDGF R-HSA-186797	0.00141169765255614	5.55959362898206	6/48	0.0797158631890212	SRC;FURIN;STAT6;STAT5B;PLAT;PDGFD
Transcriptional Regulation by MECP2 R-HSA-8986944	0.001488517467155	6.9040516644928	5/33	0.0823026116214452	AURKB;NCOR1;HIPK2;MECP2;DGCR8
Amyloid fiber formation R-HSA-977225	0.00154370050465877	4.09054151198469	8/85	0.0829714972254218	H2BC21;H2BC12;H4C9;H2AX;H2BC14;FURIN;APP;GSN
Regulation of MECP2 expression and activity R-HSA-9022692	0.00156314049030561	9.59519076988582	4/20	0.0829714972254218	AURKB;NCOR1;HIPK2;MECP2
Generic Transcription Pathway R-HSA-212436	0.0017198711198495	2.03068167005424	29/645	0.0877795760015495	SRC;AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;FURIN;ARNT;NAMPT;HIPK2;KAT5;NBN;MDC1;E2F5;MYBL2;ARID1A;SMAD3;JUNB;SOX9;GP1BA;SMAD2;TRIM33;NR5A2;MECP2;DGCR8;NOC2L
Replacement of protamines by nucleosomes in the male pronucleus R-HSA-9821993	0.00170924118337822	6.6649764811079	5/34	0.0877795760015495	H2BC21;H2BC12;H4C9;H2AX;H2BC14
TCF dependent signaling in response to WNT R-HSA-201681	0.00176423390415903	2.97426603497641	12/174	0.0883448449365673	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;FZD5;H3-4;KAT5;WNT3A;SRY;SOX9
Meiotic recombination R-HSA-912446	0.00181377179887997	4.49046024717457	7/68	0.0891435250782859	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4;NBN
Epigenetic regulation of gene expression R-HSA-212165	0.0020398689738346	3.28430969296966	10/131	0.091759529772153	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;SMARCA5;DDX21;BAZ1B;UBTF
Gene expression (Transcription) R-HSA-74160	0.00191793741626482	1.94684112043998	33/775	0.091759529772153	SRC;AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;FURIN;ARNT;SMARCA5;DDX21;BAZ1B;NAMPT;HIPK2;KAT5;NBN;MDC1;E2F5;MYBL2;ARID1A;SMAD3;JUNB;SOX9;GP1BA;SMAD2;TRIM33;NR5A2;MECP2;UBTF;DGCR8;NOC2L
Loss of Function of SMAD4 in Cancer R-HSA-3304347	0.00200718474683107	75.2264902573664	2/3	0.091759529772153	SMAD3;SMAD2
SMAD2/3 MH2 Domain Mutants in Cancer R-HSA-3315487	0.00200718474683107	75.2264902573664	2/3	0.091759529772153	SMAD3;SMAD2
SMAD4 MH2 Domain Mutants in Cancer R-HSA-3311021	0.00200718474683107	75.2264902573664	2/3	0.091759529772153	SMAD3;SMAD2
Reproduction R-HSA-1474165	0.00223156514243299	3.83645382981317	8/90	0.0987095648002859	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4;NBN;NANOG
Base Excision Repair R-HSA-73884	0.00237560217407963	4.96223127900643	6/53	0.103358166721432	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Meiotic synapsis R-HSA-1221632	0.00287553165375868	4.7582902528381	6/55	0.123091306597993	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Diseases of hemostasis R-HSA-9671793	0.00324143553079001	12.6853897822735	3/12	0.132350306134103	VWF;GP1BA;F11
Inhibition of DNA recombination at telomere R-HSA-9670095	0.00315321694569139	4.6623901224599	6/56	0.132350306134103	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Signaling by NODAL R-HSA-1181150	0.00324143553079001	12.6853897822735	3/12	0.132350306134103	FURIN;SMAD3;SMAD2
Neuronal System R-HSA-112316	0.00333323683940991	3.04987402973486	10/140	0.134036523815059	SRC;TSPOAP1;LRRC7;ARHGEF7;NRXN1;DLGAP4;DLGAP2;NRXN2;DLGAP3;SHANK2
RNA Polymerase I Promoter Opening R-HSA-73728	0.00345048061533722	4.56909167316374	6/57	0.136680232135895	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBTF
Aspartate and asparagine metabolism R-HSA-8963693	0.00394564766583367	37.6604405877783	2/4	0.145050000555678	ASPG;ASPA
Defective binding of VWF variant to GPIb:IX:V R-HSA-9846298	0.00394564766583367	37.6604405877783	2/4	0.145050000555678	VWF;GP1BA
Defective factor IX causes hemophilia B R-HSA-9668250	0.00394564766583367	37.6604405877783	2/4	0.145050000555678	GP1BA;F11
Enhanced binding of GP1BA variant to VWF multimer:collagen  R-HSA-9845620	0.00394564766583367	37.6604405877783	2/4	0.145050000555678	VWF;GP1BA
Formation of the anterior neural plate R-HSA-9823739	0.00394564766583367	37.6604405877783	2/4	0.145050000555678	ZEB2;NANOG
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function R-HSA-8936459	0.00398969481558572	3.84873855901185	7/78	0.145050000555678	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;GP1BA
NoRC negatively regulates rRNA expression R-HSA-427413	0.00428493319065228	3.79439867981776	7/79	0.153678549837718	H2BC21;H2BC12;H4C9;H2AX;H2BC14;SMARCA5;UBTF
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 R-HSA-5625886	0.0044680870509461	4.31237379040729	6/60	0.158110707109479	H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14
Negative epigenetic regulation of rRNA expression R-HSA-5250941	0.00459646019261321	3.74155874661284	7/80	0.160513228305203	H2BC21;H2BC12;H4C9;H2AX;H2BC14;SMARCA5;UBTF
Chromosome Maintenance R-HSA-73886	0.00492483498809113	3.6901579405008	7/81	0.167570667415306	H2BC21;H2BC12;H4C9;H2AX;H2BC14;SMARCA5;H3-4
Meiosis R-HSA-1500620	0.00492483498809113	3.6901579405008	7/81	0.167570667415306	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4;NBN
Condensation of Prophase Chromosomes R-HSA-2299718	0.00569211017168248	4.08249115875821	6/63	0.191226080957535	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Defects of platelet adhesion to exposed collagen R-HSA-9823587	0.00646373019032023	25.1237301121726	2/5	0.201977444933806	VWF;GP1BA
Formation of the posterior neural plate R-HSA-9832991	0.00646373019032023	25.1237301121726	2/5	0.201977444933806	ZEB2;WNT3A
RNA Polymerase II Transcription R-HSA-73857	0.0064687576561317	1.82028773330567	29/704	0.201977444933806	SRC;AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;FURIN;ARNT;NAMPT;HIPK2;KAT5;NBN;MDC1;E2F5;MYBL2;ARID1A;SMAD3;JUNB;SOX9;GP1BA;SMAD2;TRIM33;NR5A2;MECP2;DGCR8;NOC2L
Regulation of commissural axon pathfinding by SLIT and ROBO R-HSA-428542	0.00646373019032023	25.1237301121726	2/5	0.201977444933806	SRC;NTN1
Sensing of DNA Double Strand Breaks R-HSA-5693548	0.00646373019032023	25.1237301121726	2/5	0.201977444933806	KAT5;NBN
Signaling by RNF43 mutants R-HSA-5340588	0.00646373019032023	25.1237301121726	2/5	0.201977444933806	FZD5;WNT3A
Gastrulation R-HSA-9758941	0.00728058969919959	3.40799883527023	7/87	0.22468238443809	EP300;ZEB2;WNT3A;NANOG;SMAD3;SMAD2;TRIM33
Downregulation of SMAD2/3:SMAD4 transcriptional activity R-HSA-2173795	0.00813775869070436	5.67537126578356	4/31	0.245313162273996	NCOR1;SMAD3;SMAD2;TRIM33
Pre-NOTCH Expression and Processing R-HSA-1912422	0.00822640220135103	3.32320631713546	7/89	0.245313162273996	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;FURIN
Sensory processing of sound R-HSA-9659379	0.00813775869070436	5.67537126578356	4/31	0.245313162273996	GSN;SYP;PCLO;BSN
Loss of MECP2 binding ability to the NCoR/SMRT complex R-HSA-9022537	0.00953028587670753	18.8581079024204	2/6	0.266246091755598	NCOR1;MECP2
Mitochondrial tRNA aminoacylation R-HSA-379726	0.00953028587670753	18.8581079024204	2/6	0.266246091755598	CARS2;AARS2
Polo-like kinase mediated events R-HSA-156711	0.00953028587670753	18.8581079024204	2/6	0.266246091755598	EP300;MYBL2
RNA Polymerase I Promoter Escape R-HSA-73772	0.00947901364238027	3.62936413880133	6/70	0.266246091755598	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBTF
SMAD2/3 Phosphorylation Motif Mutants in Cancer R-HSA-3304356	0.00953028587670753	18.8581079024204	2/6	0.266246091755598	SMAD3;SMAD2
TGFBR1 KD Mutants in Cancer R-HSA-3656532	0.00953028587670753	18.8581079024204	2/6	0.266246091755598	SMAD3;SMAD2
Activation of HOX genes during differentiation R-HSA-5619507	0.0116095425388335	3.09194740744713	7/95	0.314405366306777	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1
Activation of anterior HOX genes in hindbrain development during early embryogenesis R-HSA-5617472	0.0116095425388335	3.09194740744713	7/95	0.314405366306777	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1
Telomere Maintenance R-HSA-157579	0.0115550012389824	3.46463704077384	6/73	0.314405366306777	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
Regulation of TP53 Activity through Phosphorylation R-HSA-6804756	0.0118985686133205	4.00930570404981	5/53	0.31897778888639	AURKB;HIPK2;KAT5;NBN;NOC2L
GRB2:SOS provides linkage to MAPK signaling for Integrins  R-HSA-354194	0.0131153765365136	15.0842318127418	2/7	0.337943779882593	SRC;VWF
Loss of Function of SMAD2/3 in Cancer R-HSA-3304349	0.0131153765365136	15.0842318127418	2/7	0.337943779882593	SMAD3;SMAD2
Loss of Function of TGFBR1 in Cancer R-HSA-3656534	0.0131153765365136	15.0842318127418	2/7	0.337943779882593	SMAD3;SMAD2
p130Cas linkage to MAPK signaling for integrins R-HSA-372708	0.0131153765365136	15.0842318127418	2/7	0.337943779882593	SRC;VWF
Signaling by WNT R-HSA-195721	0.0137774118506927	2.23180267839859	12/225	0.351588952420562	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;FZD5;H3-4;KAT5;WNT3A;SRY;SOX9
Platelet Aggregation (Plug Formation) R-HSA-76009	0.014425346182443	6.70971807181459	3/20	0.364617797792416	SRC;VWF;GP1BA
Cell Cycle R-HSA-1640170	0.014829780682174	1.90378982541624	18/400	0.371304131419715	SRC;AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;UBE2V2;SMARCA5;H3-4;KAT5;NBN;MDC1;BABAM1;UIMC1;E2F5;MYBL2
DNA methylation R-HSA-5334118	0.0159907398276487	3.6976309130015	5/57	0.396630126192333	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Assembly of the ORC complex at the origin of replication R-HSA-68616	0.0171438139056437	3.62631721835051	5/58	0.403742245547075	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Interleukin-2 signaling R-HSA-9020558	0.0171902312535115	12.5717767457962	2/8	0.403742245547075	JAK3;STAT5B
Regulation of gene expression by Hypoxia-inducible Factor R-HSA-1234158	0.0171902312535115	12.5717767457962	2/8	0.403742245547075	EP300;ARNT
SIRT1 negatively regulates rRNA expression R-HSA-427359	0.0171438139056437	3.62631721835051	5/58	0.403742245547075	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Signaling by TGF-beta Receptor Complex in Cancer R-HSA-3304351	0.0171902312535115	12.5717767457962	2/8	0.403742245547075	SMAD3;SMAD2
Synthesis of very long-chain fatty acyl-CoAs R-HSA-75876	0.0171902312535115	12.5717767457962	2/8	0.403742245547075	ACSBG1;ELOVL7
RHO GTPases activate PKNs R-HSA-5625740	0.0176132370853587	3.13142273920223	6/80	0.410048519513526	H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14
Sphingolipid metabolism R-HSA-428157	0.0181345425964435	4.36969697946695	4/39	0.418513704790966	SPHK1;GBA2;ACER1;CERS5
Chromatin modifying enzymes R-HSA-3247509	0.0185416603140541	2.30823374508658	10/180	0.418979091168083	H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14;EP300;NCOR1;KAT5;ARID1A
Chromatin organization R-HSA-4839726	0.0185416603140541	2.30823374508658	10/180	0.418979091168083	H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14;EP300;NCOR1;KAT5;ARID1A
Pre-NOTCH Transcription and Translation R-HSA-1912408	0.0186283092531401	3.08890605188008	6/81	0.418979091168083	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300
Chromatin modifications during the maternal to zygotic transition (MZT) R-HSA-9821002	0.0196129949006785	3.49307198787094	5/60	0.435319334160007	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Transcriptional regulation of granulopoiesis R-HSA-9616222	0.0196828636394879	3.04750105195947	6/82	0.435319334160007	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300
ESR-mediated signaling R-HSA-8939211	0.0198837766477566	2.28015172456354	10/182	0.436128456389636	SRC;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;SPHK1;KAT5;NR5A2
Developmental Biology R-HSA-1266738	0.0201066891169984	1.66080745582064	27/699	0.43740289275831	SRC;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;FURIN;ARHGEF7;CDC42;ZEB2;UNC5B;ABLIM2;NTN1;KAT5;ARID1A;WNT3A;NANOG;SMAD3;SRY;SOX9;SMAD2;TRIM33;NR5A2;WT1;DMRT1
Estrogen-dependent gene expression R-HSA-9018519	0.0214604003122097	2.50987988004639	8/132	0.454047295670924	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;KAT5;NR5A2
Interleukin-15 signaling R-HSA-8983432	0.0217272066880962	10.7774968438288	2/9	0.454047295670924	JAK3;STAT5B
Interleukin-9 signaling R-HSA-8985947	0.0217272066880962	10.7774968438288	2/9	0.454047295670924	JAK3;STAT5B
Signaling by ALK R-HSA-201556	0.0211749592642451	5.70045288645739	3/23	0.454047295670924	SRC;EP300;JAK3
TGF-beta receptor signaling activates SMADs R-HSA-2173789	0.0214580725266616	4.13171819373691	4/41	0.454047295670924	FURIN;SMAD3;SMAD2;PMEPA1
Signaling by Nuclear Receptors R-HSA-9006931	0.0225355056672957	2.14101979287882	11/213	0.467259625320334	SRC;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;SPHK1;KAT5;NR5A2
DSCAM interactions R-HSA-376172	0.0262116716122652	Inf	1/1	0.475497485865113	NTN1
Defective pyroptosis R-HSA-9710421	0.0237378007065036	3.30995176013714	5/63	0.475497485865113	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Diseases of programmed cell death R-HSA-9645723	0.0243086241499049	2.89222892330217	6/86	0.475497485865113	H2BC21;H2BC12;H4C9;H2AX;H2BC14;APP
Disorders of Developmental Biology R-HSA-9675151	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	NCOR1;MECP2
Disorders of Nervous System Development R-HSA-9697154	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	NCOR1;MECP2
Dissolution of Fibrin Clot R-HSA-75205	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	SERPINE2;PLAT
Formation of definitive endoderm R-HSA-9823730	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	SMAD3;SMAD2
Interleukin-21 signaling R-HSA-9020958	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	JAK3;STAT5B
Loss of MECP2 binding ability to 5hmC-DNA R-HSA-9022534	0.0262116716122652	Inf	1/1	0.475497485865113	MECP2
Loss of function of MECP2 in Rett syndrome R-HSA-9005891	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	NCOR1;MECP2
MECP2 regulates transcription of genes involved in GABA signaling R-HSA-9022927	0.0262116716122652	Inf	1/1	0.475497485865113	MECP2
Maternal to zygotic transition (MZT) R-HSA-9816359	0.026874386917772	2.82027116322085	6/88	0.475497485865113	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300
Metalloprotease DUBs R-HSA-5689901	0.0237481357901464	5.42714605505112	3/24	0.475497485865113	EP300;BABAM1;UIMC1
PRC2 methylates histones and DNA R-HSA-212300	0.0267778149706834	3.19803642083339	5/65	0.475497485865113	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Pervasive developmental disorders R-HSA-9005895	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	NCOR1;MECP2
Platelet Adhesion to exposed collagen R-HSA-75892	0.0266997486304806	9.43113156595656	2/10	0.475497485865113	VWF;GP1BA
Pyrimidine biosynthesis R-HSA-500753	0.0262116716122652	Inf	1/1	0.475497485865113	CAD
RNA Polymerase I Promoter Clearance R-HSA-73854	0.0243086241499049	2.89222892330217	6/86	0.475497485865113	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBTF
RNA Polymerase I Transcription R-HSA-73864	0.0255699600351423	2.85580608532401	6/87	0.475497485865113	H2BC21;H2BC12;H4C9;H2AX;H2BC14;UBTF
Regulation of gene expression in early pancreatic precursor cells R-HSA-210747	0.0262116716122652	Inf	1/1	0.475497485865113	NR5A2
Synthesis and processing of ENV and VPU R-HSA-171286	0.0262116716122652	Inf	1/1	0.475497485865113	FURIN
Transcriptional regulation by RUNX1 R-HSA-8878171	0.0268219071363046	2.16157963092047	10/191	0.475497485865113	SRC;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;HIPK2;ARID1A;GP1BA
Gene Silencing by RNA R-HSA-211000	0.028222434005706	2.78559203878021	6/89	0.496041985769164	H2BC21;H2BC12;H4C9;H2AX;H2BC14;DGCR8
Downregulation of TGF-beta receptor signaling R-HSA-2173788	0.0293801408703392	4.95418126570332	3/26	0.509639829214903	SMAD3;SMAD2;PMEPA1
RHOU GTPase cycle R-HSA-9013420	0.0293801408703392	4.95418126570332	3/26	0.509639829214903	SRC;ARHGEF7;CDC42
Common Pathway of Fibrin Clot Formation R-HSA-140875	0.0320823547654364	8.38292184754334	2/11	0.538902338908027	SERPINC1;SERPINE2
Ephrin signaling R-HSA-3928664	0.0320823547654364	8.38292184754334	2/11	0.538902338908027	SRC;ARHGEF7
FOXO-mediated transcription of cell cycle genes R-HSA-9617828	0.0320823547654364	8.38292184754334	2/11	0.538902338908027	SMAD3;SMAD2
Formation of axial mesoderm R-HSA-9796292	0.0320823547654364	8.38292184754334	2/11	0.538902338908027	SMAD3;SMAD2
tRNA Aminoacylation R-HSA-379724	0.0320823547654364	8.38292184754334	2/11	0.538902338908027	CARS2;AARS2
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression R-HSA-427389	0.0335789226577112	2.99520020744158	5/69	0.560493463733117	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Mitotic Prophase R-HSA-68875	0.0340606300342205	2.65484402532036	6/93	0.564980700692633	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known R-HSA-8939243	0.0356556493821513	4.55501500356168	3/28	0.584136379384133	EP300;HIPK2;ARID1A
Sensory processing of sound by inner hair cells of the cochlea R-HSA-9662360	0.0356556493821513	4.55501500356168	3/28	0.584136379384133	SYP;PCLO;BSN
Signaling by Activin R-HSA-1502540	0.0378505386123657	7.545005859355	2/12	0.612532496812308	SMAD3;SMAD2
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 R-HSA-1362300	0.0378505386123657	7.545005859355	2/12	0.612532496812308	E2F5;MYBL2
Downstream signal transduction R-HSA-186763	0.0390320193002007	4.37887416458324	3/29	0.624042043510438	SRC;STAT6;STAT5B
Regulation of TP53 Activity R-HSA-5633007	0.0389198626820789	2.56440719257258	6/96	0.624042043510438	AURKB;EP300;HIPK2;KAT5;NBN;NOC2L
HATs acetylate histones R-HSA-3214847	0.0423938886363799	2.50719628402309	6/98	0.67373281701169	H2BC21;H2BC12;H4C9;H2BC14;EP300;KAT5
Impaired BRCA2 binding to RAD51 R-HSA-9709570	0.0439807946055308	6.85679950384913	2/13	0.678633888855109	KAT5;NBN
Long-term potentiation R-HSA-9620244	0.0439807946055308	6.85679950384913	2/13	0.678633888855109	SRC;LRRC7
NPAS4 regulates expression of target genes R-HSA-9768919	0.0439807946055308	6.85679950384913	2/13	0.678633888855109	ARNT;NAMPT
Regulation of FZD by ubiquitination R-HSA-4641263	0.0439807946055308	6.85679950384913	2/13	0.678633888855109	FZD5;WNT3A
Transcriptional regulation of pluripotent stem cells R-HSA-452723	0.0439807946055308	6.85679950384913	2/13	0.678633888855109	NANOG;SMAD2
Defective F8 binding to von Willebrand factor R-HSA-9672393	0.0517426047829552	37.3139388274533	1/2	0.742296611318719	VWF
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function R-HSA-9704331	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	KAT5;NBN
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function R-HSA-9704646	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	KAT5;NBN
Defective homologous recombination repair (HRR) due to BRCA1 loss of function R-HSA-9701192	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	KAT5;NBN
Defective homologous recombination repair (HRR) due to PALB2 loss of function R-HSA-9701193	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	KAT5;NBN
Expression and Processing of Neurotrophins R-HSA-9036866	0.0517426047829552	37.3139388274533	1/2	0.742296611318719	FURIN
Fatty acyl-CoA biosynthesis R-HSA-75105	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	ACSBG1;ELOVL7
Impaired BRCA2 binding to PALB2 R-HSA-9709603	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	KAT5;NBN
Integrin signaling R-HSA-354192	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	SRC;VWF
NGF processing R-HSA-167060	0.0517426047829552	37.3139388274533	1/2	0.742296611318719	FURIN
Regulation of gap junction activity R-HSA-191650	0.0517426047829552	37.3139388274533	1/2	0.742296611318719	SRC
Role of second messengers in netrin-1 signaling R-HSA-418890	0.0517426047829552	37.3139388274533	1/2	0.742296611318719	NTN1
Sphingolipid de novo biosynthesis R-HSA-1660661	0.0504505642802822	6.28448807757008	2/14	0.742296611318719	SPHK1;CERS5
HDACs deacetylate histones R-HSA-3214815	0.0549623652389988	2.58401106115414	5/79	0.78005410344547	H2BC21;H2BC12;H4C9;H2BC14;NCOR1
Transcriptional regulation by small RNAs R-HSA-5578749	0.0549623652389988	2.58401106115414	5/79	0.78005410344547	H2BC21;H2BC12;H4C9;H2AX;H2BC14
HDR through Single Strand Annealing (SSA) R-HSA-5685938	0.0572382035321057	5.80014250477926	2/15	0.799527327232676	KAT5;NBN
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554	0.0572382035321057	5.80014250477926	2/15	0.799527327232676	KAT5;NBN
Signaling by FLT3 fusion proteins R-HSA-9703465	0.0572382035321057	5.80014250477926	2/15	0.799527327232676	STAT5B;MYO18A
Defective homologous recombination repair (HRR) due to BRCA2 loss of function R-HSA-9701190	0.0643229509162688	5.38465583232953	2/16	0.87996449346277	KAT5;NBN
Diseases of DNA Double-Strand Break Repair R-HSA-9675136	0.0643229509162688	5.38465583232953	2/16	0.87996449346277	KAT5;NBN
Presynaptic phase of homologous DNA pairing and strand exchange R-HSA-5693616	0.0643229509162688	5.38465583232953	2/16	0.87996449346277	KAT5;NBN
SARS-CoV-1 targets host intracellular signalling and regulatory pathways R-HSA-9735871	0.0643229509162688	5.38465583232953	2/16	0.87996449346277	EP300;SMAD3
Signaling by NOTCH R-HSA-157118	0.0715663746888622	1.85045341081972	9/197	0.960867255168066	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;FURIN;SMAD3
Signaling by cytosolic FGFR1 fusion mutants R-HSA-1839117	0.0716848969567736	5.02462297746666	2/17	0.960867255168066	STAT5B;MYO18A
Transcriptional Regulation by NPAS4 R-HSA-9634815	0.0716848969567736	5.02462297746666	2/17	0.960867255168066	ARNT;NAMPT
VEGFR2 mediated cell proliferation R-HSA-5218921	0.0716848969567736	5.02462297746666	2/17	0.960867255168066	SRC;SPHK1
Caspase activation via Dependence Receptors in the absence of ligand R-HSA-418889	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	UNC5B
Defective F8 cleavage by thrombin R-HSA-9672391	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	VWF
Defective VWF binding to collagen type I  R-HSA-9845622	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	VWF
Defective factor VIII causes hemophilia A R-HSA-9662001	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	VWF
Loss of MECP2 binding ability to 5mC-DNA R-HSA-9022538	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	MECP2
Loss of phosphorylation of MECP2 at T308 R-HSA-9022535	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	MECP2
NR1D1 (REV-ERBA) represses gene expression R-HSA-1368071	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	NCOR1
Removal of aminoterminal propeptides from gamma-carboxylated proteins R-HSA-159782	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	FURIN
STAT6-mediated induction of chemokines R-HSA-3249367	0.0766103148010172	18.6883578728366	1/3	0.977518151355287	STAT6
Signaling by EGFR R-HSA-177929	0.0762242774444472	3.2462787373131	3/38	0.977518151355287	SRC;ARHGEF7;CDC42
Diseases of DNA repair R-HSA-9675135	0.0793049544342275	4.71012262212217	2/18	0.992808250322829	KAT5;NBN
Homologous DNA Pairing and Strand Exchange R-HSA-5693579	0.0793049544342275	4.71012262212217	2/18	0.992808250322829	KAT5;NBN
Resolution of D-Loop Structures R-HSA-5693537	0.0793049544342275	4.71012262212217	2/18	0.992808250322829	KAT5;NBN
Resolution of D-loop Structures through Holliday Junction Intermediates R-HSA-5693568	0.0793049544342275	4.71012262212217	2/18	0.992808250322829	KAT5;NBN
2-LTR circle formation R-HSA-164843	1	0	0/5	1	
5-Phosphoribose 1-diphosphate biosynthesis R-HSA-73843	1	0	0/0	1	
A tetrasaccharide linker sequence is required for GAG synthesis R-HSA-1971475	1	0	0/10	1	
ABC transporter disorders R-HSA-5619084	1	0	0/63	1	
ABC transporters in lipid homeostasis R-HSA-1369062	1	0	0/10	1	
ABC-family proteins mediated transport R-HSA-382556	1	0	0/77	1	
ABO blood group biosynthesis R-HSA-9033807	1	0	0/2	1	
ADORA2B mediated anti-inflammatory cytokines production R-HSA-9660821	1	0	0/21	1	
ADP signalling through P2Y purinoceptor 1 R-HSA-418592	0.310966623183603	2.87416395939725	1/14	1	SRC
ADP signalling through P2Y purinoceptor 12 R-HSA-392170	1	0	0/11	1	
AKT phosphorylates targets in the cytosol R-HSA-198323	1	0	0/12	1	
AKT phosphorylates targets in the nucleus R-HSA-198693	1	0	0/10	1	
AKT-mediated inactivation of FOXO1A R-HSA-211163	1	0	0/4	1	
ALK mutants bind TKIs R-HSA-9700645	1	0	0/3	1	
ALKBH2 mediated reversal of alkylation damage R-HSA-112122	1	0	0/0	1	
ALKBH3 mediated reversal of alkylation damage R-HSA-112126	1	0	0/0	1	
AMPK inhibits chREBP transcriptional activation activity R-HSA-163680	1	0	0/6	1	
APC truncation mutants are not K63 polyubiquitinated R-HSA-5467333	1	0	0/1	1	
APC truncation mutants have impaired AXIN binding R-HSA-5467337	1	0	0/10	1	
APC-Cdc20 mediated degradation of Nek2A R-HSA-179409	1	0	0/22	1	
APC/C-mediated degradation of cell cycle proteins R-HSA-174143	0.88307499368284	0.465283065109332	1/80	1	AURKB
APC/C:Cdc20 mediated degradation of Cyclin B R-HSA-174048	1	0	0/23	1	
APC/C:Cdc20 mediated degradation of Securin R-HSA-174154	1	0	0/66	1	
APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176409	1	0	0/71	1	
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 R-HSA-174178	0.850818501612084	0.526317369514638	1/71	1	AURKB
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint R-HSA-179419	1	0	0/69	1	
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway R-HSA-5649702	1	0	0/2	1	
APOBEC3G mediated resistance to HIV-1 infection R-HSA-180689	1	0	0/5	1	
ARL13B-mediated ciliary trafficking of INPP5E R-HSA-5624958	1	0	0/0	1	
ARMS-mediated activation R-HSA-170984	1	0	0/4	1	
ASP-3026-resistant ALK mutants R-HSA-9717264	1	0	0/0	1	
ATF4 activates genes in response to endoplasmic reticulum  stress R-HSA-380994	1	0	0/24	1	
ATF6 (ATF6-alpha) activates chaperone genes R-HSA-381183	1	0	0/9	1	
ATF6 (ATF6-alpha) activates chaperones R-HSA-381033	1	0	0/11	1	
ATF6B (ATF6-beta) activates chaperones R-HSA-8874177	1	0	0/4	1	
ATP sensitive Potassium channels R-HSA-1296025	1	0	0/1	1	
AUF1 (hnRNP D0) binds and destabilizes mRNA R-HSA-450408	1	0	0/53	1	
AURKA Activation by TPX2 R-HSA-8854518	1	0	0/37	1	
AXIN missense mutants destabilize the destruction complex R-HSA-5467340	1	0	0/10	1	
Abacavir ADME R-HSA-2161522	1	0	0/3	1	
Abacavir metabolism R-HSA-2161541	1	0	0/1	1	
Abacavir transmembrane transport R-HSA-2161517	1	0	0/2	1	
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway R-HSA-73930	1	0	0/1	1	
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects R-HSA-9659787	1	0	0/17	1	
Aberrant regulation of mitotic cell cycle due to RB1 defects R-HSA-9687139	1	0	0/35	1	
Aberrant regulation of mitotic exit in cancer due to RB1 defects R-HSA-9687136	1	0	0/19	1	
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate R-HSA-2978092	1	0	0/0	1	
Abortive elongation of HIV-1 transcript in the absence of Tat R-HSA-167242	1	0	0/19	1	
Acetylation R-HSA-156582	1	0	0/2	1	
Acetylcholine Neurotransmitter Release Cycle R-HSA-264642	0.124423905593351	9.35086557215028	1/5	1	TSPOAP1
Acetylcholine binding and downstream events R-HSA-181431	1	0	0/5	1	
Acetylcholine inhibits contraction of outer hair cells R-HSA-9667769	1	0	0/1	1	
Acetylcholine regulates insulin secretion R-HSA-399997	1	0	0/4	1	
Acrosome Reaction and Sperm:Oocyte Membrane Binding R-HSA-1300645	1	0	0/1	1	
Activated NOTCH1 Transmits Signal to the Nucleus R-HSA-2122948	1	0	0/15	1	
Activated NTRK2 signals through CDK5 R-HSA-9032845	1	0	0/5	1	
Activated NTRK2 signals through FRS2 and FRS3 R-HSA-9028731	1	0	0/7	1	
Activated NTRK2 signals through FYN R-HSA-9032500	0.100831870512745	12.4605401761496	1/4	1	SRC
Activated NTRK2 signals through PI3K R-HSA-9028335	1	0	0/5	1	
Activated NTRK2 signals through PLCG1 R-HSA-9026527	1	0	0/2	1	
Activated NTRK2 signals through RAS R-HSA-9026519	1	0	0/6	1	
Activated NTRK3 signals through PI3K R-HSA-9603381	0.100831870512745	12.4605401761496	1/4	1	SRC
Activated NTRK3 signals through PLCG1 R-HSA-9034793	1	0	0/1	1	
Activated NTRK3 signals through RAS R-HSA-9034864	1	0	0/5	1	
Activated point mutants of FGFR2 R-HSA-2033519	1	0	0/4	1	
Activation and oligomerization of BAK protein R-HSA-111452	1	0	0/1	1	
Activation of AKT2 R-HSA-165158	1	0	0/3	1	
Activation of AMPA receptors R-HSA-399710	1	0	0/0	1	
Activation of AMPK downstream of NMDARs R-HSA-9619483	1	0	0/26	1	
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins R-HSA-176814	1	0	0/72	1	
Activation of ATR in response to replication stress R-HSA-176187	1	0	0/12	1	
Activation of BAD and translocation to mitochondria  R-HSA-111447	1	0	0/14	1	
Activation of BH3-only proteins R-HSA-114452	1	0	0/25	1	
Activation of BIM and translocation to mitochondria  R-HSA-111446	1	0	0/3	1	
Activation of BMF and translocation to mitochondria R-HSA-139910	1	0	0/1	1	
Activation of C3 and C5 R-HSA-174577	1	0	0/5	1	
Activation of Ca-permeable Kainate Receptor R-HSA-451308	1	0	0/4	1	
Activation of G protein gated Potassium channels R-HSA-1296041	1	0	0/11	1	
Activation of GABAB receptors R-HSA-991365	1	0	0/18	1	
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) R-HSA-936964	1	0	0/14	1	
Activation of Matrix Metalloproteinases R-HSA-1592389	0.273252368749906	3.39809007232892	1/12	1	FURIN
Activation of NF-kappaB in B cells R-HSA-1169091	1	0	0/66	1	
Activation of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767	1	0	0/4	1	
Activation of NMDA receptors and postsynaptic events R-HSA-442755	0.200433288099708	2.01858163621791	3/59	1	SRC;LRRC7;ARHGEF7
Activation of NOXA and translocation to mitochondria R-HSA-111448	1	0	0/5	1	
Activation of Na-permeable kainate receptors R-HSA-451307	1	0	0/0	1	
Activation of PPARGC1A (PGC-1alpha) by phosphorylation R-HSA-2151209	1	0	0/7	1	
Activation of PUMA and translocation to mitochondria R-HSA-139915	1	0	0/7	1	
Activation of RAC1 R-HSA-428540	1	0	0/10	1	
Activation of RAC1 downstream of NMDARs R-HSA-9619229	0.124423905593351	9.35086557215028	1/5	1	ARHGEF7
Activation of RAS in B cells R-HSA-1169092	1	0	0/5	1	
Activation of SMO R-HSA-5635838	1	0	0/7	1	
Activation of TRKA receptors R-HSA-187015	1	0	0/3	1	
Activation of caspases through apoptosome-mediated cleavage R-HSA-111459	1	0	0/2	1	
Activation of gene expression by SREBF (SREBP) R-HSA-2426168	1	0	0/24	1	
Activation of kainate receptors upon glutamate binding R-HSA-451326	1	0	0/12	1	
Activation of the AP-1 family of transcription factors R-HSA-450341	1	0	0/10	1	
Activation of the TFAP2 (AP-2) family of transcription factors R-HSA-8866907	0.14740262953668	7.48288775581792	1/6	1	EP300
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S R-HSA-72662	1	0	0/49	1	
Activation of the phototransduction cascade R-HSA-2485179	1	0	0/6	1	
Activation of the pre-replicative complex R-HSA-68962	1	0	0/14	1	
Activation, myristolyation of BID and translocation to mitochondria R-HSA-75108	1	0	0/3	1	
Activation, translocation and oligomerization of BAX R-HSA-114294	1	0	0/2	1	
Acyl chain remodeling of CL R-HSA-1482798	1	0	0/4	1	
Acyl chain remodeling of DAG and TAG R-HSA-1482883	1	0	0/3	1	
Acyl chain remodelling of PC R-HSA-1482788	1	0	0/10	1	
Acyl chain remodelling of PE R-HSA-1482839	1	0	0/9	1	
Acyl chain remodelling of PG R-HSA-1482925	1	0	0/6	1	
Acyl chain remodelling of PI R-HSA-1482922	1	0	0/7	1	
Acyl chain remodelling of PS R-HSA-1482801	1	0	0/6	1	
Adaptive Immune System R-HSA-1280218	0.998631827533139	0.265026661729745	3/393	1	SRC;CDC42;UBE2V2
Adenosine P1 receptors R-HSA-417973	1	0	0/2	1	
Adenylate cyclase activating pathway R-HSA-170660	1	0	0/5	1	
Adenylate cyclase inhibitory pathway R-HSA-170670	1	0	0/7	1	
Adherens junctions interactions R-HSA-418990	0.45806040328366	1.69494567015225	1/23	1	ZEB2
Adipogenesis R-HSA-9843745	0.536971666230817	1.12816865999562	2/68	1	EP300;NCOR1
Adrenaline signalling through Alpha-2 adrenergic receptor R-HSA-392023	1	0	0/2	1	
Adrenaline,noradrenaline inhibits insulin secretion R-HSA-400042	1	0	0/13	1	
Adrenoceptors R-HSA-390696	1	0	0/3	1	
Advanced glycosylation endproduct receptor signaling R-HSA-879415	0.253635549571777	3.73892787264533	1/11	1	APP
Aerobic respiration and respiratory electron transport R-HSA-1428517	1	0	0/109	1	
Aflatoxin activation and detoxification R-HSA-5423646	1	0	0/6	1	
Aggrephagy R-HSA-9646399	1	0	0/33	1	
Agmatine biosynthesis R-HSA-351143	1	0	0/0	1	
Alanine metabolism R-HSA-8964540	1	0	0/0	1	
Alpha-defensins R-HSA-1462054	1	0	0/3	1	
Alpha-oxidation of phytanate R-HSA-389599	1	0	0/3	1	
Alpha-protein kinase 1 signaling pathway R-HSA-9645460	1	0	0/9	1	
Alternative Lengthening of Telomeres (ALT) R-HSA-9006821	1	0	0/1	1	
Alternative complement activation R-HSA-173736	1	0	0/2	1	
Amine Oxidase reactions R-HSA-140179	1	0	0/1	1	
Amine ligand-binding receptors R-HSA-375280	1	0	0/3	1	
Amino Acid conjugation R-HSA-156587	1	0	0/4	1	
Amino acid transport across the plasma membrane R-HSA-352230	1	0	0/10	1	
Amino acids regulate mTORC1 R-HSA-9639288	1	0	0/40	1	
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal R-HSA-141444	0.585240815357872	1.16245213012818	1/33	1	AURKB
Amplification of signal from the kinetochores R-HSA-141424	0.585240815357872	1.16245213012818	1/33	1	AURKB
Anchoring fibril formation R-HSA-2214320	1	0	0/13	1	
Anchoring of the basal body to the plasma membrane R-HSA-5620912	1	0	0/45	1	
Androgen biosynthesis R-HSA-193048	1	0	0/2	1	
Antagonism of Activin by Follistatin R-HSA-2473224	1	0	0/2	1	
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851	0.301913091607522	1.87369153768745	2/42	1	SRC;FURIN
Antigen Presentation: Folding, assembly and peptide loading of class I MHC R-HSA-983170	1	0	0/20	1	
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers R-HSA-983695	1	0	0/16	1	
Antigen processing-Cross presentation R-HSA-1236975	1	0	0/86	1	
Antigen processing: Ubiquitination & Proteasome degradation R-HSA-983168	0.983685422457637	0.238899327083104	1/152	1	UBE2V2
Antimicrobial peptides R-HSA-6803157	1	0	0/16	1	
Antiviral mechanism by IFN-stimulated genes R-HSA-1169410	0.946873887190385	0.337799811209297	1/109	1	SPHK1
Apoptosis R-HSA-109581	0.861946459600737	0.572468644884618	2/130	1	GSN;UNC5B
Apoptosis induced DNA fragmentation R-HSA-140342	1	0	0/10	1	
Apoptotic cleavage of cell adhesion  proteins R-HSA-351906	1	0	0/4	1	
Apoptotic cleavage of cellular proteins R-HSA-111465	0.412861892904292	1.96395982365259	1/20	1	GSN
Apoptotic execution phase R-HSA-75153	0.5624270710316	1.24055959211337	1/31	1	GSN
Apoptotic factor-mediated response R-HSA-111471	1	0	0/9	1	
Aquaporin-mediated transport R-HSA-445717	1	0	0/21	1	
Arachidonate production from DAG R-HSA-426048	1	0	0/4	1	
Arachidonic acid metabolism R-HSA-2142753	1	0	0/21	1	
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 R-HSA-211957	1	0	0/0	1	
Aryl hydrocarbon receptor signalling R-HSA-8937144	0.14740262953668	7.48288775581792	1/6	1	ARNT
Asparagine N-linked glycosylation R-HSA-446203	1	0	0/144	1	
Aspirin ADME R-HSA-9749641	1	0	0/12	1	
Assembly Of The HIV Virion R-HSA-175474	0.212814889902584	4.67518817282894	1/9	1	FURIN
Assembly and cell surface presentation of NMDA receptors R-HSA-9609736	0.5624270710316	1.24055959211337	1/31	1	LRRC7
Assembly and release of respiratory syncytial virus (RSV) virions R-HSA-9820962	1	0	0/2	1	
Assembly of Viral Components at the Budding Site R-HSA-168316	1	0	0/2	1	
Assembly of active LPL and LIPC lipase complexes R-HSA-8963889	0.212814889902584	4.67518817282894	1/9	1	FURIN
Assembly of collagen fibrils and other multimeric structures R-HSA-2022090	1	0	0/38	1	
Assembly of the pre-replicative complex R-HSA-68867	0.238941718320708	1.54822555933816	5/127	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Association of TriC/CCT with target proteins during biosynthesis R-HSA-390471	0.443390945354158	1.77608203944115	1/22	1	SPHK1
Astrocytic Glutamate-Glutamine Uptake And Metabolism R-HSA-210455	1	0	0/2	1	
Asymmetric localization of PCP proteins R-HSA-4608870	0.788105332588753	0.648508953828324	1/58	1	FZD5
Atorvastatin ADME R-HSA-9754706	1	0	0/3	1	
Attachment and Entry R-HSA-9678110	1	0	0/1	1	
Attachment and Entry R-HSA-9694614	0.169783838370041	6.23416731470989	1/7	1	FURIN
Attachment of GPI anchor to uPAR R-HSA-162791	1	0	0/2	1	
Attenuation phase R-HSA-3371568	0.396981147981571	2.07367136211455	1/19	1	EP300
Autodegradation of Cdh1 by Cdh1:APC/C R-HSA-174084	1	0	0/63	1	
Autodegradation of the E3 ubiquitin ligase COP1 R-HSA-349425	1	0	0/51	1	
Autointegration results in viral DNA circles R-HSA-177539	1	0	0/3	1	
Autophagy R-HSA-9612973	0.915578849032772	0.402677677381543	1/92	1	SRC
Axon guidance R-HSA-422475	0.897363882708284	0.641186975025035	6/343	1	SRC;ARHGEF7;CDC42;UNC5B;ABLIM2;NTN1
Axonal growth inhibition (RHOA activation) R-HSA-193634	1	0	0/2	1	
Axonal growth stimulation R-HSA-209563	1	0	0/2	1	
Azathioprine ADME R-HSA-9748787	1	0	0/11	1	
BBSome-mediated cargo-targeting to cilium R-HSA-5620922	1	0	0/11	1	
BDNF activates NTRK2 (TRKB) signaling R-HSA-9024909	1	0	0/1	1	
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members R-HSA-111453	1	0	0/8	1	
BMAL1:CLOCK,NPAS2 activates circadian gene expression R-HSA-1368108	0.412861892904292	1.96395982365259	1/20	1	NAMPT
Bacterial Infection Pathways R-HSA-9824439	0.292124680104163	1.92217388700943	2/41	1	SRC;FURIN
Basigin interactions R-HSA-210991	1	0	0/11	1	
Beta defensins R-HSA-1461957	1	0	0/6	1	
Beta oxidation of butanoyl-CoA to acetyl-CoA R-HSA-77352	1	0	0/5	1	
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA R-HSA-77346	1	0	0/2	1	
Beta oxidation of hexanoyl-CoA to butanoyl-CoA R-HSA-77350	1	0	0/3	1	
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA R-HSA-77310	1	0	0/3	1	
Beta oxidation of myristoyl-CoA to lauroyl-CoA R-HSA-77285	1	0	0/1	1	
Beta oxidation of octanoyl-CoA to hexanoyl-CoA R-HSA-77348	1	0	0/2	1	
Beta oxidation of palmitoyl-CoA to myristoyl-CoA R-HSA-77305	1	0	0/0	1	
Beta-catenin independent WNT signaling R-HSA-3858494	0.940746365851796	0.351157191447245	1/105	1	FZD5
Beta-catenin phosphorylation cascade R-HSA-196299	1	0	0/11	1	
Beta-oxidation of pristanoyl-CoA R-HSA-389887	1	0	0/3	1	
Beta-oxidation of very long chain fatty acids R-HSA-390247	1	0	0/4	1	
Bicarbonate transporters R-HSA-425381	1	0	0/3	1	
Bile acid and bile salt metabolism R-HSA-194068	1	0	0/13	1	
Binding and Uptake of Ligands by Scavenger Receptors R-HSA-2173782	1	0	0/20	1	
Binding and entry of HIV virion R-HSA-173107	1	0	0/4	1	
Binding of TCF/LEF:CTNNB1 to target gene promoters R-HSA-4411364	1	0	0/8	1	
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB R-HSA-141333	1	0	0/1	1	
Biological oxidations R-HSA-211859	0.306535294590124	1.58611084726374	3/74	1	ARNT;CNDP2;ACSS1
Biosynthesis of A2E, implicated in retinal degradation R-HSA-2466712	1	0	0/0	1	
Biosynthesis of D-series resolvins R-HSA-9018676	1	0	0/2	1	
Biosynthesis of DHA-derived SPMs R-HSA-9018677	1	0	0/5	1	
Biosynthesis of DHA-derived sulfido conjugates R-HSA-9026395	1	0	0/0	1	
Biosynthesis of DPA-derived SPMs R-HSA-9018683	1	0	0/3	1	
Biosynthesis of DPAn-3 SPMs R-HSA-9025094	1	0	0/3	1	
Biosynthesis of DPAn-3-derived 13-series resolvins R-HSA-9026403	1	0	0/1	1	
Biosynthesis of DPAn-3-derived maresins R-HSA-9026290	1	0	0/1	1	
Biosynthesis of DPAn-3-derived protectins and resolvins R-HSA-9026286	1	0	0/2	1	
Biosynthesis of DPAn-6 SPMs R-HSA-9025106	1	0	0/1	1	
Biosynthesis of E-series 18(R)-resolvins R-HSA-9023661	1	0	0/3	1	
Biosynthesis of E-series 18(S)-resolvins R-HSA-9018896	1	0	0/3	1	
Biosynthesis of EPA-derived SPMs R-HSA-9018679	1	0	0/4	1	
Biosynthesis of aspirin-triggered D-series resolvins R-HSA-9020265	1	0	0/2	1	
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives R-HSA-9027604	1	0	0/2	1	
Biosynthesis of maresin conjugates in tissue regeneration (MCTR) R-HSA-9026762	1	0	0/0	1	
Biosynthesis of maresin-like SPMs R-HSA-9027307	1	0	0/0	1	
Biosynthesis of maresins R-HSA-9018682	1	0	0/2	1	
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR) R-HSA-9026766	1	0	0/0	1	
Biosynthesis of protectins R-HSA-9018681	1	0	0/1	1	
Biosynthesis of specialized proresolving mediators (SPMs) R-HSA-9018678	1	0	0/6	1	
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein R-HSA-446193	1	0	0/21	1	
Biotin transport and metabolism R-HSA-196780	1	0	0/6	1	
Blockage of phagosome acidification R-HSA-9636467	1	0	0/0	1	
Blood group systems biosynthesis R-HSA-9033658	1	0	0/4	1	
Branched-chain amino acid catabolism R-HSA-70895	1	0	0/10	1	
Breakdown of the nuclear lamina R-HSA-352238	1	0	0/1	1	
Budding and maturation of HIV virion R-HSA-162588	1	0	0/16	1	
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA R-HSA-450385	1	0	0/15	1	
Butyrophilin (BTN) family interactions R-HSA-8851680	1	0	0/4	1	
C-type lectin receptors (CLRs) R-HSA-5621481	0.822480484004616	0.633672267880575	2/118	1	SRC;EP300
C6 deamination of adenosine R-HSA-75102	1	0	0/0	1	
CASP8 activity is inhibited R-HSA-5218900	1	0	0/10	1	
CD163 mediating an anti-inflammatory response R-HSA-9662834	0.14740262953668	7.48288775581792	1/6	1	FURIN
CD209 (DC-SIGN) signaling R-HSA-5621575	0.42832825457232	1.86538195580771	1/21	1	EP300
CD22 mediated BCR regulation R-HSA-5690714	1	0	0/4	1	
CD28 co-stimulation R-HSA-389356	0.147516353391238	3.13461810019507	2/26	1	SRC;CDC42
CD28 dependent PI3K/Akt signaling R-HSA-389357	1	0	0/17	1	
CD28 dependent Vav1 pathway R-HSA-389359	0.212814889902584	4.67518817282894	1/9	1	CDC42
CDC42 GTPase cycle R-HSA-9013148	0.277645037072602	1.68251620176231	3/70	1	ARHGEF7;CDC42;SPATA13
CDC6 association with the ORC:origin complex R-HSA-68689	1	0	0/3	1	
CDH11 homotypic and heterotypic interactions R-HSA-9833576	1	0	0/5	1	
CDK-mediated phosphorylation and removal of Cdc6 R-HSA-69017	1	0	0/72	1	
CHL1 interactions R-HSA-447041	1	0	0/5	1	
CLEC7A (Dectin-1) induces NFAT activation R-HSA-5607763	1	0	0/9	1	
CLEC7A (Dectin-1) signaling R-HSA-5607764	0.913252713861853	0.407257211849684	1/91	1	SRC
CLEC7A/inflammasome pathway R-HSA-5660668	1	0	0/6	1	
COPI-dependent Golgi-to-ER retrograde traffic R-HSA-6811434	1	0	0/55	1	
COPI-independent Golgi-to-ER retrograde traffic R-HSA-6811436	1	0	0/36	1	
COPI-mediated anterograde transport R-HSA-6807878	1	0	0/69	1	
COPII-mediated vesicle transport R-HSA-204005	1	0	0/32	1	
COX reactions R-HSA-140180	1	0	0/1	1	
CREB phosphorylation R-HSA-199920	1	0	0/7	1	
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling R-HSA-442742	0.42832825457232	1.86538195580771	1/21	1	LRRC7
CREB1 phosphorylation through the activation of Adenylate Cyclase R-HSA-442720	1	0	0/7	1	
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde R-HSA-442729	1	0	0/6	1	
CREB3 factors activate genes R-HSA-8874211	1	0	0/4	1	
CRMPs in Sema3A signaling R-HSA-399956	1	0	0/8	1	
CS/DS degradation R-HSA-2024101	1	0	0/6	1	
CTLA4 inhibitory signaling R-HSA-389513	0.329090081730138	2.668231298019	1/15	1	SRC
CTNNB1 S33 mutants aren't phosphorylated R-HSA-5358747	1	0	0/11	1	
CTNNB1 S37 mutants aren't phosphorylated R-HSA-5358749	1	0	0/11	1	
CTNNB1 S45 mutants aren't phosphorylated R-HSA-5358751	1	0	0/11	1	
CTNNB1 T41 mutants aren't phosphorylated R-HSA-5358752	1	0	0/11	1	
CYP2E1 reactions R-HSA-211999	1	0	0/3	1	
Ca-dependent events R-HSA-111996	1	0	0/23	1	
Ca2+ activated K+ channels R-HSA-1296052	1	0	0/2	1	
Ca2+ pathway R-HSA-4086398	0.585240815357872	1.16245213012818	1/33	1	FZD5
CaM pathway R-HSA-111997	1	0	0/21	1	
CaMK IV-mediated phosphorylation of CREB R-HSA-111932	1	0	0/8	1	
Calcineurin activates NFAT R-HSA-2025928	1	0	0/9	1	
Calcitonin-like ligand receptors R-HSA-419812	1	0	0/5	1	
Calmodulin induced events R-HSA-111933	1	0	0/21	1	
Calnexin/calreticulin cycle R-HSA-901042	1	0	0/14	1	
Cam-PDE 1 activation R-HSA-111957	1	0	0/2	1	
Cap-dependent Translation Initiation R-HSA-72737	1	0	0/97	1	
Carboxyterminal post-translational modifications of tubulin R-HSA-8955332	0.45806040328366	1.69494567015225	1/23	1	TTLL3
Cardiac conduction R-HSA-5576891	0.148307850807127	2.3596654669853	3/51	1	ATP1A1;HIPK2;FXYD2
Cardiogenesis R-HSA-9733709	0.380675025962704	2.19604331875759	1/18	1	KAT5
Cargo concentration in the ER R-HSA-5694530	1	0	0/17	1	
Cargo recognition for clathrin-mediated endocytosis R-HSA-8856825	1	0	0/59	1	
Cargo trafficking to the periciliary membrane R-HSA-5620920	1	0	0/21	1	
Carnitine metabolism R-HSA-200425	1	0	0/8	1	
Carnitine synthesis R-HSA-71262	1	0	0/1	1	
Caspase activation via Death Receptors in the presence of ligand R-HSA-140534	1	0	0/13	1	
Caspase activation via extrinsic apoptotic signalling pathway R-HSA-5357769	0.346741223784396	2.49010112143882	1/16	1	UNC5B
Caspase-mediated cleavage of cytoskeletal proteins R-HSA-264870	0.169783838370041	6.23416731470989	1/7	1	GSN
Catecholamine biosynthesis R-HSA-209905	1	0	0/1	1	
Cation-coupled Chloride cotransporters R-HSA-426117	0.100831870512745	12.4605401761496	1/4	1	SLC12A2
Cdc20:Phospho-APC/C mediated degradation of Cyclin A R-HSA-174184	1	0	0/69	1	
Cell Cycle, Mitotic R-HSA-69278	0.279134041254331	1.26588283562904	11/341	1	SRC;AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;H3-4;E2F5;MYBL2
Cell death signalling via NRAGE, NRIF and NADE R-HSA-204998	0.665296215798888	0.928111617266124	1/41	1	ARHGEF7
Cell junction organization R-HSA-446728	0.70734552573649	0.823950589376898	1/46	1	ZEB2
Cell recruitment (pro-inflammatory response) R-HSA-9664424	0.472346799019033	1.62085821553598	1/24	1	APP
Cell surface interactions at the vascular wall R-HSA-202733	0.829237688052024	0.567530733548644	1/66	1	SRC
Cell-Cell communication R-HSA-1500931	0.552788353017978	1.09442292312148	2/70	1	SRC;ZEB2
Cell-cell junction organization R-HSA-421270	0.538370942160232	1.32982264644569	1/29	1	ZEB2
Cell-extracellular matrix interactions R-HSA-446353	1	0	0/13	1	
Cellular Senescence R-HSA-2559583	0.0821893375095696	1.8663502586459	8/173	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4;KAT5;NBN
Cellular hexose transport R-HSA-189200	1	0	0/5	1	
Cellular response to chemical stress R-HSA-9711123	0.941375385948298	0.434310021188043	2/169	1	EP300;NCOR1
Cellular response to heat stress R-HSA-3371556	0.770269380049468	0.685060564559151	1/55	1	EP300
Cellular response to hypoxia R-HSA-1234174	0.520780901481395	1.16401425612549	2/66	1	EP300;ARNT
Cellular response to mitochondrial stress R-HSA-9840373	1	0	0/7	1	
Cellular response to starvation R-HSA-9711097	1	0	0/132	1	
Cellular responses to stimuli R-HSA-8953897	0.948062223192751	0.633008396992105	11/620	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;ARNT;H3-4;KAT5;NBN
Cellular responses to stress R-HSA-2262752	0.948062223192751	0.633008396992105	11/620	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;ARNT;H3-4;KAT5;NBN
Centrosome maturation R-HSA-380287	1	0	0/41	1	
Ceramide signalling R-HSA-193681	1	0	0/2	1	
ChREBP activates metabolic gene expression R-HSA-163765	1	0	0/3	1	
Chaperone Mediated Autophagy R-HSA-9613829	1	0	0/15	1	
Chaperonin-mediated protein folding R-HSA-390466	0.799226720764437	0.626205951964421	1/60	1	SPHK1
Chemokine receptors bind chemokines R-HSA-380108	1	0	0/31	1	
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex R-HSA-75035	1	0	0/11	1	
Cholesterol biosynthesis R-HSA-191273	1	0	0/6	1	
Cholesterol biosynthesis via desmosterol R-HSA-6807047	1	0	0/0	1	
Cholesterol biosynthesis via lathosterol R-HSA-6807062	1	0	0/0	1	
Choline catabolism R-HSA-6798163	1	0	0/2	1	
Chondroitin sulfate biosynthesis R-HSA-2022870	1	0	0/10	1	
Chondroitin sulfate/dermatan sulfate metabolism R-HSA-1793185	1	0	0/21	1	
Chylomicron assembly R-HSA-8963888	1	0	0/5	1	
Chylomicron clearance R-HSA-8964026	1	0	0/1	1	
Chylomicron remodeling R-HSA-8963901	1	0	0/6	1	
Cilium Assembly R-HSA-5617833	1	0	0/96	1	
Ciprofloxacin ADME R-HSA-9793528	1	0	0/2	1	
Circadian Clock R-HSA-400253	0.154561751034726	2.31095075286511	3/52	1	EP300;NCOR1;NAMPT
Citric acid cycle (TCA cycle) R-HSA-71403	1	0	0/12	1	
Class A/1 (Rhodopsin-like receptors) R-HSA-373076	0.88307499368284	0.465283065109332	1/80	1	APP
Class B/2 (Secretin family receptors) R-HSA-373080	0.262688602605588	2.0838592247051	2/38	1	FZD5;WNT3A
Class C/3 (Metabotropic glutamate/pheromone receptors) R-HSA-420499	1	0	0/1	1	
Class I MHC mediated antigen processing & presentation R-HSA-983169	0.995453530238679	0.180894711580469	1/198	1	UBE2V2
Class I peroxisomal membrane protein import R-HSA-9603798	1	0	0/8	1	
Classical Kir channels R-HSA-1296053	1	0	0/1	1	
Classical antibody-mediated complement activation R-HSA-173623	1	0	0/3	1	
Clathrin-mediated endocytosis R-HSA-8856828	1	0	0/82	1	
Cobalamin (Cbl) metabolism R-HSA-9759218	1	0	0/4	1	
Cobalamin (Cbl, vitamin B12) transport and metabolism R-HSA-196741	1	0	0/7	1	
Coenzyme A biosynthesis R-HSA-196783	1	0	0/1	1	
Cohesin Loading onto Chromatin R-HSA-2470946	1	0	0/10	1	
Collagen biosynthesis and modifying enzymes R-HSA-1650814	1	0	0/31	1	
Collagen chain trimerization R-HSA-8948216	1	0	0/22	1	
Collagen degradation R-HSA-1442490	0.596201791067686	1.1269479513211	1/34	1	FURIN
Collagen formation R-HSA-1474290	1	0	0/45	1	
Competing endogenous RNAs (ceRNAs) regulate PTEN translation R-HSA-8948700	1	0	0/1	1	
Complement cascade R-HSA-166658	1	0	0/25	1	
Complex I biogenesis R-HSA-6799198	1	0	0/41	1	
Condensation of Prometaphase Chromosomes R-HSA-2514853	1	0	0/6	1	
Conjugation of benzoate with glycine R-HSA-177135	1	0	0/2	1	
Conjugation of carboxylic acids R-HSA-159424	1	0	0/4	1	
Conjugation of phenylacetate with glutamine R-HSA-177162	1	0	0/1	1	
Conjugation of salicylate with glycine R-HSA-177128	1	0	0/4	1	
Constitutive Signaling by AKT1 E17K in Cancer R-HSA-5674400	1	0	0/25	1	
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530	0.682789684296271	0.883471871866155	1/43	1	SRC
Constitutive Signaling by EGFRvIII R-HSA-5637810	1	0	0/13	1	
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants R-HSA-1236382	1	0	0/17	1	
Constitutive Signaling by NOTCH1 HD Domain Mutants R-HSA-2691232	1	0	0/9	1	
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants R-HSA-2894862	0.379005316273045	1.55825939331202	2/50	1	EP300;NCOR1
Constitutive Signaling by NOTCH1 PEST Domain Mutants R-HSA-2644606	0.379005316273045	1.55825939331202	2/50	1	EP300;NCOR1
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660826	1	0	0/4	1	
Constitutive Signaling by Overexpressed ERBB2 R-HSA-9634285	1	0	0/7	1	
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase R-HSA-176407	1	0	0/18	1	
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding R-HSA-6814122	1	0	0/23	1	
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding R-HSA-389958	1	0	0/33	1	
Costimulation by the CD28 family R-HSA-388841	0.388421539353286	1.52607203902034	2/51	1	SRC;CDC42
Creatine metabolism R-HSA-71288	1	0	0/1	1	
Creation of C4 and C2 activators R-HSA-166786	1	0	0/7	1	
Cristae formation R-HSA-8949613	1	0	0/25	1	
Cross-presentation of particulate exogenous antigens (phagosomes) R-HSA-1236973	1	0	0/5	1	
Cross-presentation of soluble exogenous antigens (endosomes) R-HSA-1236978	1	0	0/45	1	
Crosslinking of collagen fibrils R-HSA-2243919	1	0	0/14	1	
Cyclin A/B1/B2 associated events during G2/M transition R-HSA-69273	1	0	0/15	1	
Cyclin A:Cdk2-associated events at S phase entry R-HSA-69656	0.862446136502824	0.504298930258438	1/74	1	E2F5
Cyclin D associated events in G1 R-HSA-69231	0.311679669158283	1.8275988096346	2/43	1	SRC;E2F5
Cyclin E associated events during G1/S transition  R-HSA-69202	0.854798677506653	0.518771170585774	1/72	1	E2F5
Cysteine formation from homocysteine R-HSA-1614603	1	0	0/1	1	
Cytochrome P450 - arranged by substrate type R-HSA-211897	0.346741223784396	2.49010112143882	1/16	1	ARNT
Cytochrome c-mediated apoptotic response R-HSA-111461	1	0	0/5	1	
Cytokine Signaling in Immune system R-HSA-1280215	0.856251796905904	0.746223921463865	11/540	1	SRC;CDC42;APP;SPHK1;NANOG;SMAD3;STAT6;IL4R;JUNB;JAK3;STAT5B
Cytoprotection by HMOX1 R-HSA-9707564	0.737180506582421	0.755924037913128	1/50	1	NCOR1
Cytosolic iron-sulfur cluster assembly R-HSA-2564830	1	0	0/2	1	
Cytosolic sensors of pathogen-associated DNA  R-HSA-1834949	0.311679669158283	1.8275988096346	2/43	1	EP300;STAT6
Cytosolic sulfonation of small molecules R-HSA-156584	1	0	0/11	1	
Cytosolic tRNA aminoacylation R-HSA-379716	1	0	0/7	1	
DAG and IP3 signaling R-HSA-1489509	1	0	0/25	1	
DAP12 interactions R-HSA-2172127	1	0	0/23	1	
DAP12 signaling R-HSA-2424491	1	0	0/21	1	
DARPP-32 events R-HSA-180024	1	0	0/14	1	
DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168928	0.536971666230817	1.12816865999562	2/68	1	EP300;APP
DEx/H-box helicases activate type I IFN and inflammatory cytokines production  R-HSA-3134963	1	0	0/7	1	
DNA Damage Bypass R-HSA-73893	1	0	0/25	1	
DNA Damage Recognition in GG-NER R-HSA-5696394	1	0	0/18	1	
DNA Damage Reversal R-HSA-73942	1	0	0/0	1	
DNA Replication Pre-Initiation R-HSA-69002	0.273958277988899	1.46155707661995	5/134	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14
DNA Replication R-HSA-69306	0.357263017453052	1.29488676796777	5/150	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14
DNA replication initiation R-HSA-68952	1	0	0/3	1	
DNA strand elongation R-HSA-69190	1	0	0/13	1	
Dasatinib-resistant KIT mutants R-HSA-9669914	1	0	0/1	1	
Deactivation of the beta-catenin transactivating complex R-HSA-3769402	0.175443135561908	2.7844288421488	2/29	1	SRY;SOX9
Deadenylation of mRNA R-HSA-429947	1	0	0/18	1	
Deadenylation-dependent mRNA decay R-HSA-429914	1	0	0/39	1	
Death Receptor Signaling R-HSA-73887	0.915578849032772	0.402677677381543	1/92	1	ARHGEF7
Dectin-1 mediated noncanonical NF-kB signaling R-HSA-5607761	1	0	0/59	1	
Dectin-2 family R-HSA-5621480	1	0	0/12	1	
Defective ABCA1 causes TGD R-HSA-5682113	1	0	0/2	1	
Defective ABCA12 causes ARCI4B R-HSA-5682294	1	0	0/1	1	
Defective ABCA3 causes SMDP3 R-HSA-5683678	1	0	0/0	1	
Defective ABCA3 causes SMDP3 R-HSA-5688399	1	0	0/0	1	
Defective ABCB11 causes PFIC2 and BRIC2 R-HSA-5678520	1	0	0/1	1	
Defective ABCB4 causes PFIC3, ICP3 and GBD1 R-HSA-5678771	1	0	0/0	1	
Defective ABCB6 causes MCOPCB7 R-HSA-5683371	1	0	0/0	1	
Defective ABCC2 causes DJS R-HSA-5679001	1	0	0/0	1	
Defective ABCC6 causes PXE R-HSA-5690338	1	0	0/0	1	
Defective ABCC8 can cause hypo- and hyper-glycemias R-HSA-5683177	1	0	0/0	1	
Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome R-HSA-5678420	1	0	0/1	1	
Defective ABCD1 causes ALD R-HSA-5684045	1	0	0/0	1	
Defective ABCD4 causes MAHCJ R-HSA-5683329	1	0	0/2	1	
Defective ABCG5 causes sitosterolemia R-HSA-5679096	1	0	0/0	1	
Defective ABCG8 causes GBD4 and sitosterolemia R-HSA-5679090	1	0	0/0	1	
Defective ACTH causes obesity and POMCD R-HSA-5579031	1	0	0/1	1	
Defective ACY1 causes encephalopathy R-HSA-5579007	1	0	0/0	1	
Defective ADA disrupts (deoxy)adenosine deamination R-HSA-9734735	1	0	0/0	1	
Defective AHCY causes HMAHCHD R-HSA-5578997	1	0	0/1	1	
Defective ALG1 causes CDG-1k R-HSA-4549380	1	0	0/0	1	
Defective ALG11 causes CDG-1p R-HSA-4551295	1	0	0/0	1	
Defective ALG12 causes CDG-1g R-HSA-4720489	1	0	0/0	1	
Defective ALG14 causes ALG14-CMS R-HSA-5633231	1	0	0/0	1	
Defective ALG2 causes CDG-1i R-HSA-4549349	1	0	0/0	1	
Defective ALG3 causes CDG-1d R-HSA-4720475	1	0	0/1	1	
Defective ALG6 causes CDG-1c R-HSA-4724289	1	0	0/0	1	
Defective ALG8 causes CDG-1h R-HSA-4724325	1	0	0/0	1	
Defective ALG9 causes CDG-1l R-HSA-4720454	1	0	0/0	1	
Defective AMN causes MGA1 R-HSA-3359462	1	0	0/0	1	
Defective APRT disrupts adenine salvage R-HSA-9734195	1	0	0/1	1	
Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-5619099	1	0	0/0	1	
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) R-HSA-9036092	1	0	0/1	1	
Defective B3GALT6 causes EDSP2 and SEMDJL1 R-HSA-4420332	1	0	0/7	1	
Defective B3GALTL causes PpS R-HSA-5083635	1	0	0/14	1	
Defective B3GAT3 causes JDSSDHD R-HSA-3560801	1	0	0/8	1	
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) R-HSA-3656244	1	0	0/4	1	
Defective B4GALT1 causes CDG-2d R-HSA-4793953	1	0	0/0	1	
Defective B4GALT7 causes EDS, progeroid type R-HSA-3560783	1	0	0/7	1	
Defective BTD causes biotidinase deficiency R-HSA-3371598	1	0	0/1	1	
Defective Base Excision Repair Associated with MUTYH R-HSA-9605310	1	0	0/0	1	
Defective Base Excision Repair Associated with NEIL1 R-HSA-9616334	1	0	0/1	1	
Defective Base Excision Repair Associated with NEIL3 R-HSA-9629232	1	0	0/0	1	
Defective Base Excision Repair Associated with NTHL1 R-HSA-9616333	1	0	0/0	1	
Defective Base Excision Repair Associated with OGG1 R-HSA-9656249	1	0	0/0	1	
Defective C1GALT1C1 causes TNPS R-HSA-5083632	1	0	0/10	1	
Defective CBLIF causes IFD R-HSA-3359457	1	0	0/0	1	
Defective CD320 causes MMATC R-HSA-3359485	1	0	0/0	1	
Defective CFTR causes cystic fibrosis R-HSA-5678895	1	0	0/56	1	
Defective CHST14 causes EDS, musculocontractural type R-HSA-3595174	1	0	0/3	1	
Defective CHST3 causes SEDCJD R-HSA-3595172	1	0	0/4	1	
Defective CHST6 causes MCDC1 R-HSA-3656225	1	0	0/4	1	
Defective CHSY1 causes TPBS R-HSA-3595177	1	0	0/3	1	
Defective CP causes aceruloplasminemia (ACERULOP) R-HSA-5619060	1	0	0/1	1	
Defective CSF2RA causes SMDP4 R-HSA-5688890	1	0	0/2	1	
Defective CSF2RB causes SMDP5 R-HSA-5688849	1	0	0/2	1	
Defective CUBN causes MGA1 R-HSA-3359463	1	0	0/0	1	
Defective CYP11A1 causes AICSR R-HSA-5579026	1	0	0/0	1	
Defective CYP11B1 causes AH4 R-HSA-5579017	1	0	0/0	1	
Defective CYP11B2 causes CMO-1 deficiency R-HSA-5579009	1	0	0/0	1	
Defective CYP17A1 causes AH5 R-HSA-5579028	1	0	0/0	1	
Defective CYP19A1 causes AEXS R-HSA-5579030	1	0	0/0	1	
Defective CYP1B1 causes Glaucoma R-HSA-5579000	1	0	0/0	1	
Defective CYP21A2 causes AH3 R-HSA-5579021	1	0	0/0	1	
Defective CYP24A1 causes HCAI R-HSA-5579010	1	0	0/0	1	
Defective CYP26B1 causes RHFCA R-HSA-5579015	1	0	0/0	1	
Defective CYP26C1 causes FFDD4 R-HSA-5579004	1	0	0/0	1	
Defective CYP27A1 causes CTX R-HSA-5578996	1	0	0/1	1	
Defective CYP27B1 causes VDDR1A R-HSA-5579014	1	0	0/0	1	
Defective CYP27B1 causes VDDR1B R-HSA-5579027	1	0	0/0	1	
Defective CYP2U1 causes SPG56 R-HSA-5579011	1	0	0/1	1	
Defective CYP4F22 causes ARCI5 R-HSA-5579005	1	0	0/0	1	
Defective CYP7B1 causes SPG5A and CBAS3 R-HSA-5579013	1	0	0/0	1	
Defective DHDDS causes RP59 R-HSA-4755609	1	0	0/0	1	
Defective DNA double strand break response due to BARD1 loss of function R-HSA-9699150	1	0	0/1	1	
Defective DNA double strand break response due to BRCA1 loss of function R-HSA-9663199	1	0	0/1	1	
Defective DOLK causes DOLK-CDG R-HSA-4755583	1	0	0/0	1	
Defective DPAGT1 causes CDG-1j, CMSTA2 R-HSA-4549356	1	0	0/1	1	
Defective DPM1 causes DPM1-CDG R-HSA-4717374	1	0	0/2	1	
Defective DPM2 causes DPM2-CDG R-HSA-4719377	1	0	0/2	1	
Defective DPM3 causes DPM3-CDG R-HSA-4719360	1	0	0/2	1	
Defective EXT1 causes exostoses 1, TRPS2 and CHDS R-HSA-3656253	1	0	0/4	1	
Defective EXT2 causes exostoses 2 R-HSA-3656237	1	0	0/4	1	
Defective F8 accelerates dissociation of the A2 domain R-HSA-9672387	1	0	0/1	1	
Defective F8 binding to the cell membrane R-HSA-9672395	1	0	0/1	1	
Defective F8 secretion R-HSA-9672397	1	0	0/1	1	
Defective F8 sulfation at Y1699 R-HSA-9674519	1	0	0/1	1	
Defective F9 secretion R-HSA-9673218	1	0	0/0	1	
Defective F9 variant does not activate FX R-HSA-9673202	1	0	0/1	1	
Defective FMO3 causes TMAU R-HSA-5579019	1	0	0/0	1	
Defective GALE causes EDG R-HSA-5609977	1	0	0/0	1	
Defective GALK1 causes GALCT2 R-HSA-5609976	1	0	0/0	1	
Defective GALNT12 causes CRCS1 R-HSA-5083636	1	0	0/8	1	
Defective GALNT3 causes HFTC R-HSA-5083625	1	0	0/8	1	
Defective GALT can cause GALCT R-HSA-5609978	1	0	0/0	1	
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2) R-HSA-5619073	1	0	0/0	1	
Defective GCLC causes HAGGSD R-HSA-5578999	1	0	0/2	1	
Defective GFPT1 causes CMSTA1 R-HSA-4085023	1	0	0/0	1	
Defective GGT1 causes GLUTH R-HSA-5579022	1	0	0/0	1	
Defective GGT1 in aflatoxin detoxification causes GLUTH R-HSA-9035968	1	0	0/0	1	
Defective GNE causes sialuria, NK and IBM2 R-HSA-4085011	1	0	0/1	1	
Defective GSS causes GSS deficiency R-HSA-5579006	1	0	0/1	1	
Defective HEXA causes GM2G1 R-HSA-3656234	1	0	0/1	1	
Defective HEXB causes GM2G2 R-HSA-3656248	1	0	0/1	1	
Defective HK1 causes hexokinase deficiency (HK deficiency) R-HSA-5619056	1	0	0/1	1	
Defective HLCS causes multiple carboxylase deficiency R-HSA-3371599	1	0	0/3	1	
Defective HPRT1 disrupts guanine and hypoxanthine salvage R-HSA-9734281	1	0	0/0	1	
Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations R-HSA-9670615	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations R-HSA-9670613	1	0	0/1	1	
Defective Inhibition of DNA Recombination at Telomere R-HSA-9670621	1	0	0/1	1	
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function R-HSA-9645722	1	0	0/2	1	
Defective Intrinsic Pathway for Apoptosis R-HSA-9734009	0.346741223784396	2.49010112143882	1/16	1	APP
Defective LARGE causes MDDGA6 and MDDGB6 R-HSA-5083627	1	0	0/0	1	
Defective LFNG causes SCDO3 R-HSA-5083630	1	0	0/5	1	
Defective MAN1B1 causes MRT15 R-HSA-4793950	1	0	0/0	1	
Defective MAOA causes BRUNS R-HSA-5579012	1	0	0/1	1	
Defective MAT1A causes MATD R-HSA-5579024	1	0	0/1	1	
Defective MGAT2 causes CDG-2a R-HSA-4793952	1	0	0/0	1	
Defective MMAA causes MMA, cblA type R-HSA-3359475	1	0	0/2	1	
Defective MMAB causes MMA, cblB type R-HSA-3359471	1	0	0/0	1	
Defective MMACHC causes MAHCC R-HSA-3359474	1	0	0/1	1	
Defective MMADHC causes MMAHCD R-HSA-3359473	1	0	0/1	1	
Defective MOGS causes CDG-2b R-HSA-4793954	1	0	0/0	1	
Defective MPDU1 causes CDG-1f R-HSA-4687000	1	0	0/0	1	
Defective MPI causes MPI-CDG R-HSA-4043916	1	0	0/0	1	
Defective MTR causes HMAG R-HSA-3359469	1	0	0/1	1	
Defective MTRR causes HMAE R-HSA-3359467	1	0	0/1	1	
Defective MUT causes MMAM R-HSA-3359478	1	0	0/2	1	
Defective MUTYH substrate binding R-HSA-9608287	1	0	0/0	1	
Defective MUTYH substrate processing R-HSA-9608290	1	0	0/0	1	
Defective Mismatch Repair Associated With MLH1 R-HSA-5545483	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH2 R-HSA-5632928	1	0	0/1	1	
Defective Mismatch Repair Associated With MSH3 R-HSA-5632927	1	0	0/0	1	
Defective Mismatch Repair Associated With MSH6 R-HSA-5632968	1	0	0/1	1	
Defective Mismatch Repair Associated With PMS2 R-HSA-5632987	1	0	0/0	1	
Defective NEU1 causes sialidosis R-HSA-4341670	1	0	0/2	1	
Defective NTHL1 substrate binding R-HSA-9630222	1	0	0/0	1	
Defective NTHL1 substrate processing R-HSA-9630221	1	0	0/0	1	
Defective OGG1 Localization R-HSA-9657050	1	0	0/0	1	
Defective OGG1 Substrate Binding R-HSA-9656255	1	0	0/0	1	
Defective OGG1 Substrate Processing R-HSA-9656256	1	0	0/0	1	
Defective OPLAH causes OPLAHD R-HSA-5578998	1	0	0/1	1	
Defective PAPSS2 causes SEMD-PA R-HSA-3560796	1	0	0/0	1	
Defective PGM1 causes PGM1-CDG R-HSA-5609974	1	0	0/1	1	
Defective PMM2 causes PMM2-CDG R-HSA-4043911	1	0	0/1	1	
Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine R-HSA-9735763	1	0	0/1	1	
Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 R-HSA-5083628	1	0	0/0	1	
Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 R-HSA-5083633	1	0	0/1	1	
Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 R-HSA-5083629	1	0	0/1	1	
Defective RFT1 causes CDG-1n R-HSA-4570571	1	0	0/0	1	
Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) R-HSA-5619042	1	0	0/0	1	
Defective RIPK1-mediated regulated necrosis R-HSA-9693928	1	0	0/7	1	
Defective SERPING1 causes hereditary angioedema R-HSA-9657689	1	0	0/3	1	
Defective SFTPA2 causes IPF R-HSA-5687868	1	0	0/0	1	
Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1) R-HSA-5619048	1	0	0/1	1	
Defective SLC12A1 causes Bartter syndrome 1 (BS1) R-HSA-5619104	1	0	0/1	1	
Defective SLC12A3 causes Gitelman syndrome (GS) R-HSA-5619087	1	0	0/0	1	
Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) R-HSA-5619039	1	0	0/1	1	
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) R-HSA-5619070	1	0	0/2	1	
Defective SLC17A5 causes Salla disease (SD) and ISSD R-HSA-5619035	1	0	0/1	1	
Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25) R-HSA-5619076	1	0	0/0	1	
Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) R-HSA-5619067	1	0	0/0	1	
Defective SLC1A3 causes episodic ataxia 6 (EA6) R-HSA-5619062	1	0	0/1	1	
Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) R-HSA-5619111	1	0	0/1	1	
Defective SLC22A12 causes renal hypouricemia 1 (RHUC1) R-HSA-5619071	1	0	0/0	1	
Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1) R-HSA-5619066	1	0	0/0	1	
Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP) R-HSA-5619053	1	0	0/1	1	
Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D) R-HSA-5619077	1	0	0/1	1	
Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI) R-HSA-5619055	1	0	0/0	1	
Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6) R-HSA-5619036	1	0	0/0	1	
Defective SLC26A2 causes chondrodysplasias R-HSA-3560792	1	0	0/1	1	
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1) R-HSA-5619085	1	0	0/0	1	
Defective SLC26A4 causes Pendred syndrome (PDS) R-HSA-5619046	1	0	0/0	1	
Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS) R-HSA-5619108	1	0	0/1	1	
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS) R-HSA-5619063	1	0	0/0	1	
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) R-HSA-5619043	1	0	0/0	1	
Defective SLC2A10 causes arterial tortuosity syndrome (ATS) R-HSA-5619068	1	0	0/0	1	
Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS) R-HSA-5619098	1	0	0/0	1	
Defective SLC2A9 causes hypouricemia renal 2 (RHUC2) R-HSA-5619047	1	0	0/0	1	
Defective SLC33A1 causes spastic paraplegia 42 (SPG42) R-HSA-5619061	1	0	0/0	1	
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1) R-HSA-5619040	1	0	0/1	1	
Defective SLC34A2 causes PALM R-HSA-5687583	1	0	0/0	1	
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM) R-HSA-5619045	1	0	0/0	1	
Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) R-HSA-5619097	1	0	0/0	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5619037	1	0	0/1	1	
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F) R-HSA-5663020	1	0	0/1	1	
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M) R-HSA-5619072	1	0	0/1	1	
Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS) R-HSA-5619083	1	0	0/0	1	
Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C) R-HSA-5619078	1	0	0/0	1	
Defective SLC35D1 causes SCHBCKD R-HSA-5579020	1	0	0/0	1	
Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG) R-HSA-5619041	1	0	0/0	1	
Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ) R-HSA-5619088	1	0	0/0	1	
Defective SLC3A1 causes cystinuria (CSNU) R-HSA-5619113	1	0	0/1	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) R-HSA-5655799	1	0	0/2	1	
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) R-HSA-5619049	1	0	0/1	1	
Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) R-HSA-5619050	1	0	0/1	1	
Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) R-HSA-5619054	1	0	0/0	1	
Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM) R-HSA-5656364	1	0	0/1	1	
Defective SLC5A2 causes renal glucosuria (GLYS1) R-HSA-5658208	1	0	0/0	1	
Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1) R-HSA-5619096	1	0	0/1	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5619114	1	0	0/0	1	
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) R-HSA-5658471	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5619079	1	0	0/0	1	
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria R-HSA-5659729	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5619044	1	0	0/0	1	
Defective SLC6A19 causes Hartnup disorder (HND) R-HSA-5659735	1	0	0/0	1	
Defective SLC6A2 causes orthostatic intolerance (OI) R-HSA-5619109	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5619081	1	0	0/0	1	
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) R-HSA-5660724	1	0	0/0	1	
Defective SLC6A5 causes hyperekplexia 3 (HKPX3) R-HSA-5619089	1	0	0/0	1	
Defective SLC7A7 causes lysinuric protein intolerance (LPI) R-HSA-5660862	1	0	0/1	1	
Defective SLC7A9 causes cystinuria (CSNU) R-HSA-5660883	1	0	0/1	1	
Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH) R-HSA-5619092	1	0	0/1	1	
Defective SLC9A9 causes autism 16 (AUTS16) R-HSA-5619052	1	0	0/1	1	
Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619110	1	0	0/0	1	
Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR) R-HSA-5619058	1	0	0/0	1	
Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2) R-HSA-5619095	1	0	0/0	1	
Defective SRD5A3 causes SRD5A3-CDG, KHRZ R-HSA-4755579	1	0	0/1	1	
Defective ST3GAL3 causes MCT12 and EIEE15 R-HSA-3656243	1	0	0/5	1	
Defective TBXAS1 causes GHDD R-HSA-5579032	1	0	0/0	1	
Defective TCN2 causes TCN2 deficiency R-HSA-3359454	1	0	0/0	1	
Defective TPMT causes TPMT deficiency R-HSA-5578995	1	0	0/1	1	
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) R-HSA-5619107	1	0	0/10	1	
Defective UGT1A1 causes hyperbilirubinemia R-HSA-5579002	1	0	0/0	1	
Defective UGT1A4 causes hyperbilirubinemia R-HSA-5579016	1	0	0/0	1	
Defective VWF cleavage by ADAMTS13 variant R-HSA-9845621	0.100831870512745	12.4605401761496	1/4	1	VWF
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) R-HSA-9661069	1	0	0/17	1	
Defective cofactor function of FVIIIa variant R-HSA-9672396	1	0	0/1	1	
Defective factor IX causes thrombophilia R-HSA-9672383	1	0	0/1	1	
Defective factor XII causes hereditary angioedema R-HSA-9657688	1	0	0/3	1	
Defective gamma-carboxylation of F9 R-HSA-9673240	1	0	0/1	1	
Defective pro-SFTPB causes SMDP1 and RDS R-HSA-5688031	1	0	0/1	1	
Defective pro-SFTPC causes SMDP2 and RDS R-HSA-5688354	1	0	0/0	1	
Defective regulation of TLR7 by endogenous ligand R-HSA-9824856	1	0	0/1	1	
Defective translocation of RB1 mutants to the nucleus R-HSA-9661070	1	0	0/1	1	
Defects in biotin (Btn) metabolism R-HSA-3323169	1	0	0/4	1	
Defects in cobalamin (B12) metabolism R-HSA-3296469	1	0	0/6	1	
Defects in vitamin and cofactor metabolism R-HSA-3296482	1	0	0/10	1	
Defensins R-HSA-1461973	1	0	0/9	1	
Degradation of AXIN R-HSA-4641257	1	0	0/52	1	
Degradation of DVL R-HSA-4641258	1	0	0/52	1	
Degradation of GABA R-HSA-916853	1	0	0/1	1	
Degradation of GLI1 by the proteasome R-HSA-5610780	1	0	0/58	1	
Degradation of GLI2 by the proteasome R-HSA-5610783	1	0	0/59	1	
Degradation of beta-catenin by the destruction complex R-HSA-195253	1	0	0/77	1	
Degradation of cysteine and homocysteine R-HSA-1614558	1	0	0/5	1	
Degradation of the extracellular matrix R-HSA-1474228	0.799226720764437	0.626205951964421	1/60	1	FURIN
Deletions in the AMER1 gene destabilize the destruction complex R-HSA-5467343	1	0	0/1	1	
Deletions in the AXIN1 gene destabilize the destruction complex R-HSA-5467345	1	0	0/1	1	
Depolymerization of the Nuclear Lamina R-HSA-4419969	1	0	0/7	1	
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models R-HSA-8862803	0.292358333261937	3.11429423158507	1/13	1	APP
Dermatan sulfate biosynthesis R-HSA-2022923	1	0	0/4	1	
Detoxification of Reactive Oxygen Species R-HSA-3299685	1	0	0/18	1	
Deubiquitination R-HSA-5688426	0.107765561998289	1.74458890591963	8/184	1	H2BC21;H2BC12;H2BC14;EP300;BABAM1;UIMC1;SMAD3;SMAD2
Developmental Cell Lineages R-HSA-9734767	1	0	0/5	1	
Differentiation of keratinocytes in interfollicular epidermis in mammalian skin R-HSA-9725554	1	0	0/5	1	
Digestion R-HSA-8935690	1	0	0/2	1	
Digestion and absorption R-HSA-8963743	1	0	0/4	1	
Digestion of dietary carbohydrate R-HSA-189085	1	0	0/1	1	
Digestion of dietary lipid R-HSA-192456	1	0	0/1	1	
Dimerization of procaspase-8 R-HSA-69416	1	0	0/10	1	
Disassembly of the destruction complex and recruitment of AXIN to the membrane R-HSA-4641262	0.0952469944498643	4.18502489709519	2/20	1	FZD5;WNT3A
Disease R-HSA-1643685	0.648920671526522	0.937614368776855	27/1079	1	SRC;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;NCOR1;FURIN;CDC42;APP;FZD5;ATP1A1;FXYD2;KAT5;NBN;WNT3A;SMAD3;JUNB;JAK3;STAT5B;VWF;GP1BA;F11;SMAD2;MYO18A;MECP2
Diseases associated with N-glycosylation of proteins R-HSA-3781860	1	0	0/4	1	
Diseases associated with O-glycosylation of proteins R-HSA-3906995	1	0	0/30	1	
Diseases associated with glycosaminoglycan metabolism R-HSA-3560782	1	0	0/17	1	
Diseases associated with glycosylation precursor biosynthesis R-HSA-5609975	1	0	0/6	1	
Diseases associated with surfactant metabolism R-HSA-5687613	1	0	0/2	1	
Diseases associated with the TLR signaling cascade R-HSA-5602358	1	0	0/24	1	
Diseases associated with visual transduction R-HSA-2474795	1	0	0/1	1	
Diseases of Base Excision Repair R-HSA-9605308	1	0	0/1	1	
Diseases of Cellular Senescence R-HSA-9630747	1	0	0/3	1	
Diseases of Immune System R-HSA-5260271	1	0	0/24	1	
Diseases of Mismatch Repair (MMR) R-HSA-5423599	1	0	0/1	1	
Diseases of Telomere Maintenance R-HSA-9673013	1	0	0/1	1	
Diseases of carbohydrate metabolism R-HSA-5663084	1	0	0/17	1	
Diseases of cellular response to stress R-HSA-9675132	1	0	0/3	1	
Diseases of glycosylation R-HSA-3781865	1	0	0/57	1	
Diseases of metabolism R-HSA-5668914	1	0	0/99	1	
Diseases of mitochondrial beta oxidation R-HSA-9759774	1	0	0/2	1	
Diseases of mitotic cell cycle R-HSA-9675126	1	0	0/36	1	
Diseases of nucleotide metabolism R-HSA-9735804	1	0	0/2	1	
Diseases of propionyl-CoA catabolism R-HSA-9759785	1	0	0/2	1	
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202	0.121581458516789	1.52583564365801	12/316	1	SRC;EP300;NCOR1;FZD5;WNT3A;SMAD3;JUNB;STAT5B;VWF;SMAD2;MYO18A;MECP2
Diseases of the neuronal system R-HSA-9675143	1	0	0/1	1	
Disinhibition of SNARE formation R-HSA-114516	1	0	0/4	1	
Disorders of transmembrane transporters R-HSA-5619115	1	0	0/100	1	
Displacement of DNA glycosylase by APEX1 R-HSA-110357	1	0	0/2	1	
Dopamine Neurotransmitter Release Cycle R-HSA-212676	0.124423905593351	9.35086557215028	1/5	1	TSPOAP1
Dopamine clearance from the synaptic cleft R-HSA-379401	1	0	0/1	1	
Dopamine receptors R-HSA-390651	1	0	0/0	1	
Downregulation of ERBB2 signaling R-HSA-8863795	1	0	0/19	1	
Downregulation of ERBB2:ERBB3 signaling R-HSA-1358803	1	0	0/8	1	
Downregulation of ERBB4 signaling R-HSA-1253288	0.191582925100974	5.34296079232313	1/8	1	SRC
Downstream TCR signaling R-HSA-202424	1	0	0/93	1	
Downstream signaling events of B Cell Receptor (BCR) R-HSA-1168372	1	0	0/80	1	
Downstream signaling of activated FGFR1 R-HSA-5654687	1	0	0/12	1	
Downstream signaling of activated FGFR2 R-HSA-5654696	1	0	0/14	1	
Downstream signaling of activated FGFR3 R-HSA-5654708	1	0	0/12	1	
Downstream signaling of activated FGFR4 R-HSA-5654716	1	0	0/12	1	
Drug ADME R-HSA-9748784	0.637249115747812	1.00411758787702	1/38	1	CNDP2
Drug resistance in ERBB2 KD mutants R-HSA-9665230	1	0	0/2	1	
Drug resistance in ERBB2 TMD/JMD mutants R-HSA-9665737	1	0	0/2	1	
Drug resistance of ALK mutants R-HSA-9700649	1	0	0/0	1	
Drug resistance of FLT3 mutants R-HSA-9702506	1	0	0/0	1	
Drug resistance of KIT mutants R-HSA-9669937	1	0	0/1	1	
Drug resistance of PDGFR mutants R-HSA-9674415	1	0	0/1	1	
Drug-mediated inhibition of CDK4/CDK6 activity R-HSA-9754119	1	0	0/5	1	
Drug-mediated inhibition of ERBB2 signaling R-HSA-9652282	1	0	0/2	1	
Drug-mediated inhibition of MET activation R-HSA-9734091	1	0	0/1	1	
Dual Incision in GG-NER R-HSA-5696400	1	0	0/17	1	
Dual incision in TC-NER R-HSA-6782135	1	0	0/35	1	
E2F mediated regulation of DNA replication R-HSA-113510	1	0	0/14	1	
E2F-enabled inhibition of pre-replication complex formation R-HSA-113507	1	0	0/4	1	
E3 ubiquitin ligases ubiquitinate target proteins R-HSA-8866654	0.0860363406470605	3.06934450564815	3/40	1	H2BC12;H2BC14;UBE2V2
ECM proteoglycans R-HSA-3000178	0.656194471025846	0.952147964858822	1/40	1	APP
EGFR Transactivation by Gastrin R-HSA-2179392	1	0	0/9	1	
EGFR downregulation R-HSA-182971	0.129473301370098	3.4211512686734	2/24	1	ARHGEF7;CDC42
EGFR interacts with phospholipase C-gamma R-HSA-212718	1	0	0/9	1	
EGR2 and SOX10-mediated initiation of Schwann cell myelination R-HSA-9619665	1	0	0/13	1	
EML4 and NUDC in mitotic spindle formation R-HSA-9648025	0.757560564753126	0.711770937734954	1/53	1	AURKB
EPH-Ephrin signaling R-HSA-2682334	0.17380231547448	2.17603445835261	3/55	1	SRC;ARHGEF7;CDC42
EPH-ephrin mediated repulsion of cells R-HSA-3928665	0.486260042626989	1.55293979689739	1/25	1	SRC
EPHA-mediated growth cone collapse R-HSA-3928663	0.310966623183603	2.87416395939725	1/14	1	SRC
EPHB-mediated forward signaling R-HSA-3928662	0.166035472371445	2.89218521695033	2/28	1	SRC;CDC42
ER Quality Control Compartment (ERQC) R-HSA-901032	1	0	0/10	1	
ER to Golgi Anterograde Transport R-HSA-199977	1	0	0/94	1	
ER-Phagosome pathway R-HSA-1236974	1	0	0/81	1	
ERBB2 Activates PTK6 Signaling R-HSA-8847993	1	0	0/8	1	
ERBB2 Regulates Cell Motility R-HSA-6785631	1	0	0/9	1	
ERK/MAPK targets R-HSA-198753	1	0	0/16	1	
ERKs are inactivated R-HSA-202670	1	0	0/7	1	
Early Phase of HIV Life Cycle R-HSA-162594	1	0	0/10	1	
Early SARS-CoV-2 Infection Events R-HSA-9772572	0.346741223784396	2.49010112143882	1/16	1	FURIN
Effects of PIP2 hydrolysis R-HSA-114508	1	0	0/12	1	
Eicosanoid ligand-binding receptors R-HSA-391903	1	0	0/1	1	
Eicosanoids R-HSA-211979	1	0	0/3	1	
Elastic fibre formation R-HSA-1566948	0.443390945354158	1.77608203944115	1/22	1	FURIN
Electric Transmission Across Gap Junctions R-HSA-112303	1	0	0/1	1	
Electron transport from NADPH to Ferredoxin R-HSA-2395516	1	0	0/0	1	
Elevation of cytosolic Ca2+ levels R-HSA-139853	1	0	0/5	1	
Endogenous sterols R-HSA-211976	0.191582925100974	5.34296079232313	1/8	1	ARNT
Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729	1	0	0/17	1	
Endosomal/Vacuolar pathway R-HSA-1236977	1	0	0/7	1	
Energy dependent regulation of mTOR by LKB1-AMPK R-HSA-380972	1	0	0/24	1	
Enhanced cleavage of VWF variant by ADAMTS13 R-HSA-9845619	0.100831870512745	12.4605401761496	1/4	1	VWF
Entry of Influenza Virion into Host Cell via Endocytosis R-HSA-168275	1	0	0/2	1	
Enzymatic degradation of Dopamine by monoamine oxidase R-HSA-379398	1	0	0/1	1	
Enzymatic degradation of dopamine by COMT R-HSA-379397	1	0	0/1	1	
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919	1	0	0/3	1	
Erythrocytes take up carbon dioxide and release oxygen R-HSA-1237044	1	0	0/7	1	
Erythrocytes take up oxygen and release carbon dioxide R-HSA-1247673	1	0	0/7	1	
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276	1	0	0/9	1	
Erythropoietin activates Phospholipase C gamma (PLCG) R-HSA-9027277	1	0	0/4	1	
Erythropoietin activates RAS R-HSA-9027284	1	0	0/10	1	
Erythropoietin activates STAT5 R-HSA-9027283	0.124423905593351	9.35086557215028	1/5	1	STAT5B
Essential fructosuria R-HSA-5657562	1	0	0/1	1	
Essential pentosuria R-HSA-5662853	1	0	0/0	1	
Establishment of Sister Chromatid Cohesion R-HSA-2468052	1	0	0/9	1	
Estrogen biosynthesis R-HSA-193144	1	0	0/0	1	
Estrogen-dependent nuclear events downstream of ESR-membrane signaling R-HSA-9634638	1	0	0/24	1	
Estrogen-stimulated signaling through PRKCZ R-HSA-9634635	1	0	0/6	1	
Ethanol oxidation R-HSA-71384	0.100831870512745	12.4605401761496	1/4	1	ACSS1
Eukaryotic Translation Elongation R-HSA-156842	1	0	0/83	1	
Eukaryotic Translation Initiation R-HSA-72613	1	0	0/97	1	
Eukaryotic Translation Termination R-HSA-72764	1	0	0/81	1	
Evasion by RSV of host interferon responses R-HSA-9833109	0.596201791067686	1.1269479513211	1/34	1	EP300
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9630791	1	0	0/2	1	
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9630794	1	0	0/3	1	
Evasion of Oncogene Induced Senescence Due to p14ARF Defects R-HSA-9646303	1	0	0/1	1	
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects R-HSA-9630750	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 R-HSA-9632697	1	0	0/2	1	
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 R-HSA-9632700	1	0	0/3	1	
Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects R-HSA-9646304	1	0	0/1	1	
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects R-HSA-9632693	1	0	0/3	1	
Events associated with phagocytolytic activity of PMN cells R-HSA-8941413	1	0	0/0	1	
Export of Viral Ribonucleoproteins from Nucleus R-HSA-168274	1	0	0/12	1	
Expression and translocation of olfactory receptors R-HSA-9752946	1	0	0/1	1	
Extension of Telomeres R-HSA-180786	1	0	0/17	1	
Extra-nuclear estrogen signaling R-HSA-9009391	0.443514510133133	1.35755844502624	2/57	1	SRC;SPHK1
Extracellular matrix organization R-HSA-1474244	0.463451965816274	1.15788083201338	4/133	1	FURIN;APP;VWF;NRXN1
Extrinsic Pathway of Fibrin Clot Formation R-HSA-140834	1	0	0/3	1	
FASTK family proteins regulate processing and stability of mitochondrial RNAs R-HSA-9837092	1	0	0/0	1	
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis R-HSA-8854050	1	0	0/53	1	
FBXW7 Mutants and NOTCH1 in Cancer R-HSA-2644605	1	0	0/5	1	
FCERI mediated Ca+2 mobilization R-HSA-2871809	1	0	0/19	1	
FCERI mediated MAPK activation R-HSA-2871796	1	0	0/23	1	
FCERI mediated NF-kB activation R-HSA-2871837	1	0	0/75	1	
FCGR activation R-HSA-2029481	0.233494350043928	4.15469625193707	1/10	1	SRC
FCGR3A-mediated IL10 synthesis R-HSA-9664323	0.486260042626989	1.55293979689739	1/25	1	SRC
FCGR3A-mediated phagocytosis R-HSA-9664422	0.243071584258469	2.20755486092926	2/36	1	SRC;CDC42
FGFR1 ligand binding and activation R-HSA-190242	1	0	0/3	1	
FGFR1 mutant receptor activation R-HSA-1839124	0.0952469944498643	4.18502489709519	2/20	1	STAT5B;MYO18A
FGFR1b ligand binding and activation R-HSA-190370	1	0	0/2	1	
FGFR1c and Klotho ligand binding and activation R-HSA-190374	1	0	0/0	1	
FGFR1c ligand binding and activation R-HSA-190373	1	0	0/3	1	
FGFR2 alternative splicing R-HSA-6803529	1	0	0/20	1	
FGFR2 ligand binding and activation R-HSA-190241	1	0	0/4	1	
FGFR2 mutant receptor activation R-HSA-1839126	1	0	0/19	1	
FGFR2b ligand binding and activation R-HSA-190377	1	0	0/3	1	
FGFR2c ligand binding and activation R-HSA-190375	1	0	0/3	1	
FGFR3 ligand binding and activation R-HSA-190239	1	0	0/2	1	
FGFR3 mutant receptor activation R-HSA-2033514	1	0	0/2	1	
FGFR3b ligand binding and activation R-HSA-190371	1	0	0/0	1	
FGFR3c ligand binding and activation R-HSA-190372	1	0	0/2	1	
FGFR4 ligand binding and activation R-HSA-190322	1	0	0/2	1	
FGFR4 mutant receptor activation R-HSA-1839128	1	0	0/1	1	
FGFRL1 modulation of FGFR1 signaling R-HSA-5658623	1	0	0/4	1	
FLT3 Signaling R-HSA-9607240	0.550558409191618	1.28365245717333	1/30	1	STAT5B
FLT3 mutants bind TKIs R-HSA-9702509	1	0	0/0	1	
FLT3 signaling by CBL mutants R-HSA-9706377	1	0	0/5	1	
FLT3 signaling in disease R-HSA-9682385	0.112011748153723	3.76519981573746	2/22	1	STAT5B;MYO18A
FLT3 signaling through SRC family kinases R-HSA-9706374	1	0	0/4	1	
FMO oxidises nucleophiles R-HSA-217271	1	0	0/0	1	
FOXO-mediated transcription R-HSA-9614085	0.136062328580695	2.46337170631247	3/49	1	EP300;SMAD3;SMAD2
FOXO-mediated transcription of cell death genes R-HSA-9614657	0.310966623183603	2.87416395939725	1/14	1	EP300
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes R-HSA-9615017	0.10353465954373	3.9639924847644	2/21	1	SMAD3;SMAD2
FRS-mediated FGFR1 signaling R-HSA-5654693	1	0	0/8	1	
FRS-mediated FGFR2 signaling R-HSA-5654700	1	0	0/10	1	
FRS-mediated FGFR3 signaling R-HSA-5654706	1	0	0/8	1	
FRS-mediated FGFR4 signaling R-HSA-5654712	1	0	0/8	1	
Factors involved in megakaryocyte development and platelet production R-HSA-983231	0.739522522220589	0.761541073158329	2/99	1	CDC42;DOCK5
Fanconi Anemia Pathway R-HSA-6783310	1	0	0/23	1	
FasL/ CD95L signaling R-HSA-75157	1	0	0/4	1	
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion R-HSA-434316	1	0	0/3	1	
Fatty acid metabolism R-HSA-8978868	0.306535294590124	1.58611084726374	3/74	1	ACSBG1;ELOVL7;ACAD11
Fatty acids R-HSA-211935	1	0	0/5	1	
Fc epsilon receptor (FCERI) signaling R-HSA-2454202	1	0	0/114	1	
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480	0.416286511328687	1.43695399372548	2/54	1	SRC;CDC42
Fertilization R-HSA-1187000	1	0	0/4	1	
Fibronectin matrix formation R-HSA-1566977	1	0	0/3	1	
Ficolins bind to repetitive carbohydrate structures on the target cell surface R-HSA-2855086	1	0	0/3	1	
Folding of actin by CCT/TriC R-HSA-390450	1	0	0/10	1	
Formation of ATP by chemiosmotic coupling R-HSA-163210	1	0	0/15	1	
Formation of HIV elongation complex in the absence of HIV Tat R-HSA-167152	1	0	0/28	1	
Formation of HIV-1 elongation complex containing HIV-1 Tat R-HSA-167200	1	0	0/26	1	
Formation of Incision Complex in GG-NER R-HSA-5696395	0.42832825457232	1.86538195580771	1/21	1	UBE2V2
Formation of RNA Pol II elongation complex  R-HSA-112382	1	0	0/34	1	
Formation of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584	1	0	0/16	1	
Formation of TC-NER Pre-Incision Complex R-HSA-6781823	1	0	0/32	1	
Formation of WDR5-containing histone-modifying complexes R-HSA-9772755	1	0	0/26	1	
Formation of a pool of free 40S subunits R-HSA-72689	1	0	0/88	1	
Formation of annular gap junctions R-HSA-196025	1	0	0/9	1	
Formation of apoptosome R-HSA-111458	1	0	0/5	1	
Formation of editosomes by ADAR proteins R-HSA-77042	1	0	0/0	1	
Formation of intermediate mesoderm R-HSA-9761174	1	0	0/3	1	
Formation of lateral plate mesoderm R-HSA-9758920	1	0	0/1	1	
Formation of paraxial mesoderm R-HSA-9793380	0.45243709882314	1.33299416308349	2/58	1	EP300;WNT3A
Formation of the Early Elongation Complex R-HSA-113418	1	0	0/22	1	
Formation of the Editosome R-HSA-75094	1	0	0/0	1	
Formation of the HIV-1 Early Elongation Complex R-HSA-167158	1	0	0/22	1	
Formation of the active cofactor, UDP-glucuronate R-HSA-173599	1	0	0/0	1	
Formation of the cornified envelope R-HSA-6809371	0.253635549571777	3.73892787264533	1/11	1	FURIN
Formation of the nephric duct R-HSA-9830364	1	0	0/9	1	
Formation of the ternary complex, and subsequently, the 43S complex R-HSA-72695	1	0	0/43	1	
Formation of the ureteric bud R-HSA-9830674	1	0	0/8	1	
Formation of tubulin folding intermediates by CCT/TriC R-HSA-389960	1	0	0/26	1	
Formation of xylulose-5-phosphate R-HSA-5661270	1	0	0/1	1	
Formyl peptide receptors bind formyl peptides and many other ligands R-HSA-444473	0.124423905593351	9.35086557215028	1/5	1	APP
Free fatty acid receptors R-HSA-444209	1	0	0/0	1	
Free fatty acids regulate insulin secretion R-HSA-400451	1	0	0/4	1	
Frs2-mediated activation R-HSA-170968	1	0	0/7	1	
Fructose biosynthesis R-HSA-5652227	1	0	0/1	1	
Fructose catabolism R-HSA-70350	1	0	0/2	1	
Fructose metabolism R-HSA-5652084	1	0	0/3	1	
G alpha (12/13) signalling events R-HSA-416482	0.637249115747812	1.00411758787702	1/38	1	ARHGEF7
G alpha (i) signalling events R-HSA-418594	0.786607801706756	0.688582131200177	2/109	1	SRC;APP
G alpha (q) signalling events R-HSA-416476	0.876564176060502	0.477614199252055	1/78	1	APP
G alpha (s) signalling events R-HSA-418555	0.70734552573649	0.823950589376898	1/46	1	SRC
G alpha (z) signalling events R-HSA-418597	1	0	0/25	1	
G beta:gamma signalling through BTK R-HSA-8964315	1	0	0/9	1	
G beta:gamma signalling through CDC42 R-HSA-8964616	0.253635549571777	3.73892787264533	1/11	1	CDC42
G beta:gamma signalling through PI3Kgamma R-HSA-392451	1	0	0/15	1	
G beta:gamma signalling through PLC beta R-HSA-418217	1	0	0/8	1	
G protein gated Potassium channels R-HSA-1296059	1	0	0/11	1	
G-protein activation R-HSA-202040	1	0	0/13	1	
G-protein beta:gamma signalling R-HSA-397795	0.396981147981571	2.07367136211455	1/19	1	CDC42
G-protein mediated events R-HSA-112040	1	0	0/30	1	
G0 and Early G1 R-HSA-1538133	0.112011748153723	3.76519981573746	2/22	1	E2F5;MYBL2
G1 Phase R-HSA-69236	0.311679669158283	1.8275988096346	2/43	1	SRC;E2F5
G1/S DNA Damage Checkpoints R-HSA-69615	1	0	0/64	1	
G1/S Transition R-HSA-69206	0.924281419886271	0.385323556874356	1/96	1	E2F5
G1/S-Specific Transcription R-HSA-69205	0.346741223784396	2.49010112143882	1/16	1	E2F5
G2 Phase R-HSA-68911	1	0	0/5	1	
G2/M DNA replication checkpoint R-HSA-69478	1	0	0/2	1	
G2/M Transition R-HSA-69275	0.870485693985429	0.558919462366508	2/133	1	EP300;MYBL2
GAB1 signalosome R-HSA-180292	0.329090081730138	2.668231298019	1/15	1	SRC
GABA B receptor activation R-HSA-977444	1	0	0/18	1	
GABA receptor activation R-HSA-977443	1	0	0/18	1	
GABA synthesis R-HSA-888568	1	0	0/0	1	
GABA synthesis, release, reuptake and degradation R-HSA-888590	1	0	0/6	1	
GDP-fucose biosynthesis R-HSA-6787639	1	0	0/1	1	
GLI proteins bind promoters of Hh responsive genes to promote transcription R-HSA-5635851	1	0	0/7	1	
GLI3 is processed to GLI3R by the proteasome R-HSA-5610785	1	0	0/59	1	
GPCR downstream signalling R-HSA-388396	0.821641726591547	0.696207769946767	4/214	1	SRC;ARHGEF7;CDC42;APP
GPCR ligand binding R-HSA-500792	0.609730635967178	0.95966793063194	3/119	1	APP;FZD5;WNT3A
GPER1 signaling R-HSA-9634597	0.443390945354158	1.77608203944115	1/22	1	SRC
GPVI-mediated activation cascade R-HSA-114604	0.499809790196419	1.490459536904	1/26	1	CDC42
GRB2 events in EGFR signaling R-HSA-179812	1	0	0/13	1	
GRB2 events in ERBB2 signaling R-HSA-1963640	1	0	0/11	1	
GRB7 events in ERBB2 signaling R-HSA-1306955	1	0	0/2	1	
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 R-HSA-9762114	1	0	0/51	1	
GTP hydrolysis and joining of the 60S ribosomal subunit R-HSA-72706	1	0	0/95	1	
Gain-of-function MRAS complexes activate RAF signaling R-HSA-9726842	1	0	0/5	1	
Galactose catabolism R-HSA-70370	1	0	0/1	1	
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation R-HSA-163841	0.42832825457232	1.86538195580771	1/21	1	FURIN
Gamma-carboxylation of protein precursors R-HSA-159740	1	0	0/3	1	
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins R-HSA-159854	0.100831870512745	12.4605401761496	1/4	1	FURIN
Gap junction assembly R-HSA-190861	1	0	0/21	1	
Gap junction degradation R-HSA-190873	1	0	0/9	1	
Gap junction trafficking R-HSA-190828	1	0	0/29	1	
Gap junction trafficking and regulation R-HSA-157858	0.550558409191618	1.28365245717333	1/30	1	SRC
Gap-filling DNA repair synthesis and ligation in GG-NER R-HSA-5696397	1	0	0/12	1	
Gap-filling DNA repair synthesis and ligation in TC-NER R-HSA-6782210	1	0	0/34	1	
Gastrin-CREB signalling pathway via PKC and MAPK R-HSA-881907	1	0	0/16	1	
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation R-HSA-8950505	0.42832825457232	1.86538195580771	1/21	1	CDC42
Generation of second messenger molecules R-HSA-202433	1	0	0/24	1	
Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399	0.646847616429472	0.977449047960505	1/39	1	UBE2V2
Glucagon signaling in metabolic regulation R-HSA-163359	1	0	0/17	1	
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion R-HSA-381676	1	0	0/17	1	
Glucagon-type ligand receptors R-HSA-420092	1	0	0/14	1	
Glucocorticoid biosynthesis R-HSA-194002	1	0	0/1	1	
Gluconeogenesis R-HSA-70263	1	0	0/11	1	
Glucose metabolism R-HSA-70326	1	0	0/36	1	
Glucuronidation R-HSA-156588	1	0	0/2	1	
Glutamate Neurotransmitter Release Cycle R-HSA-210500	0.233494350043928	4.15469625193707	1/10	1	TSPOAP1
Glutamate and glutamine metabolism R-HSA-8964539	1	0	0/4	1	
Glutamate binding, activation of AMPA receptors and synaptic plasticity R-HSA-399721	1	0	0/14	1	
Glutathione conjugation R-HSA-156590	0.443390945354158	1.77608203944115	1/22	1	CNDP2
Glutathione synthesis and recycling R-HSA-174403	0.212814889902584	4.67518817282894	1/9	1	CNDP2
Glycerophospholipid biosynthesis R-HSA-1483206	1	0	0/40	1	
Glycerophospholipid catabolism R-HSA-6814848	1	0	0/0	1	
Glycine degradation R-HSA-6783984	1	0	0/4	1	
Glycogen breakdown (glycogenolysis) R-HSA-70221	1	0	0/7	1	
Glycogen metabolism R-HSA-8982491	1	0	0/12	1	
Glycogen storage disease type 0 (liver GYS2) R-HSA-3858516	1	0	0/0	1	
Glycogen storage disease type 0 (muscle GYS1) R-HSA-3828062	1	0	0/2	1	
Glycogen storage disease type II (GAA) R-HSA-5357609	1	0	0/1	1	
Glycogen storage disease type IV (GBE1) R-HSA-3878781	1	0	0/0	1	
Glycogen storage disease type Ia (G6PC) R-HSA-3274531	1	0	0/0	1	
Glycogen storage disease type Ib (SLC37A4) R-HSA-3229133	1	0	0/1	1	
Glycogen storage disease type XV (GYG1) R-HSA-3814836	1	0	0/2	1	
Glycogen storage diseases R-HSA-3229121	1	0	0/8	1	
Glycogen synthesis R-HSA-3322077	1	0	0/7	1	
Glycolysis R-HSA-70171	1	0	0/32	1	
Glycoprotein hormones R-HSA-209822	1	0	0/3	1	
Glycosaminoglycan metabolism R-HSA-1630316	1	0	0/41	1	
Glycosphingolipid biosynthesis R-HSA-9840309	1	0	0/5	1	
Glycosphingolipid catabolism R-HSA-9840310	0.310966623183603	2.87416395939725	1/14	1	GBA2
Glycosphingolipid metabolism R-HSA-1660662	0.396981147981571	2.07367136211455	1/19	1	GBA2
Glycosphingolipid transport R-HSA-9845576	1	0	0/2	1	
Glyoxylate metabolism and glycine degradation R-HSA-389661	1	0	0/8	1	
Golgi Associated Vesicle Biogenesis R-HSA-432722	1	0	0/27	1	
Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658	1	0	0/8	1	
Golgi-to-ER retrograde transport R-HSA-8856688	1	0	0/72	1	
Growth hormone receptor signaling R-HSA-982772	0.472346799019033	1.62085821553598	1/24	1	STAT5B
HCMV Early Events R-HSA-9609690	0.128027171224822	1.95985286680539	5/102	1	H2BC21;H2BC12;H4C9;H2BC14;NCOR1
HCMV Infection R-HSA-9609646	0.173530613147386	1.75527417078736	5/113	1	H2BC21;H2BC12;H4C9;H2BC14;NCOR1
HCMV Late Events R-HSA-9610379	0.127906444496105	2.16636219042719	4/74	1	H2BC21;H2BC12;H4C9;H2BC14
HCN channels R-HSA-1296061	1	0	0/0	1	
HDL assembly R-HSA-8963896	1	0	0/8	1	
HDL clearance R-HSA-8964011	1	0	0/2	1	
HDL remodeling R-HSA-8964058	1	0	0/7	1	
HDMs demethylate histones R-HSA-3214842	0.252874690755001	2.14392610076967	2/37	1	H4C9;KDM4C
HDR through Homologous Recombination (HRR) R-HSA-5685942	0.194498553992152	2.59120206533674	2/31	1	KAT5;NBN
HDR through MMEJ (alt-NHEJ) R-HSA-5685939	0.14740262953668	7.48288775581792	1/6	1	NBN
HHAT G278V doesn't palmitoylate Hh-Np R-HSA-5658034	1	0	0/2	1	
HIV Infection R-HSA-162906	0.981781462836597	0.245658701050264	1/148	1	FURIN
HIV Life Cycle R-HSA-162587	0.87986326767361	0.471369595896877	1/79	1	FURIN
HIV Transcription Elongation R-HSA-167169	1	0	0/26	1	
HIV Transcription Initiation R-HSA-167161	1	0	0/29	1	
HIV elongation arrest and recovery R-HSA-167287	1	0	0/24	1	
HS-GAG biosynthesis R-HSA-2022928	1	0	0/4	1	
HS-GAG degradation R-HSA-2024096	1	0	0/8	1	
HSF1 activation R-HSA-3371511	1	0	0/20	1	
HSF1-dependent transactivation R-HSA-3371571	0.525856190208566	1.3793942445188	1/28	1	EP300
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand R-HSA-3371497	1	0	0/46	1	
Hedgehog 'off' state R-HSA-5610787	1	0	0/91	1	
Hedgehog 'on' state R-HSA-5632684	1	0	0/69	1	
Hedgehog ligand biogenesis R-HSA-5358346	1	0	0/57	1	
Heme biosynthesis R-HSA-189451	1	0	0/5	1	
Heme degradation R-HSA-189483	1	0	0/9	1	
Heme signaling R-HSA-9707616	0.321418872254881	1.7835341296187	2/44	1	EP300;NCOR1
Hemostasis R-HSA-109582	0.172853019634682	1.43500149460294	11/305	1	SRC;CDC42;APP;SERPINC1;SERPINE2;VWF;GP1BA;F11;PLAT;DOCK5;TTN
Heparan sulfate/heparin (HS-GAG) metabolism R-HSA-1638091	1	0	0/14	1	
Hereditary fructose intolerance R-HSA-5657560	1	0	0/0	1	
Hh mutants abrogate ligand secretion R-HSA-5387390	1	0	0/56	1	
Hh mutants are degraded by ERAD R-HSA-5362768	1	0	0/54	1	
Highly calcium permeable nicotinic acetylcholine receptors R-HSA-629597	1	0	0/3	1	
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors R-HSA-629594	1	0	0/3	1	
Highly sodium permeable postsynaptic acetylcholine nicotinic receptors R-HSA-629587	1	0	0/3	1	
Histamine receptors R-HSA-390650	1	0	0/0	1	
Histidine catabolism R-HSA-70921	1	0	0/4	1	
Hormone ligand-binding receptors R-HSA-375281	1	0	0/2	1	
Host Interactions of HIV factors R-HSA-162909	1	0	0/95	1	
HuR (ELAVL1) binds and stabilizes mRNA R-HSA-450520	1	0	0/7	1	
Hyaluronan biosynthesis and export R-HSA-2142850	1	0	0/0	1	
Hyaluronan metabolism R-HSA-2142845	1	0	0/4	1	
Hyaluronan uptake and degradation R-HSA-2160916	1	0	0/4	1	
Hydrolysis of LPC R-HSA-1483115	1	0	0/4	1	
Hydrolysis of LPE R-HSA-1483152	1	0	0/0	1	
Hydroxycarboxylic acid-binding receptors R-HSA-3296197	1	0	0/0	1	
Hypusine synthesis from eIF5A-lysine R-HSA-204626	1	0	0/4	1	
IFNG signaling activates MAPKs R-HSA-9732724	1	0	0/8	1	
IGF1R signaling cascade R-HSA-2428924	1	0	0/27	1	
IKBKB deficiency causes SCID R-HSA-5602636	1	0	0/3	1	
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) R-HSA-5603027	1	0	0/3	1	
IKK complex recruitment mediated by RIP1 R-HSA-937041	1	0	0/20	1	
IL-6-type cytokine receptor ligand interactions R-HSA-6788467	1	0	0/12	1	
IRAK1 recruits IKK complex R-HSA-937039	1	0	0/11	1	
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation R-HSA-975144	1	0	0/11	1	
IRAK2 mediated activation of TAK1 complex R-HSA-937042	1	0	0/9	1	
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation R-HSA-975163	1	0	0/12	1	
IRAK4 deficiency (TLR2/4) R-HSA-5603041	1	0	0/13	1	
IRAK4 deficiency (TLR5) R-HSA-5603037	1	0	0/1	1	
IRE1alpha activates chaperones R-HSA-381070	1	0	0/24	1	
IRF3 mediated activation of type 1 IFN R-HSA-1606341	1	0	0/3	1	
IRF3-mediated induction of type I IFN R-HSA-3270619	1	0	0/6	1	
IRS activation R-HSA-74713	1	0	0/4	1	
IRS-mediated signalling R-HSA-112399	1	0	0/25	1	
IRS-related events triggered by IGF1R R-HSA-2428928	1	0	0/27	1	
ISG15 antiviral mechanism R-HSA-1169408	1	0	0/39	1	
IkBA variant leads to EDA-ID R-HSA-5603029	1	0	0/7	1	
Imatinib-resistant KIT mutants R-HSA-9669917	1	0	0/1	1	
Imatinib-resistant PDGFR mutants R-HSA-9674396	1	0	0/1	1	
Immune System R-HSA-168256	0.997518453824993	0.495563175735757	15/998	1	SRC;EP300;LRRC7;CDC42;UBE2V2;APP;GSN;SPHK1;NANOG;SMAD3;STAT6;IL4R;JUNB;JAK3;STAT5B
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell R-HSA-198933	1	0	0/45	1	
Impaired BRCA2 binding to SEM1 (DSS1) R-HSA-9763198	1	0	0/1	1	
Impaired BRCA2 translocation to the nucleus R-HSA-9709275	1	0	0/1	1	
Inactivation of APC/C via direct inhibition of the APC/C complex R-HSA-141430	1	0	0/18	1	
Inactivation of CDC42 and RAC1 R-HSA-428543	0.124423905593351	9.35086557215028	1/5	1	CDC42
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462	0.486260042626989	1.55293979689739	1/25	1	STAT5B
Inactivation, recovery and regulation of the phototransduction cascade R-HSA-2514859	1	0	0/9	1	
Incretin synthesis, secretion, and inactivation R-HSA-400508	1	0	0/11	1	
Induction of Cell-Cell Fusion R-HSA-9733458	0.100831870512745	12.4605401761496	1/4	1	FURIN
Infection with Mycobacterium tuberculosis R-HSA-9635486	1	0	0/16	1	
Infectious disease R-HSA-5663205	0.864676931292271	0.757224151778231	14/673	1	SRC;H2BC21;H2BC12;H4C9;H2BC14;EP300;NCOR1;FURIN;CDC42;APP;ATP1A1;FXYD2;SMAD3;JAK3
Inflammasomes R-HSA-622312	0.396981147981571	2.07367136211455	1/19	1	APP
Influenza Infection R-HSA-168255	1	0	0/119	1	
Influenza Viral RNA Transcription and Replication R-HSA-168273	1	0	0/106	1	
Influenza Virus Induced Apoptosis R-HSA-168277	1	0	0/1	1	
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits R-HSA-997272	1	0	0/11	1	
Inhibition of Host mRNA Processing and RNA Silencing R-HSA-168315	1	0	0/0	1	
Inhibition of PKR R-HSA-169131	1	0	0/1	1	
Inhibition of Signaling by Overexpressed EGFR R-HSA-5638303	1	0	0/8	1	
Inhibition of TSC complex formation by PKB R-HSA-165181	1	0	0/3	1	
Inhibition of membrane repair R-HSA-9635644	1	0	0/1	1	
Inhibition of nitric oxide production R-HSA-9636249	1	0	0/3	1	
Inhibition of replication initiation of damaged DNA by RB1/E2F1 R-HSA-113501	1	0	0/10	1	
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components R-HSA-141405	1	0	0/18	1	
Initial triggering of complement R-HSA-166663	1	0	0/11	1	
Initiation of Nuclear Envelope (NE) Reformation R-HSA-2995383	1	0	0/8	1	
InlA-mediated entry of Listeria monocytogenes into host cells R-HSA-8876493	0.191582925100974	5.34296079232313	1/8	1	SRC
InlB-mediated entry of Listeria monocytogenes into host cell R-HSA-8875360	1	0	0/10	1	
Innate Immune System R-HSA-168249	0.988458913328006	0.470030452331551	7/522	1	SRC;EP300;LRRC7;CDC42;APP;GSN;STAT6
Inositol phosphate metabolism R-HSA-1483249	1	0	0/15	1	
Inositol transporters R-HSA-429593	1	0	0/0	1	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane R-HSA-9609523	0.292358333261937	3.11429423158507	1/13	1	APP
Insulin effects increased synthesis of Xylulose-5-Phosphate R-HSA-163754	1	0	0/2	1	
Insulin processing R-HSA-264876	1	0	0/8	1	
Insulin receptor recycling R-HSA-77387	1	0	0/16	1	
Insulin receptor signalling cascade R-HSA-74751	1	0	0/29	1	
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA R-HSA-428359	1	0	0/0	1	
Integration of energy metabolism R-HSA-163685	1	0	0/48	1	
Integration of provirus R-HSA-162592	1	0	0/7	1	
Integration of viral DNA into host genomic DNA R-HSA-175567	1	0	0/3	1	
Integrin cell surface interactions R-HSA-216083	0.737180506582421	0.755924037913128	1/50	1	VWF
Interaction With Cumulus Cells And The Zona Pellucida R-HSA-2534343	1	0	0/3	1	
Interaction between L1 and Ankyrins R-HSA-445095	1	0	0/13	1	
Interaction between PHLDA1 and AURKA R-HSA-8854521	1	0	0/2	1	
Interactions of Rev with host cellular proteins R-HSA-177243	1	0	0/14	1	
Interactions of Tat with host cellular proteins R-HSA-176034	1	0	0/2	1	
Interactions of Vpr with host cellular proteins R-HSA-176033	1	0	0/14	1	
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate R-HSA-880009	1	0	0/3	1	
Interconversion of nucleotide di- and triphosphates R-HSA-499943	1	0	0/12	1	
Interconversion of polyamines R-HSA-351200	1	0	0/0	1	
Interferon Signaling R-HSA-913531	0.992896978174248	0.197726397297058	1/182	1	SPHK1
Interferon alpha/beta signaling R-HSA-909733	1	0	0/59	1	
Interferon gamma signaling R-HSA-877300	1	0	0/59	1	
Interleukin receptor SHC signaling R-HSA-912526	0.346741223784396	2.49010112143882	1/16	1	JAK3
Interleukin-1 family signaling R-HSA-446652	0.815004139344731	0.645125342135349	2/116	1	APP;SMAD3
Interleukin-1 processing R-HSA-448706	1	0	0/8	1	
Interleukin-1 signaling R-HSA-9020702	0.926314390882232	0.381210969773804	1/97	1	APP
Interleukin-10 signaling R-HSA-6783783	1	0	0/36	1	
Interleukin-12 family signaling R-HSA-447115	0.637249115747812	1.00411758787702	1/38	1	CDC42
Interleukin-12 signaling R-HSA-9020591	0.525856190208566	1.3793942445188	1/28	1	CDC42
Interleukin-17 signaling R-HSA-448424	1	0	0/53	1	
Interleukin-18 signaling R-HSA-9012546	1	0	0/4	1	
Interleukin-2 family signaling R-HSA-451927	0.184934398250033	2.68425490364007	2/30	1	JAK3;STAT5B
Interleukin-20 family signaling R-HSA-8854691	0.138428952428092	3.27166082707728	2/25	1	JAK3;STAT5B
Interleukin-23 signaling R-HSA-9020933	1	0	0/7	1	
Interleukin-27 signaling R-HSA-9020956	1	0	0/11	1	
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988	0.233286892067172	2.27484794144367	2/35	1	JAK3;STAT5B
Interleukin-33 signaling R-HSA-9014843	1	0	0/1	1	
Interleukin-35 Signalling R-HSA-8984722	1	0	0/12	1	
Interleukin-36 pathway R-HSA-9014826	1	0	0/1	1	
Interleukin-37 signaling R-HSA-9008059	0.253635549571777	3.73892787264533	1/11	1	SMAD3
Interleukin-38 signaling R-HSA-9007892	1	0	0/2	1	
Interleukin-4 and Interleukin-13 signaling R-HSA-6785807	0.116705863496404	2.02394783856825	5/99	1	NANOG;STAT6;IL4R;JUNB;JAK3
Interleukin-6 family signaling R-HSA-6783589	1	0	0/19	1	
Interleukin-6 signaling R-HSA-1059683	1	0	0/11	1	
Interleukin-7 signaling R-HSA-1266695	0.213805170739805	2.42282427164737	2/33	1	JAK3;STAT5B
Intestinal absorption R-HSA-8963676	1	0	0/2	1	
Intestinal hexose absorption R-HSA-8981373	1	0	0/2	1	
Intestinal infectious diseases R-HSA-8942233	1	0	0/0	1	
Intestinal lipid absorption R-HSA-8963678	1	0	0/0	1	
Intestinal saccharidase deficiencies R-HSA-5659898	1	0	0/1	1	
Intra-Golgi and retrograde Golgi-to-ER traffic R-HSA-6811442	1	0	0/105	1	
Intra-Golgi traffic R-HSA-6811438	1	0	0/25	1	
Intracellular metabolism of fatty acids regulates insulin secretion R-HSA-434313	1	0	0/1	1	
Intracellular oxygen transport R-HSA-8981607	1	0	0/0	1	
Intracellular signaling by second messengers R-HSA-9006925	0.98299247715356	0.325057330660471	2/222	1	SRC;PIP5K1A
Intraflagellar transport R-HSA-5620924	1	0	0/30	1	
Intrinsic Pathway for Apoptosis R-HSA-109606	1	0	0/38	1	
Invadopodia formation R-HSA-8941237	1	0	0/3	1	
Inwardly rectifying K+ channels R-HSA-1296065	1	0	0/13	1	
Ion homeostasis R-HSA-5578775	0.15672262787221	3.00855819333667	2/27	1	ATP1A1;FXYD2
Ion influx/efflux at host-pathogen interface R-HSA-6803544	1	0	0/2	1	
Ion transport by P-type ATPases R-HSA-936837	0.0871648296231222	4.43225988266371	2/19	1	ATP1A1;FXYD2
Ionotropic activity of kainate receptors R-HSA-451306	1	0	0/4	1	
Iron uptake and transport R-HSA-917937	1	0	0/31	1	
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1 R-HSA-450321	1	0	0/21	1	
Josephin domain DUBs R-HSA-5689877	1	0	0/6	1	
KEAP1-NFE2L2 pathway R-HSA-9755511	0.952373110842635	0.325396449309576	1/113	1	EP300
KIT mutants bind TKIs R-HSA-9669921	1	0	0/1	1	
KSRP (KHSRP) binds and destabilizes mRNA R-HSA-450604	1	0	0/16	1	
KW2449-resistant FLT3 mutants R-HSA-9702569	1	0	0/0	1	
Keratan sulfate biosynthesis R-HSA-2022854	1	0	0/9	1	
Keratan sulfate degradation R-HSA-2022857	1	0	0/7	1	
Keratan sulfate/keratin metabolism R-HSA-1638074	1	0	0/12	1	
Keratinization R-HSA-6805567	0.253635549571777	3.73892787264533	1/11	1	FURIN
Ketone body metabolism R-HSA-74182	1	0	0/1	1	
Kidney development R-HSA-9830369	0.42832825457232	1.86538195580771	1/21	1	WT1
Killing mechanisms R-HSA-9664420	1	0	0/6	1	
Kinesins R-HSA-983189	1	0	0/28	1	
L13a-mediated translational silencing of Ceruloplasmin expression R-HSA-156827	1	0	0/96	1	
L1CAM interactions R-HSA-373760	0.846730280611795	0.534082269757296	1/70	1	SRC
LDL clearance R-HSA-8964038	1	0	0/8	1	
LDL remodeling R-HSA-8964041	1	0	0/3	1	
LGI-ADAM interactions R-HSA-5682910	1	0	0/1	1	
LGK974 inhibits PORCN R-HSA-5340573	1	0	0/0	1	
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production R-HSA-3134973	0.124423905593351	9.35086557215028	1/5	1	EP300
LTC4-CYSLTR mediated IL4 production R-HSA-9664535	1	0	0/2	1	
Lactose synthesis R-HSA-5653890	1	0	0/0	1	
Lagging Strand Synthesis R-HSA-69186	1	0	0/7	1	
Laminin interactions R-HSA-3000157	1	0	0/17	1	
Late Phase of HIV Life Cycle R-HSA-162599	0.846730280611795	0.534082269757296	1/70	1	FURIN
Late SARS-CoV-2 Infection Events R-HSA-9772573	0.585240815357872	1.16245213012818	1/33	1	FURIN
Late endosomal microautophagy R-HSA-9615710	1	0	0/16	1	
Latent infection - Other responses of Mtb to phagocytosis R-HSA-1222499	1	0	0/0	1	
Leading Strand Synthesis R-HSA-69109	1	0	0/5	1	
Lectin pathway of complement activation R-HSA-166662	1	0	0/4	1	
Leishmania infection R-HSA-9658195	0.260515983890269	1.58613749308496	4/99	1	SRC;FURIN;CDC42;APP
Leishmania parasite growth and survival R-HSA-9664433	0.301913091607522	1.87369153768745	2/42	1	SRC;FURIN
Leishmania phagocytosis R-HSA-9664417	0.243071584258469	2.20755486092926	2/36	1	SRC;CDC42
Leukotriene receptors R-HSA-391906	1	0	0/1	1	
Lewis blood group biosynthesis R-HSA-9037629	1	0	0/3	1	
Ligand-receptor interactions R-HSA-5632681	1	0	0/5	1	
Linoleic acid (LA) metabolism R-HSA-2046105	1	0	0/3	1	
Lipid particle organization R-HSA-8964572	1	0	0/2	1	
Lipophagy R-HSA-9613354	1	0	0/4	1	
Listeria monocytogenes entry into host cells R-HSA-8876384	0.310966623183603	2.87416395939725	1/14	1	SRC
Localization of the PINCH-ILK-PARVIN complex to focal adhesions R-HSA-446343	1	0	0/4	1	
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling R-HSA-2644607	1	0	0/5	1	
Loss of Function of TGFBR2 in Cancer R-HSA-3642278	1	0	0/3	1	
Loss of Function of TP53 in Cancer R-HSA-9723907	1	0	0/1	1	
Loss of Nlp from mitotic centrosomes R-HSA-380259	1	0	0/36	1	
Loss of function of TP53 in cancer due to loss of tetramerization ability R-HSA-9723905	1	0	0/1	1	
Loss of proteins required for interphase microtubule organization from the centrosome R-HSA-380284	1	0	0/36	1	
Lysine catabolism R-HSA-71064	1	0	0/6	1	
Lysosomal oligosaccharide catabolism R-HSA-8853383	1	0	0/2	1	
Lysosome Vesicle Biogenesis R-HSA-432720	0.472346799019033	1.62085821553598	1/24	1	APP
Lysosphingolipid and LPA receptors R-HSA-419408	1	0	0/2	1	
M Phase R-HSA-68886	0.515475646019763	1.04307270126499	7/257	1	AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;H3-4
M-decay: degradation of maternal mRNAs by maternally stored factors R-HSA-9820841	1	0	0/18	1	
MAP kinase activation R-HSA-450294	1	0	0/53	1	
MAP2K and MAPK activation R-HSA-5674135	0.112011748153723	3.76519981573746	2/22	1	SRC;VWF
MAP3K8 (TPL2)-dependent MAPK1/3 activation R-HSA-5684264	1	0	0/13	1	
MAPK family signaling cascades R-HSA-5683057	0.518440012610663	1.05817827974219	5/181	1	SRC;LRRC7;CDC42;JAK3;VWF
MAPK targets/ Nuclear events mediated by MAP kinases R-HSA-450282	1	0	0/25	1	
MAPK1 (ERK2) activation R-HSA-112411	1	0	0/8	1	
MAPK1/MAPK3 signaling R-HSA-5684996	0.590540679261004	0.976785702470311	4/156	1	SRC;LRRC7;JAK3;VWF
MAPK3 (ERK1) activation R-HSA-110056	1	0	0/9	1	
MAPK6/MAPK4 signaling R-HSA-5687128	0.862446136502824	0.504298930258438	1/74	1	CDC42
MASTL Facilitates Mitotic Progression R-HSA-2465910	1	0	0/10	1	
MDK and PTN in ALK signaling R-HSA-9851151	1	0	0/1	1	
MECP2 regulates neuronal receptors and channels R-HSA-9022699	0.212814889902584	4.67518817282894	1/9	1	MECP2
MECP2 regulates transcription factors R-HSA-9022707	0.100831870512745	12.4605401761496	1/4	1	MECP2
MECP2 regulates transcription of neuronal ligands R-HSA-9022702	0.124423905593351	9.35086557215028	1/5	1	MECP2
MET Receptor Activation R-HSA-6806942	1	0	0/1	1	
MET activates PI3K/AKT signaling R-HSA-8851907	1	0	0/5	1	
MET activates PTK2 signaling R-HSA-8874081	0.396981147981571	2.07367136211455	1/19	1	SRC
MET activates PTPN11 R-HSA-8865999	1	0	0/4	1	
MET activates RAP1 and RAC1 R-HSA-8875555	1	0	0/7	1	
MET activates RAS signaling R-HSA-8851805	1	0	0/8	1	
MET activates STAT3 R-HSA-8875791	1	0	0/2	1	
MET interacts with TNS proteins R-HSA-8875513	1	0	0/2	1	
MET promotes cell motility R-HSA-8875878	0.486260042626989	1.55293979689739	1/25	1	SRC
MET receptor recycling R-HSA-8875656	1	0	0/7	1	
MGMT-mediated DNA damage reversal R-HSA-5657655	1	0	0/0	1	
MHC class II antigen presentation R-HSA-2132295	1	0	0/66	1	
MITF-M-dependent gene expression R-HSA-9856651	0.715104748916063	0.805835053399797	1/47	1	ARID1A
MITF-M-regulated melanocyte development R-HSA-9730414	0.504222652838153	1.202171898016	2/64	1	ARID1A;WNT3A
MPS I - Hurler syndrome R-HSA-2206302	1	0	0/1	1	
MPS II - Hunter syndrome R-HSA-2206296	1	0	0/0	1	
MPS IIIA - Sanfilippo syndrome A R-HSA-2206307	1	0	0/1	1	
MPS IIIB - Sanfilippo syndrome B R-HSA-2206282	1	0	0/1	1	
MPS IIIC - Sanfilippo syndrome C R-HSA-2206291	1	0	0/1	1	
MPS IIID - Sanfilippo syndrome D R-HSA-2206305	1	0	0/1	1	
MPS IV - Morquio syndrome A R-HSA-2206290	1	0	0/0	1	
MPS IV - Morquio syndrome B R-HSA-2206308	1	0	0/0	1	
MPS IX - Natowicz syndrome R-HSA-2206280	1	0	0/0	1	
MPS VI - Maroteaux-Lamy syndrome R-HSA-2206285	1	0	0/0	1	
MPS VII - Sly syndrome R-HSA-2206292	1	0	0/0	1	
MTF1 activates gene expression R-HSA-5660489	1	0	0/0	1	
MTOR signalling R-HSA-165159	1	0	0/34	1	
Macroautophagy R-HSA-1632852	0.892208603102462	0.447914083222512	1/83	1	SRC
Major pathway of rRNA processing in the nucleolus and cytosol R-HSA-6791226	0.958460281057115	0.311084781759856	1/118	1	DDX21
Malate-aspartate shuttle R-HSA-9856872	1	0	0/3	1	
Manipulation of host energy metabolism R-HSA-9636667	1	0	0/2	1	
Masitinib-resistant KIT mutants R-HSA-9669924	1	0	0/1	1	
Maturation of TCA enzymes and regulation of TCA cycle R-HSA-9854311	1	0	0/5	1	
Maturation of hRSV A proteins R-HSA-9828806	0.273252368749906	3.39809007232892	1/12	1	FURIN
Maturation of nucleoprotein R-HSA-9683610	1	0	0/8	1	
Maturation of nucleoprotein R-HSA-9694631	1	0	0/10	1	
Maturation of protein 3a R-HSA-9683673	1	0	0/4	1	
Maturation of protein 3a R-HSA-9694719	1	0	0/4	1	
Maturation of protein E R-HSA-9683683	1	0	0/4	1	
Maturation of protein E R-HSA-9694493	1	0	0/4	1	
Maturation of replicase proteins R-HSA-9694301	1	0	0/0	1	
Maturation of spike protein R-HSA-9683686	1	0	0/2	1	
Maturation of spike protein R-HSA-9694548	1	0	0/14	1	
Melanin biosynthesis R-HSA-5662702	1	0	0/1	1	
Membrane Trafficking R-HSA-199991	0.996575619896877	0.246540724368668	2/287	1	SRC;APP
Membrane binding and targetting of GAG proteins R-HSA-174490	1	0	0/7	1	
Metabolic disorders of biological oxidation enzymes R-HSA-5579029	1	0	0/10	1	
Metabolism R-HSA-1430728	0.88796972932505	0.757853322719179	19/900	1	TSPOAP1;EP300;NCOR1;SPHK1;ARNT;ASPG;ASPA;NAMPT;CNDP2;ACSS1;ACSBG1;ELOVL7;ACAD11;GBA2;PIP5K1A;ACER1;ASS1;CAD;CERS5
Metabolism of Angiotensinogen to Angiotensins R-HSA-2022377	1	0	0/7	1	
Metabolism of RNA R-HSA-8953854	0.999977963707445	0.0884222390147283	1/384	1	DDX21
Metabolism of amine-derived hormones R-HSA-209776	1	0	0/5	1	
Metabolism of amino acids and derivatives R-HSA-71291	0.929179242084151	0.509404611351383	3/216	1	ASPG;ASPA;ASS1
Metabolism of carbohydrates R-HSA-71387	1	0	0/107	1	
Metabolism of cofactors R-HSA-8978934	1	0	0/6	1	
Metabolism of fat-soluble vitamins R-HSA-6806667	1	0	0/13	1	
Metabolism of folate and pterines R-HSA-196757	1	0	0/9	1	
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se R-HSA-2408550	1	0	0/3	1	
Metabolism of ingested MeSeO2H into MeSeH R-HSA-5263617	1	0	0/1	1	
Metabolism of ingested SeMet, Sec, MeSec into H2Se R-HSA-2408508	1	0	0/4	1	
Metabolism of lipids R-HSA-556833	0.0946971064648443	1.60563090667658	12/302	1	TSPOAP1;EP300;NCOR1;SPHK1;ARNT;ACSBG1;ELOVL7;ACAD11;GBA2;PIP5K1A;ACER1;CERS5
Metabolism of nitric oxide: NOS3 activation and regulation R-HSA-202131	1	0	0/7	1	
Metabolism of non-coding RNA R-HSA-194441	1	0	0/21	1	
Metabolism of nucleotides R-HSA-15869	0.656194471025846	0.952147964858822	1/40	1	CAD
Metabolism of polyamines R-HSA-351202	1	0	0/51	1	
Metabolism of porphyrins R-HSA-189445	1	0	0/13	1	
Metabolism of proteins R-HSA-392499	0.796666439879485	0.842163246586463	23/998	1	AURKB;H2BC21;H2BC12;H4C9;H2AX;H2BC14;EP300;FURIN;UBE2V2;APP;GSN;SPHK1;TTLL3;HIPK2;MDC1;BABAM1;UIMC1;SERPINC1;SMAD3;SMAD2;NR5A2;CARS2;AARS2
Metabolism of serotonin R-HSA-380612	1	0	0/1	1	
Metabolism of steroid hormones R-HSA-196071	0.169783838370041	6.23416731470989	1/7	1	TSPOAP1
Metabolism of steroids R-HSA-8957322	0.750947445829768	0.725911579475404	1/52	1	TSPOAP1
Metabolism of vitamin K R-HSA-6806664	1	0	0/0	1	
Metabolism of vitamins and cofactors R-HSA-196854	0.814833509799108	0.595448991611103	1/63	1	NAMPT
Metabolism of water-soluble vitamins and cofactors R-HSA-196849	0.691193656669326	0.862708842774289	1/44	1	NAMPT
Metal ion SLC transporters R-HSA-425410	1	0	0/3	1	
Metal sequestration by antimicrobial proteins R-HSA-6799990	1	0	0/3	1	
Metallothioneins bind metals R-HSA-5661231	1	0	0/0	1	
Methionine salvage pathway R-HSA-1237112	1	0	0/4	1	
Methylation R-HSA-156581	1	0	0/7	1	
Methylation of MeSeH for excretion R-HSA-2408552	1	0	0/1	1	
MicroRNA (miRNA) biogenesis R-HSA-203927	0.380675025962704	2.19604331875759	1/18	1	DGCR8
Microbial modulation of RIPK1-mediated regulated necrosis R-HSA-9686347	1	0	0/4	1	
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane R-HSA-190840	1	0	0/20	1	
Mineralocorticoid biosynthesis R-HSA-193993	1	0	0/0	1	
Minus-strand DNA synthesis R-HSA-164516	1	0	0/1	1	
Miro GTPase Cycle R-HSA-9715370	1	0	0/1	1	
Miscellaneous substrates R-HSA-211958	1	0	0/5	1	
Miscellaneous transport and binding events R-HSA-5223345	1	0	0/8	1	
Mismatch Repair R-HSA-5358508	1	0	0/5	1	
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) R-HSA-5358606	1	0	0/4	1	
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) R-HSA-5358565	1	0	0/5	1	
Mitochondrial ABC transporters R-HSA-1369007	1	0	0/3	1	
Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289	0.42832825457232	1.86538195580771	1/21	1	ACAD11
Mitochondrial RNA degradation R-HSA-9836573	1	0	0/0	1	
Mitochondrial Uncoupling R-HSA-166187	1	0	0/0	1	
Mitochondrial biogenesis R-HSA-1592230	0.824564100376711	0.576546046121986	1/65	1	NCOR1
Mitochondrial calcium ion transport R-HSA-8949215	1	0	0/13	1	
Mitochondrial iron-sulfur cluster biogenesis R-HSA-1362409	1	0	0/1	1	
Mitochondrial protein degradation R-HSA-9837999	0.737180506582421	0.755924037913128	1/50	1	APP
Mitochondrial protein import R-HSA-1268020	1	0	0/26	1	
Mitochondrial transcription initiation R-HSA-163282	1	0	0/2	1	
Mitochondrial transcription termination R-HSA-163316	1	0	0/0	1	
Mitochondrial translation R-HSA-5368287	1	0	0/55	1	
Mitochondrial translation elongation R-HSA-5389840	1	0	0/54	1	
Mitochondrial translation initiation R-HSA-5368286	1	0	0/54	1	
Mitochondrial translation termination R-HSA-5419276	1	0	0/53	1	
Mitophagy R-HSA-5205647	0.346741223784396	2.49010112143882	1/16	1	SRC
Mitotic Anaphase R-HSA-68882	0.9807485418154	0.249178227997776	1/146	1	AURKB
Mitotic G1 phase and G1/S transition R-HSA-453279	0.574176070286612	1.01359077692673	3/113	1	SRC;E2F5;MYBL2
Mitotic G2-G2/M phases R-HSA-453274	0.875908821610115	0.550226196750985	2/135	1	EP300;MYBL2
Mitotic Metaphase and Anaphase R-HSA-2555396	0.9807485418154	0.249178227997776	1/146	1	AURKB
Mitotic Metaphase/Anaphase Transition R-HSA-68881	1	0	0/1	1	
Mitotic Prometaphase R-HSA-68877	0.926314390882232	0.381210969773804	1/97	1	AURKB
Mitotic Spindle Checkpoint R-HSA-69618	0.737180506582421	0.755924037913128	1/50	1	AURKB
Mitotic Telophase/Cytokinesis R-HSA-68884	1	0	0/11	1	
Modulation by Mtb of host immune system R-HSA-9637628	1	0	0/6	1	
Molecules associated with elastic fibres R-HSA-2129379	1	0	0/17	1	
Molybdenum cofactor biosynthesis R-HSA-947581	1	0	0/2	1	
Mtb iron assimilation by chelation R-HSA-1222449	1	0	0/0	1	
Mucopolysaccharidoses R-HSA-2206281	1	0	0/5	1	
Multifunctional anion exchangers R-HSA-427601	1	0	0/2	1	
Muscarinic acetylcholine receptors R-HSA-390648	1	0	0/0	1	
Muscle contraction R-HSA-397014	0.109439462474369	2.06890711708295	5/97	1	ATP1A1;HIPK2;FXYD2;TTN;NEB
MyD88 cascade initiated on plasma membrane R-HSA-975871	0.866118859306527	0.497356129905137	1/75	1	APP
MyD88 deficiency (TLR2/4) R-HSA-5602498	1	0	0/13	1	
MyD88 deficiency (TLR5) R-HSA-5602680	1	0	0/1	1	
MyD88 dependent cascade initiated on endosome R-HSA-975155	0.886201646223107	0.459348679850541	1/81	1	APP
MyD88-independent TLR4 cascade  R-HSA-166166	0.910863105667819	0.411939646370659	1/90	1	APP
MyD88:MAL(TIRAP) cascade initiated on plasma membrane R-HSA-166058	0.908408309409255	0.41672848853144	1/89	1	APP
Myoclonic epilepsy of Lafora R-HSA-3785653	1	0	0/6	1	
Myogenesis R-HSA-525793	0.380675025962704	2.19604331875759	1/18	1	CDC42
N-Glycan antennae elongation R-HSA-975577	1	0	0/3	1	
N-glycan antennae elongation in the medial/trans-Golgi R-HSA-975576	1	0	0/5	1	
N-glycan trimming and elongation in the cis-Golgi R-HSA-964739	1	0	0/0	1	
N-glycan trimming in the ER and Calnexin/Calreticulin cycle R-HSA-532668	1	0	0/19	1	
NADE modulates death signalling R-HSA-205025	1	0	0/4	1	
NADPH regeneration R-HSA-389542	1	0	0/0	1	
NCAM signaling for neurite out-growth R-HSA-375165	0.585240815357872	1.16245213012818	1/33	1	SRC
NCAM1 interactions R-HSA-419037	1	0	0/20	1	
NEIL3-mediated resolution of ICLs R-HSA-9636003	1	0	0/0	1	
NEP/NS2 Interacts with the Cellular Export Machinery R-HSA-168333	1	0	0/11	1	
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 R-HSA-933543	1	0	0/11	1	
NF-kB is activated and signals survival R-HSA-209560	1	0	0/12	1	
NFE2L2 regulates pentose phosphate pathway genes R-HSA-9818028	0.191582925100974	5.34296079232313	1/8	1	EP300
NFE2L2 regulating ER-stress associated genes R-HSA-9818035	0.124423905593351	9.35086557215028	1/5	1	EP300
NFE2L2 regulating MDR associated enzymes R-HSA-9818032	0.169783838370041	6.23416731470989	1/7	1	EP300
NFE2L2 regulating TCA cycle genes R-HSA-9818025	1	0	0/1	1	
NFE2L2 regulating anti-oxidant/detoxification enzymes R-HSA-9818027	0.396981147981571	2.07367136211455	1/19	1	EP300
NFE2L2 regulating inflammation associated genes R-HSA-9818026	0.124423905593351	9.35086557215028	1/5	1	EP300
NFE2L2 regulating tumorigenic genes R-HSA-9818030	0.253635549571777	3.73892787264533	1/11	1	EP300
NFG and proNGF binds to p75NTR R-HSA-205017	1	0	0/1	1	
NGF-independant TRKA activation R-HSA-187024	1	0	0/3	1	
NGF-stimulated transcription R-HSA-9031628	0.243071584258469	2.20755486092926	2/36	1	EP300;JUNB
NIK-->noncanonical NF-kB signaling R-HSA-5676590	1	0	0/57	1	
NOD1/2 Signaling Pathway R-HSA-168638	1	0	0/31	1	
NOSIP mediated eNOS trafficking R-HSA-203754	1	0	0/0	1	
NOSTRIN mediated eNOS trafficking R-HSA-203641	1	0	0/2	1	
NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947	0.360001386168959	1.62682998198651	2/48	1	EP300;NCOR1
NOTCH2 Activation and Transmission of Signal to the Nucleus R-HSA-2979096	1	0	0/13	1	
NOTCH2 intracellular domain regulates transcription R-HSA-2197563	0.273252368749906	3.39809007232892	1/12	1	EP300
NOTCH3 Activation and Transmission of Signal to the Nucleus R-HSA-9013507	1	0	0/16	1	
NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508	0.472346799019033	1.62085821553598	1/24	1	EP300
NOTCH4 Activation and Transmission of Signal to the Nucleus R-HSA-9013700	1	0	0/8	1	
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695	0.0952469944498643	4.18502489709519	2/20	1	EP300;SMAD3
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis  R-HSA-9632974	1	0	0/4	1	
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis R-HSA-9029558	1	0	0/5	1	
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose R-HSA-9031528	1	0	0/3	1	
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis R-HSA-9623433	0.14740262953668	7.48288775581792	1/6	1	NCOR1
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake  R-HSA-9031525	1	0	0/4	1	
NR1H2 and NR1H3-mediated signaling R-HSA-9024446	0.120662870905102	3.58472021345235	2/23	1	EP300;NCOR1
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux R-HSA-9029569	0.0952469944498643	4.18502489709519	2/20	1	EP300;NCOR1
NRAGE signals death through JNK R-HSA-193648	0.525856190208566	1.3793942445188	1/28	1	ARHGEF7
NRIF signals cell death from the nucleus R-HSA-205043	1	0	0/12	1	
NS1 Mediated Effects on Host Pathways R-HSA-168276	1	0	0/14	1	
NTF3 activates NTRK2 (TRKB) signaling R-HSA-9025046	1	0	0/1	1	
NTF3 activates NTRK3 signaling R-HSA-9034013	1	0	0/0	1	
NTF4 activates NTRK2 (TRKB) signaling R-HSA-9026357	1	0	0/1	1	
NTRK2 activates RAC1 R-HSA-9032759	1	0	0/3	1	
NTRK3 as a dependence receptor R-HSA-9603505	1	0	0/1	1	
NVP-TAE684-resistant ALK mutants R-HSA-9717301	1	0	0/0	1	
Na+/Cl- dependent neurotransmitter transporters R-HSA-442660	1	0	0/4	1	
Nectin/Necl  trans heterodimerization R-HSA-420597	1	0	0/2	1	
Neddylation R-HSA-8951664	1	0	0/133	1	
Nef Mediated CD4 Down-regulation R-HSA-167590	1	0	0/6	1	
Nef Mediated CD8 Down-regulation R-HSA-182218	1	0	0/4	1	
Nef and signal transduction R-HSA-164944	1	0	0/7	1	
Nef mediated downregulation of CD28 cell surface expression R-HSA-164939	1	0	0/1	1	
Nef mediated downregulation of MHC class I complex cell surface expression R-HSA-164940	1	0	0/5	1	
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters R-HSA-164938	1	0	0/12	1	
Negative feedback regulation of MAPK pathway R-HSA-5674499	1	0	0/4	1	
Negative regulation of FGFR1 signaling R-HSA-5654726	0.363932244211123	2.33377333495509	1/17	1	SRC
Negative regulation of FGFR2 signaling R-HSA-5654727	0.396981147981571	2.07367136211455	1/19	1	SRC
Negative regulation of FGFR3 signaling R-HSA-5654732	0.363932244211123	2.33377333495509	1/17	1	SRC
Negative regulation of FGFR4 signaling R-HSA-5654733	0.363932244211123	2.33377333495509	1/17	1	SRC
Negative regulation of FLT3 R-HSA-9706369	1	0	0/8	1	
Negative regulation of MAPK pathway R-HSA-5675221	1	0	0/21	1	
Negative regulation of MET activity R-HSA-6807004	1	0	0/13	1	
Negative regulation of NMDA receptor-mediated neuronal transmission R-HSA-9617324	0.273252368749906	3.39809007232892	1/12	1	LRRC7
Negative regulation of NOTCH4 signaling R-HSA-9604323	1	0	0/52	1	
Negative regulation of TCF-dependent signaling by DVL-interacting proteins R-HSA-5368598	1	0	0/2	1	
Negative regulation of TCF-dependent signaling by WNT ligand antagonists R-HSA-3772470	0.14740262953668	7.48288775581792	1/6	1	WNT3A
Negative regulation of activity of TFAP2 (AP-2) family transcription factors R-HSA-8866904	1	0	0/6	1	
Negative regulation of the PI3K/AKT network R-HSA-199418	0.504222652838153	1.202171898016	2/64	1	SRC;PIP5K1A
Negative regulators of DDX58/IFIH1 signaling R-HSA-936440	1	0	0/27	1	
Nephrin family interactions R-HSA-373753	1	0	0/15	1	
Nephron development R-HSA-9831926	0.169783838370041	6.23416731470989	1/7	1	WT1
Nervous system development R-HSA-9675108	0.915959095049347	0.615147122359863	6/356	1	SRC;ARHGEF7;CDC42;UNC5B;ABLIM2;NTN1
Neurodegenerative Diseases R-HSA-8863678	0.292358333261937	3.11429423158507	1/13	1	APP
Neurofascin interactions R-HSA-447043	1	0	0/4	1	
Neurophilin interactions with VEGF and VEGFR R-HSA-194306	1	0	0/2	1	
Neurotoxicity of clostridium toxins R-HSA-168799	1	0	0/3	1	
Neurotransmitter clearance R-HSA-112311	1	0	0/2	1	
Neurotransmitter receptors and postsynaptic signal transmission R-HSA-112314	0.442868393147752	1.24523092494617	3/93	1	SRC;LRRC7;ARHGEF7
Neurotransmitter release cycle R-HSA-112310	0.329090081730138	2.668231298019	1/15	1	TSPOAP1
Neurotransmitter uptake and metabolism In glial cells R-HSA-112313	1	0	0/2	1	
Neutrophil degranulation R-HSA-6798695	0.96542608425927	0.379413182354101	2/192	1	LRRC7;GSN
Nicotinamide salvaging R-HSA-197264	0.169783838370041	6.23416731470989	1/7	1	NAMPT
Nicotinate metabolism R-HSA-196807	0.273252368749906	3.39809007232892	1/12	1	NAMPT
Nilotinib-resistant KIT mutants R-HSA-9669926	1	0	0/1	1	
Nitric oxide stimulates guanylate cyclase R-HSA-392154	1	0	0/7	1	
Non-integrin membrane-ECM interactions R-HSA-3000171	0.585240815357872	1.16245213012818	1/33	1	NRXN1
Noncanonical activation of NOTCH3 R-HSA-9017802	1	0	0/6	1	
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) R-HSA-975957	1	0	0/92	1	
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) R-HSA-975956	1	0	0/84	1	
Nonsense-Mediated Decay (NMD) R-HSA-927802	1	0	0/92	1	
Norepinephrine Neurotransmitter Release Cycle R-HSA-181430	0.14740262953668	7.48288775581792	1/6	1	TSPOAP1
Notch-HLH transcription pathway R-HSA-350054	0.525856190208566	1.3793942445188	1/28	1	NCOR1
NrCAM interactions R-HSA-447038	1	0	0/3	1	
Nuclear Envelope (NE) Reassembly R-HSA-2995410	1	0	0/43	1	
Nuclear Envelope Breakdown R-HSA-2980766	1	0	0/19	1	
Nuclear Events (kinase and transcription factor activation) R-HSA-198725	0.397775930886028	1.49517783895063	2/52	1	EP300;JUNB
Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854	1	0	0/12	1	
Nuclear Receptor transcription pathway R-HSA-383280	0.213805170739805	2.42282427164737	2/33	1	NCOR1;NR5A2
Nuclear events mediated by NFE2L2 R-HSA-9759194	0.913252713861853	0.407257211849684	1/91	1	EP300
Nuclear events stimulated by ALK signaling in cancer R-HSA-9725371	0.15672262787221	3.00855819333667	2/27	1	JUNB;MECP2
Nuclear import of Rev protein R-HSA-180746	1	0	0/12	1	
Nuclear signaling by ERBB4 R-HSA-1251985	0.112011748153723	3.76519981573746	2/22	1	SRC;NCOR1
Nucleotide Excision Repair R-HSA-5696398	0.782317949247967	0.660257757933192	1/57	1	UBE2V2
Nucleotide biosynthesis R-HSA-8956320	0.124423905593351	9.35086557215028	1/5	1	CAD
Nucleotide catabolism R-HSA-8956319	1	0	0/17	1	
Nucleotide catabolism defects R-HSA-9735786	1	0	0/1	1	
Nucleotide salvage R-HSA-8956321	1	0	0/9	1	
Nucleotide salvage defects R-HSA-9734207	1	0	0/1	1	
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways R-HSA-168643	0.730017002776234	0.771867971889616	1/49	1	APP
Nucleotide-like (purinergic) receptors R-HSA-418038	1	0	0/5	1	
O-glycosylation of TSR domain-containing proteins R-HSA-5173214	1	0	0/15	1	
O-linked glycosylation R-HSA-5173105	1	0	0/38	1	
O-linked glycosylation of mucins R-HSA-913709	1	0	0/22	1	
O2/CO2 exchange in erythrocytes R-HSA-1480926	1	0	0/7	1	
OAS antiviral response R-HSA-8983711	1	0	0/5	1	
OGDH complex synthesizes succinyl-CoA from 2-OG R-HSA-9853506	1	0	0/2	1	
Oleoyl-phe metabolism R-HSA-9673163	1	0	0/0	1	
Olfactory Signaling Pathway R-HSA-381753	1	0	0/3	1	
Oligomerization of connexins into connexons R-HSA-190704	1	0	0/2	1	
Oncogene Induced Senescence R-HSA-2559585	1	0	0/26	1	
Oncogenic MAPK signaling R-HSA-6802957	0.301913091607522	1.87369153768745	2/42	1	SRC;VWF
Opioid Signalling R-HSA-111885	1	0	0/50	1	
Opsins R-HSA-419771	1	0	0/1	1	
Orc1 removal from chromatin R-HSA-68949	1	0	0/60	1	
Orexin and neuropeptides FF and QRFP bind to their respective receptors R-HSA-389397	1	0	0/3	1	
Organelle biogenesis and maintenance R-HSA-1852241	0.987278650108457	0.224926360373134	1/161	1	NCOR1
Organic anion transport R-HSA-561048	1	0	0/0	1	
Organic anion transporters R-HSA-428643	1	0	0/4	1	
Organic cation transport R-HSA-549127	1	0	0/4	1	
Organic cation/anion/zwitterion transport R-HSA-549132	1	0	0/4	1	
Other interleukin signaling R-HSA-449836	1	0	0/11	1	
Other semaphorin interactions R-HSA-416700	1	0	0/13	1	
Ovarian tumor domain proteases R-HSA-5689896	1	0	0/26	1	
Oxidative Stress Induced Senescence R-HSA-2559580	0.160537816772925	1.80673953132689	5/110	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha R-HSA-1234176	1	0	0/60	1	
P2Y receptors R-HSA-417957	1	0	0/3	1	
PAOs oxidise polyamines to amines R-HSA-141334	1	0	0/0	1	
PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801	1	0	0/8	1	
PCP/CE pathway R-HSA-4086400	0.869694420131296	0.490598448204506	1/76	1	FZD5
PD-1 signaling R-HSA-389948	1	0	0/18	1	
PDE3B signalling R-HSA-165160	1	0	0/2	1	
PDGFR mutants bind TKIs R-HSA-9674428	1	0	0/1	1	
PDH complex synthesizes acetyl-CoA from PYR R-HSA-9861559	1	0	0/2	1	
PECAM1 interactions R-HSA-210990	0.253635549571777	3.73892787264533	1/11	1	SRC
PERK regulates gene expression R-HSA-381042	1	0	0/28	1	
PI Metabolism R-HSA-1483255	0.646847616429472	0.977449047960505	1/39	1	PIP5K1A
PI and PC transport between ER and Golgi membranes R-HSA-1483196	1	0	0/0	1	
PI-3K cascade:FGFR1 R-HSA-5654689	1	0	0/7	1	
PI-3K cascade:FGFR2 R-HSA-5654695	1	0	0/9	1	
PI-3K cascade:FGFR3 R-HSA-5654710	1	0	0/7	1	
PI-3K cascade:FGFR4 R-HSA-5654720	1	0	0/7	1	
PI3K Cascade R-HSA-109704	1	0	0/21	1	
PI3K events in ERBB2 signaling R-HSA-1963642	1	0	0/11	1	
PI3K events in ERBB4 signaling R-HSA-1250342	1	0	0/6	1	
PI3K/AKT Signaling in Cancer R-HSA-2219528	0.842531110217598	0.542075518603833	1/69	1	SRC
PI3K/AKT activation R-HSA-198203	1	0	0/8	1	
PI5P Regulates TP53 Acetylation R-HSA-6811555	0.14740262953668	7.48288775581792	1/6	1	EP300
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558	0.461279337795891	1.3092783051562	2/59	1	SRC;PIP5K1A
PINK1-PRKN Mediated Mitophagy R-HSA-5205685	1	0	0/10	1	
PIP3 activates AKT signaling R-HSA-1257604	0.969946631722077	0.367210975999682	2/198	1	SRC;PIP5K1A
PIWI-interacting RNA (piRNA) biogenesis R-HSA-5601884	1	0	0/18	1	
PKA activation R-HSA-163615	1	0	0/10	1	
PKA activation in glucagon signalling R-HSA-164378	1	0	0/8	1	
PKA-mediated phosphorylation of CREB R-HSA-111931	1	0	0/12	1	
PKA-mediated phosphorylation of key metabolic factors R-HSA-163358	1	0	0/5	1	
PKB-mediated events R-HSA-109703	1	0	0/2	1	
PKMTs methylate histone lysines R-HSA-3214841	0.770269380049468	0.685060564559151	1/55	1	H4C9
PKR-mediated signaling R-HSA-9833482	0.854798677506653	0.518771170585774	1/72	1	SPHK1
PLC beta mediated events R-HSA-112043	1	0	0/28	1	
PLC-gamma1 signalling R-HSA-167021	1	0	0/2	1	
PLCG1 events in ERBB2 signaling R-HSA-1251932	1	0	0/3	1	
POLB-Dependent Long Patch Base Excision Repair R-HSA-110362	1	0	0/2	1	
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation R-HSA-2892247	0.14740262953668	7.48288775581792	1/6	1	NANOG
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation R-HSA-2892245	0.100831870512745	12.4605401761496	1/4	1	NANOG
PP2A-mediated dephosphorylation of key metabolic factors R-HSA-163767	1	0	0/6	1	
PPARA activates gene expression R-HSA-1989781	0.256173363982082	1.76272125971583	3/67	1	EP300;NCOR1;ARNT
PTEN Loss of Function in Cancer R-HSA-5674404	1	0	0/1	1	
PTEN Regulation R-HSA-6807070	1	0	0/119	1	
PTK6 Activates STAT3 R-HSA-8849474	1	0	0/3	1	
PTK6 Down-Regulation R-HSA-8849472	1	0	0/2	1	
PTK6 Expression R-HSA-8849473	1	0	0/5	1	
PTK6 Regulates Cell Cycle R-HSA-8849470	1	0	0/6	1	
PTK6 Regulates Proteins Involved in RNA Processing R-HSA-8849468	1	0	0/1	1	
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases R-HSA-8849471	1	0	0/12	1	
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 R-HSA-8849469	1	0	0/8	1	
PTK6 promotes HIF1A stabilization R-HSA-8857538	1	0	0/6	1	
Paracetamol ADME R-HSA-9753281	0.273252368749906	3.39809007232892	1/12	1	CNDP2
Paradoxical activation of RAF signaling by kinase inactive BRAF R-HSA-6802955	0.15672262787221	3.00855819333667	2/27	1	SRC;VWF
Parasite infection R-HSA-9664407	0.243071584258469	2.20755486092926	2/36	1	SRC;CDC42
Parasitic Infection Pathways R-HSA-9824443	0.260515983890269	1.58613749308496	4/99	1	SRC;FURIN;CDC42;APP
Passive transport by Aquaporins R-HSA-432047	1	0	0/3	1	
Pausing and recovery of HIV elongation R-HSA-167290	1	0	0/24	1	
Pausing and recovery of Tat-mediated HIV elongation R-HSA-167238	1	0	0/22	1	
Pentose phosphate pathway R-HSA-71336	1	0	0/9	1	
Pentose phosphate pathway disease R-HSA-6791465	1	0	0/2	1	
Peptide chain elongation R-HSA-156902	1	0	0/81	1	
Peptide hormone biosynthesis R-HSA-209952	1	0	0/5	1	
Peptide hormone metabolism R-HSA-2980736	1	0	0/35	1	
Peptide ligand-binding receptors R-HSA-375276	0.824564100376711	0.576546046121986	1/65	1	APP
Peroxisomal lipid metabolism R-HSA-390918	1	0	0/10	1	
Peroxisomal protein import R-HSA-9033241	1	0	0/25	1	
Pexophagy R-HSA-9664873	1	0	0/9	1	
Phase 0 - rapid depolarisation R-HSA-5576892	1	0	0/16	1	
Phase 1 - inactivation of fast Na+ channels R-HSA-5576894	1	0	0/0	1	
Phase 2 - plateau phase R-HSA-5576893	1	0	0/6	1	
Phase 3 - rapid repolarisation R-HSA-5576890	1	0	0/2	1	
Phase 4 - resting membrane potential R-HSA-5576886	1	0	0/4	1	
Phase I - Functionalization of compounds R-HSA-211945	0.147516353391238	3.13461810019507	2/26	1	ARNT;ACSS1
Phase II - Conjugation of compounds R-HSA-156580	0.715104748916063	0.805835053399797	1/47	1	CNDP2
Phenylalanine and tyrosine metabolism R-HSA-8963691	1	0	0/4	1	
Phenylalanine metabolism R-HSA-8964208	1	0	0/3	1	
Phenylketonuria R-HSA-2160456	1	0	0/0	1	
Phosphate bond hydrolysis by NTPDase proteins R-HSA-8850843	1	0	0/3	1	
Phosphate bond hydrolysis by NUDT proteins R-HSA-2393930	1	0	0/3	1	
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219	1	0	0/3	1	
Phospholipase C-mediated cascade; FGFR2 R-HSA-5654221	1	0	0/5	1	
Phospholipase C-mediated cascade; FGFR3 R-HSA-5654227	1	0	0/3	1	
Phospholipase C-mediated cascade; FGFR4 R-HSA-5654228	1	0	0/3	1	
Phospholipid metabolism R-HSA-1483257	0.87986326767361	0.471369595896877	1/79	1	PIP5K1A
Phosphorylation of CD3 and TCR zeta chains R-HSA-202427	1	0	0/16	1	
Phosphorylation of Emi1 R-HSA-176417	1	0	0/4	1	
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes R-HSA-69200	1	0	0/4	1	
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes R-HSA-170145	1	0	0/3	1	
Phosphorylation of the APC/C R-HSA-176412	1	0	0/20	1	
Physiological factors R-HSA-5578768	0.169783838370041	6.23416731470989	1/7	1	HIPK2
Plasma lipoprotein assembly R-HSA-8963898	1	0	0/14	1	
Plasma lipoprotein assembly, remodeling, and clearance R-HSA-174824	0.674159218827945	0.905247488900418	1/42	1	FURIN
Plasma lipoprotein clearance R-HSA-8964043	1	0	0/19	1	
Plasma lipoprotein remodeling R-HSA-8963899	0.380675025962704	2.19604331875759	1/18	1	FURIN
Plasmalogen biosynthesis R-HSA-75896	1	0	0/0	1	
Platelet activation, signaling and aggregation R-HSA-76002	0.114586809950128	1.89235931632625	6/127	1	SRC;CDC42;APP;VWF;GP1BA;TTN
Platelet calcium homeostasis R-HSA-418360	1	0	0/12	1	
Platelet degranulation  R-HSA-114608	0.148307850807127	2.3596654669853	3/51	1	APP;VWF;TTN
Platelet homeostasis R-HSA-418346	1	0	0/38	1	
Platelet sensitization by LDL R-HSA-432142	1	0	0/12	1	
Plus-strand DNA synthesis R-HSA-164525	1	0	0/1	1	
Polymerase switching R-HSA-69091	1	0	0/5	1	
Polymerase switching on the C-strand of the telomere R-HSA-174411	1	0	0/6	1	
Post NMDA receptor activation events R-HSA-438064	0.186990659760325	2.09437608925023	3/57	1	SRC;LRRC7;ARHGEF7
Post-chaperonin tubulin folding pathway R-HSA-389977	1	0	0/20	1	
Post-transcriptional silencing by small RNAs R-HSA-426496	1	0	0/1	1	
Post-translational modification: synthesis of GPI-anchored proteins R-HSA-163125	1	0	0/13	1	
Post-translational protein modification R-HSA-597592	0.464636080483193	1.05207997652459	18/659	1	AURKB;H2BC21;H2BC12;H4C9;H2BC14;EP300;FURIN;UBE2V2;APP;TTLL3;HIPK2;MDC1;BABAM1;UIMC1;SERPINC1;SMAD3;SMAD2;NR5A2
Post-translational protein phosphorylation R-HSA-8957275	0.223528616933996	2.34659521093487	2/34	1	APP;SERPINC1
Postmitotic nuclear pore complex (NPC) reformation R-HSA-9615933	1	0	0/12	1	
Postsynaptic nicotinic acetylcholine receptors R-HSA-622327	1	0	0/5	1	
Potassium Channels R-HSA-1296071	1	0	0/25	1	
Potassium transport channels R-HSA-1296067	1	0	0/1	1	
Potential therapeutics for SARS R-HSA-9679191	0.0895529465711505	2.49141072131402	4/65	1	FURIN;ATP1A1;FXYD2;JAK3
Pre-NOTCH Processing in Golgi R-HSA-1912420	0.253635549571777	3.73892787264533	1/11	1	FURIN
Pre-NOTCH Processing in the Endoplasmic Reticulum R-HSA-1912399	1	0	0/5	1	
Prednisone ADME R-HSA-9757110	1	0	0/1	1	
Prefoldin mediated transfer of substrate  to CCT/TriC R-HSA-389957	1	0	0/28	1	
Pregnenolone biosynthesis R-HSA-196108	0.124423905593351	9.35086557215028	1/5	1	TSPOAP1
Presynaptic depolarization and calcium channel opening R-HSA-112308	1	0	0/2	1	
Presynaptic function of Kainate receptors R-HSA-500657	1	0	0/8	1	
Presynaptic nicotinic acetylcholine receptors R-HSA-622323	1	0	0/5	1	
Prevention of phagosomal-lysosomal fusion R-HSA-9636383	1	0	0/5	1	
Processing and activation of SUMO R-HSA-3215018	1	0	0/6	1	
Processing of Capped Intron-Containing Pre-mRNA R-HSA-72203	1	0	0/142	1	
Processing of Capped Intronless Pre-mRNA R-HSA-75067	1	0	0/15	1	
Processing of Intronless Pre-mRNAs R-HSA-77595	1	0	0/8	1	
Processing of SMDT1 R-HSA-8949664	1	0	0/9	1	
Processive synthesis on the C-strand of the telomere R-HSA-174414	1	0	0/7	1	
Processive synthesis on the lagging strand R-HSA-69183	1	0	0/6	1	
Programmed Cell Death R-HSA-5357801	0.906389109626504	0.499524523019924	2/148	1	GSN;UNC5B
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 R-HSA-964827	1	0	0/0	1	
Prolactin receptor signaling R-HSA-1170546	0.329090081730138	2.668231298019	1/15	1	STAT5B
Proline catabolism R-HSA-70688	1	0	0/0	1	
Prolonged ERK activation events R-HSA-169893	1	0	0/8	1	
Propionyl-CoA catabolism R-HSA-71032	1	0	0/4	1	
Prostacyclin signalling through prostacyclin receptor R-HSA-392851	1	0	0/8	1	
Prostanoid ligand receptors R-HSA-391908	1	0	0/0	1	
Protein folding R-HSA-391251	0.814833509799108	0.595448991611103	1/63	1	SPHK1
Protein hydroxylation R-HSA-9629569	1	0	0/7	1	
Protein lipoylation R-HSA-9857492	1	0	0/3	1	
Protein localization R-HSA-9609507	0.850818501612084	0.526317369514638	1/71	1	APP
Protein methylation R-HSA-8876725	1	0	0/8	1	
Protein repair R-HSA-5676934	1	0	0/2	1	
Protein ubiquitination R-HSA-8852135	0.136062328580695	2.46337170631247	3/49	1	H2BC12;H2BC14;UBE2V2
Proton-coupled monocarboxylate transport R-HSA-433692	1	0	0/2	1	
Proton-coupled neutral amino acid transporters R-HSA-428559	1	0	0/0	1	
Proton/oligopeptide cotransporters R-HSA-427975	1	0	0/0	1	
Purine catabolism R-HSA-74259	1	0	0/9	1	
Purine ribonucleoside monophosphate biosynthesis R-HSA-73817	1	0	0/4	1	
Purine salvage R-HSA-74217	1	0	0/7	1	
Purinergic signaling in leishmaniasis infection R-HSA-9660826	0.472346799019033	1.62085821553598	1/24	1	APP
Pyrimidine catabolism R-HSA-73621	1	0	0/7	1	
Pyrimidine salvage R-HSA-73614	1	0	0/3	1	
Pyrophosphate hydrolysis R-HSA-71737	1	0	0/2	1	
Pyroptosis R-HSA-5620971	1	0	0/14	1	
Pyruvate metabolism R-HSA-70268	1	0	0/13	1	
RA biosynthesis pathway R-HSA-5365859	1	0	0/5	1	
RAB GEFs exchange GTP for GDP on RABs R-HSA-8876198	1	0	0/20	1	
RAB geranylgeranylation R-HSA-8873719	1	0	0/10	1	
RAC1 GTPase cycle R-HSA-9013149	0.137244385072679	2.10509488224503	4/76	1	ARHGEF7;CDC42;SPATA13;DOCK5
RAC2 GTPase cycle R-HSA-9013404	0.665296215798888	0.928111617266124	1/41	1	CDC42
RAC3 GTPase cycle R-HSA-9013423	0.699377024767589	0.842889378428536	1/45	1	CDC42
RAF activation R-HSA-5673000	0.443390945354158	1.77608203944115	1/22	1	SRC
RAF-independent MAPK1/3 activation R-HSA-112409	1	0	0/12	1	
RAF/MAP kinase cascade R-HSA-5673001	0.558995597893154	1.01853209124373	4/150	1	SRC;LRRC7;JAK3;VWF
RAS GTPase cycle mutants R-HSA-9649913	1	0	0/3	1	
RAS processing R-HSA-9648002	1	0	0/13	1	
RAS signaling downstream of NF1 loss-of-function variants R-HSA-6802953	1	0	0/5	1	
RET signaling R-HSA-8853659	0.443390945354158	1.77608203944115	1/22	1	SRC
RHO GTPase Effectors R-HSA-195258	0.0809627522144777	1.8000091548445	9/202	1	SRC;AURKB;H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14;CDC42
RHO GTPase cycle R-HSA-9012999	0.648286376262368	0.906153370090127	5/209	1	SRC;ARHGEF7;CDC42;SPATA13;DOCK5
RHO GTPases Activate Formins R-HSA-5663220	0.284845566729955	1.65735246689129	3/71	1	SRC;AURKB;CDC42
RHO GTPases Activate NADPH Oxidases R-HSA-5668599	1	0	0/17	1	
RHO GTPases Activate ROCKs R-HSA-5627117	1	0	0/13	1	
RHO GTPases Activate Rhotekin and Rhophilins R-HSA-5666185	1	0	0/3	1	
RHO GTPases Activate WASPs and WAVEs R-HSA-5663213	0.486260042626989	1.55293979689739	1/25	1	CDC42
RHO GTPases activate CIT R-HSA-5625900	1	0	0/11	1	
RHO GTPases activate IQGAPs R-HSA-5626467	0.5624270710316	1.24055959211337	1/31	1	CDC42
RHO GTPases activate KTN1 R-HSA-5625970	0.14740262953668	7.48288775581792	1/6	1	CDC42
RHO GTPases activate PAKs R-HSA-5627123	0.329090081730138	2.668231298019	1/15	1	CDC42
RHO GTPases regulate CFTR trafficking R-HSA-5627083	1	0	0/1	1	
RHOA GTPase cycle R-HSA-8980692	0.829237688052024	0.567530733548644	1/66	1	ARHGEF7
RHOB GTPase cycle R-HSA-9013026	1	0	0/36	1	
RHOBTB GTPase Cycle R-HSA-9706574	1	0	0/22	1	
RHOBTB1 GTPase cycle R-HSA-9013422	1	0	0/15	1	
RHOBTB2 GTPase cycle R-HSA-9013418	1	0	0/14	1	
RHOBTB3 ATPase cycle R-HSA-9706019	1	0	0/4	1	
RHOC GTPase cycle R-HSA-9013106	1	0	0/40	1	
RHOD GTPase cycle R-HSA-9013405	1	0	0/23	1	
RHOF GTPase cycle R-HSA-9035034	1	0	0/18	1	
RHOG GTPase cycle R-HSA-9013408	0.184934398250033	2.68425490364007	2/30	1	CDC42;DOCK5
RHOH GTPase cycle R-HSA-9013407	1	0	0/17	1	
RHOJ GTPase cycle R-HSA-9013409	0.204125390346287	2.50439587958004	2/32	1	ARHGEF7;CDC42
RHOQ GTPase cycle R-HSA-9013406	0.175443135561908	2.7844288421488	2/29	1	ARHGEF7;CDC42
RHOT1 GTPase cycle R-HSA-9013425	1	0	0/1	1	
RHOT2 GTPase cycle R-HSA-9013419	1	0	0/1	1	
RHOV GTPase cycle R-HSA-9013424	0.0952469944498643	4.18502489709519	2/20	1	ARHGEF7;CDC42
RIP-mediated NFkB activation via ZBP1 R-HSA-1810476	1	0	0/17	1	
RIPK1-mediated regulated necrosis R-HSA-5213460	1	0	0/25	1	
RMTs methylate histone arginines R-HSA-3214858	0.207240813612481	1.98267476348702	3/60	1	H4C9;H2AX;ARID1A
RNA Pol II CTD phosphorylation and interaction with CE R-HSA-77075	1	0	0/19	1	
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection R-HSA-167160	1	0	0/19	1	
RNA Polymerase I Transcription Initiation R-HSA-73762	0.538370942160232	1.32982264644569	1/29	1	UBTF
RNA Polymerase I Transcription Termination R-HSA-73863	0.329090081730138	2.668231298019	1/15	1	UBTF
RNA Polymerase II HIV Promoter Escape R-HSA-167162	1	0	0/29	1	
RNA Polymerase II Pre-transcription Events R-HSA-674695	1	0	0/46	1	
RNA Polymerase II Promoter Escape R-HSA-73776	1	0	0/29	1	
RNA Polymerase II Transcription Elongation R-HSA-75955	1	0	0/34	1	
RNA Polymerase II Transcription Initiation And Promoter Clearance R-HSA-76042	1	0	0/29	1	
RNA Polymerase II Transcription Initiation R-HSA-75953	1	0	0/29	1	
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening R-HSA-73779	1	0	0/29	1	
RNA Polymerase II Transcription Termination R-HSA-73856	1	0	0/30	1	
RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476	1	0	0/22	1	
RNA Polymerase III Chain Elongation R-HSA-73780	1	0	0/8	1	
RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061	1	0	0/15	1	
RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066	1	0	0/14	1	
RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071	1	0	0/12	1	
RNA Polymerase III Transcription Initiation R-HSA-76046	1	0	0/18	1	
RNA Polymerase III Transcription R-HSA-74158	1	0	0/22	1	
RNA Polymerase III Transcription Termination R-HSA-73980	1	0	0/12	1	
RNA polymerase II transcribes snRNA genes R-HSA-6807505	1	0	0/48	1	
RND1 GTPase cycle R-HSA-9696273	1	0	0/14	1	
RND2 GTPase cycle R-HSA-9696270	1	0	0/15	1	
RND3 GTPase cycle R-HSA-9696264	1	0	0/15	1	
ROBO receptors bind AKAP5 R-HSA-9010642	1	0	0/6	1	
RORA activates gene expression R-HSA-1368082	0.346741223784396	2.49010112143882	1/16	1	EP300
ROS and RNS production in phagocytes R-HSA-1222556	1	0	0/16	1	
RPIA deficiency: failed conversion of R5P to RU5P R-HSA-5659996	1	0	0/1	1	
RPIA deficiency: failed conversion of RU5P to R5P R-HSA-6791461	1	0	0/1	1	
RSK activation R-HSA-444257	1	0	0/6	1	
RSV-host interactions R-HSA-9833110	0.838218008843713	0.550307339219923	1/68	1	EP300
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) R-HSA-8877330	1	0	0/5	1	
RUNX1 regulates estrogen receptor mediated transcription R-HSA-8931987	1	0	0/6	1	
RUNX1 regulates expression of components of tight junctions R-HSA-8935964	1	0	0/3	1	
RUNX1 regulates transcription of genes involved in BCR signaling R-HSA-8939245	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in WNT signaling R-HSA-8939256	1	0	0/5	1	
RUNX1 regulates transcription of genes involved in differentiation of HSCs R-HSA-8939236	0.21003868151086	1.63084558039288	5/121	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes R-HSA-8939242	1	0	0/3	1	
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells R-HSA-8939246	1	0	0/6	1	
RUNX1 regulates transcription of genes involved in interleukin signaling R-HSA-8939247	1	0	0/4	1	
RUNX2 regulates bone development R-HSA-8941326	0.472346799019033	1.62085821553598	1/24	1	SRC
RUNX2 regulates chondrocyte maturation R-HSA-8941284	1	0	0/5	1	
RUNX2 regulates genes involved in cell migration R-HSA-8941332	1	0	0/7	1	
RUNX2 regulates genes involved in differentiation of myeloid cells R-HSA-8941333	1	0	0/4	1	
RUNX2 regulates osteoblast differentiation R-HSA-8940973	0.396981147981571	2.07367136211455	1/19	1	SRC
RUNX3 Regulates Immune Response and Cell Migration R-HSA-8949275	1	0	0/5	1	
RUNX3 regulates BCL2L11 (BIM) transcription R-HSA-8952158	0.124423905593351	9.35086557215028	1/5	1	SMAD3
RUNX3 regulates CDKN1A transcription R-HSA-8941855	0.169783838370041	6.23416731470989	1/7	1	SMAD3
RUNX3 regulates NOTCH signaling R-HSA-8941856	0.310966623183603	2.87416395939725	1/14	1	EP300
RUNX3 regulates RUNX1-mediated transcription R-HSA-8951911	1	0	0/3	1	
RUNX3 regulates WNT signaling R-HSA-8951430	1	0	0/8	1	
RUNX3 regulates YAP1-mediated transcription R-HSA-8951671	1	0	0/6	1	
RUNX3 regulates p14-ARF R-HSA-8951936	0.233494350043928	4.15469625193707	1/10	1	EP300
Rab regulation of trafficking R-HSA-9007101	1	0	0/34	1	
Rap1 signalling R-HSA-392517	1	0	0/8	1	
Ras activation upon Ca2+ influx through NMDA receptor R-HSA-442982	0.310966623183603	2.87416395939725	1/14	1	LRRC7
Reactions specific to the complex N-glycan synthesis pathway R-HSA-975578	1	0	0/2	1	
Reactions specific to the hybrid N-glycan synthesis pathway R-HSA-975574	1	0	0/0	1	
Receptor Mediated Mitophagy R-HSA-8934903	0.191582925100974	5.34296079232313	1/8	1	SRC
Receptor-type tyrosine-protein phosphatases R-HSA-388844	1	0	0/3	1	
Recognition of DNA damage by PCNA-containing replication complex R-HSA-110314	1	0	0/15	1	
Recruitment of NuMA to mitotic centrosomes R-HSA-380320	1	0	0/56	1	
Recruitment of mitotic centrosome proteins and complexes R-HSA-380270	1	0	0/41	1	
Recycling of bile acids and salts R-HSA-159418	1	0	0/7	1	
Recycling of eIF2:GDP R-HSA-72731	1	0	0/3	1	
Recycling pathway of L1 R-HSA-437239	0.617270163668973	1.06199041272826	1/36	1	SRC
Reduction of cytosolic Ca++ levels R-HSA-418359	1	0	0/7	1	
Reelin signalling pathway R-HSA-8866376	1	0	0/3	1	
Regorafenib-resistant KIT mutants R-HSA-9669929	1	0	0/1	1	
Regorafenib-resistant PDGFR mutants R-HSA-9674403	1	0	0/1	1	
Regulated Necrosis R-HSA-5218859	1	0	0/39	1	
Regulated proteolysis of p75NTR R-HSA-193692	1	0	0/9	1	
Regulation by TREX1 R-HSA-3248023	1	0	0/0	1	
Regulation by c-FLIP R-HSA-3371378	1	0	0/10	1	
Regulation of APC/C activators between G1/S and early anaphase R-HSA-176408	1	0	0/76	1	
Regulation of Apoptosis R-HSA-169911	1	0	0/49	1	
Regulation of BACH1 activity R-HSA-9708530	1	0	0/9	1	
Regulation of CDH11 Expression and Function R-HSA-9759475	0.273252368749906	3.39809007232892	1/12	1	ZEB2
Regulation of CDH11 function R-HSA-9762292	1	0	0/6	1	
Regulation of CDH11 gene transcription R-HSA-9762293	0.14740262953668	7.48288775581792	1/6	1	ZEB2
Regulation of CDH11 mRNA translation by microRNAs R-HSA-9759811	1	0	0/2	1	
Regulation of CDH19 Expression and Function R-HSA-9764302	1	0	0/3	1	
Regulation of Complement cascade R-HSA-977606	1	0	0/21	1	
Regulation of Expression and Function of Type II Classical Cadherins R-HSA-9764260	0.273252368749906	3.39809007232892	1/12	1	ZEB2
Regulation of FOXO transcriptional activity by acetylation R-HSA-9617629	0.233494350043928	4.15469625193707	1/10	1	EP300
Regulation of Glucokinase by Glucokinase Regulatory Protein R-HSA-170822	1	0	0/10	1	
Regulation of HMOX1 expression and activity R-HSA-9707587	1	0	0/4	1	
Regulation of HSF1-mediated heat shock response R-HSA-3371453	1	0	0/38	1	
Regulation of Homotypic Cell-Cell Adhesion R-HSA-9759476	0.273252368749906	3.39809007232892	1/12	1	ZEB2
Regulation of IFNA/IFNB signaling R-HSA-912694	1	0	0/26	1	
Regulation of IFNG signaling R-HSA-877312	1	0	0/14	1	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) R-HSA-381426	0.321418872254881	1.7835341296187	2/44	1	APP;SERPINC1
Regulation of KIT signaling R-HSA-1433559	0.292358333261937	3.11429423158507	1/13	1	SRC
Regulation of MITF-M dependent genes involved in invasion R-HSA-9854909	1	0	0/2	1	
Regulation of MITF-M dependent genes involved in metabolism R-HSA-9854907	1	0	0/3	1	
Regulation of MITF-M-dependent genes involved in DNA damage repair and senescence R-HSA-9825895	1	0	0/2	1	
Regulation of MITF-M-dependent genes involved in apoptosis R-HSA-9824594	1	0	0/7	1	
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation R-HSA-9825892	1	0	0/12	1	
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy R-HSA-9857377	1	0	0/13	1	
Regulation of MITF-M-dependent genes involved in pigmentation R-HSA-9824585	0.346741223784396	2.49010112143882	1/16	1	ARID1A
Regulation of NF-kappa B signaling R-HSA-9758274	1	0	0/15	1	
Regulation of NFE2L2 gene expression R-HSA-9818749	0.191582925100974	5.34296079232313	1/8	1	EP300
Regulation of NPAS4 gene expression R-HSA-9768759	1	0	0/4	1	
Regulation of NPAS4 gene transcription R-HSA-9768777	1	0	0/3	1	
Regulation of NPAS4 mRNA translation R-HSA-9768778	1	0	0/1	1	
Regulation of PAK-2p34 activity by PS-GAP/RHG10 R-HSA-211728	1	0	0/1	1	
Regulation of PLK1 Activity at G2/M Transition R-HSA-2565942	1	0	0/49	1	
Regulation of PTEN gene transcription R-HSA-8943724	1	0	0/58	1	
Regulation of PTEN localization R-HSA-8948747	1	0	0/7	1	
Regulation of PTEN mRNA translation R-HSA-8943723	1	0	0/2	1	
Regulation of PTEN stability and activity R-HSA-8948751	1	0	0/59	1	
Regulation of RAS by GAPs R-HSA-5658442	1	0	0/56	1	
Regulation of RUNX1 Expression and Activity R-HSA-8934593	0.233494350043928	4.15469625193707	1/10	1	SRC
Regulation of RUNX2 expression and activity R-HSA-8939902	1	0	0/65	1	
Regulation of RUNX3 expression and activity R-HSA-8941858	0.416286511328687	1.43695399372548	2/54	1	SRC;EP300
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7  R-HSA-9824878	1	0	0/11	1	
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation R-HSA-9828211	1	0	0/10	1	
Regulation of TLR by endogenous ligand R-HSA-5686938	1	0	0/13	1	
Regulation of TNFR1 signaling R-HSA-5357905	1	0	0/33	1	
Regulation of TP53 Activity through Acetylation R-HSA-6804758	0.45806040328366	1.69494567015225	1/23	1	EP300
Regulation of TP53 Activity through Association with Co-factors R-HSA-6804759	1	0	0/7	1	
Regulation of TP53 Activity through Methylation R-HSA-6804760	0.273252368749906	3.39809007232892	1/12	1	EP300
Regulation of TP53 Degradation R-HSA-6804757	1	0	0/32	1	
Regulation of TP53 Expression R-HSA-6804754	1	0	0/2	1	
Regulation of TP53 Expression and Degradation R-HSA-6806003	1	0	0/33	1	
Regulation of actin dynamics for phagocytic cup formation R-HSA-2029482	0.617270163668973	1.06199041272826	1/36	1	CDC42
Regulation of activated PAK-2p34 by proteasome mediated degradation R-HSA-211733	1	0	0/49	1	
Regulation of beta-cell development R-HSA-186712	0.10353465954373	3.9639924847644	2/21	1	EP300;NR5A2
Regulation of cholesterol biosynthesis by SREBP (SREBF) R-HSA-1655829	1	0	0/31	1	
Regulation of cortical dendrite branching R-HSA-8985801	1	0	0/2	1	
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components R-HSA-446388	1	0	0/5	1	
Regulation of expression of SLITs and ROBOs R-HSA-9010553	1	0	0/143	1	
Regulation of gene expression in beta cells R-HSA-210745	1	0	0/8	1	
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells R-HSA-210746	1	0	0/0	1	
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells R-HSA-210744	0.273252368749906	3.39809007232892	1/12	1	EP300
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism R-HSA-9634600	1	0	0/8	1	
Regulation of innate immune responses to cytosolic DNA R-HSA-3134975	1	0	0/9	1	
Regulation of insulin secretion R-HSA-422356	1	0	0/28	1	
Regulation of lipid metabolism by PPARalpha R-HSA-400206	0.27046411840867	1.70844177996021	3/69	1	EP300;NCOR1;ARNT
Regulation of localization of FOXO transcription factors R-HSA-9614399	1	0	0/12	1	
Regulation of mRNA stability by proteins that bind AU-rich elements R-HSA-450531	1	0	0/81	1	
Regulation of mitotic cell cycle R-HSA-453276	0.88307499368284	0.465283065109332	1/80	1	AURKB
Regulation of necroptotic cell death R-HSA-5675482	1	0	0/25	1	
Regulation of ornithine decarboxylase (ODC) R-HSA-350562	1	0	0/49	1	
Regulation of pyruvate dehydrogenase (PDH) complex R-HSA-204174	1	0	0/5	1	
Regulation of pyruvate metabolism R-HSA-9861718	1	0	0/10	1	
Regulation of signaling by CBL R-HSA-912631	1	0	0/19	1	
Regulation of signaling by NODAL R-HSA-1433617	1	0	0/2	1	
Regulation of the apoptosome activity R-HSA-9627069	1	0	0/5	1	
Regulation of thyroid hormone activity R-HSA-350864	1	0	0/0	1	
Relaxin receptors R-HSA-444821	1	0	0/0	1	
Release of Hh-Np from the secreting cell R-HSA-5362798	1	0	0/3	1	
Release of apoptotic factors from the mitochondria R-HSA-111457	1	0	0/3	1	
Removal of the Flap Intermediate R-HSA-69166	1	0	0/6	1	
Removal of the Flap Intermediate from the C-strand R-HSA-174437	1	0	0/6	1	
Replication of the SARS-CoV-1 genome R-HSA-9682706	1	0	0/4	1	
Replication of the SARS-CoV-2 genome R-HSA-9694686	1	0	0/4	1	
Repression of WNT target genes R-HSA-4641265	1	0	0/13	1	
Resistance of ERBB2 KD mutants to AEE788 R-HSA-9665250	1	0	0/2	1	
Resistance of ERBB2 KD mutants to afatinib R-HSA-9665249	1	0	0/2	1	
Resistance of ERBB2 KD mutants to lapatinib R-HSA-9665251	1	0	0/2	1	
Resistance of ERBB2 KD mutants to neratinib R-HSA-9665246	1	0	0/2	1	
Resistance of ERBB2 KD mutants to osimertinib R-HSA-9665247	1	0	0/2	1	
Resistance of ERBB2 KD mutants to sapitinib R-HSA-9665244	1	0	0/2	1	
Resistance of ERBB2 KD mutants to tesevatinib R-HSA-9665245	1	0	0/2	1	
Resistance of ERBB2 KD mutants to trastuzumab R-HSA-9665233	1	0	0/2	1	
Resolution of AP sites via the multiple-nucleotide patch replacement pathway R-HSA-110373	1	0	0/9	1	
Resolution of AP sites via the single-nucleotide replacement pathway R-HSA-110381	1	0	0/2	1	
Resolution of Abasic Sites (AP sites) R-HSA-73933	1	0	0/12	1	
Resolution of Sister Chromatid Cohesion R-HSA-2500257	0.814833509799108	0.595448991611103	1/63	1	AURKB
Respiratory Syncytial Virus Infection Pathway R-HSA-9820952	0.659211849500134	0.893211148909054	2/85	1	EP300;FURIN
Respiratory electron transport R-HSA-611105	1	0	0/70	1	
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. R-HSA-163200	1	0	0/85	1	
Respiratory syncytial virus (RSV) attachment and entry R-HSA-9820960	0.212814889902584	4.67518817282894	1/9	1	FURIN
Respiratory syncytial virus (RSV) genome replication, transcription and translation R-HSA-9820965	0.329090081730138	2.668231298019	1/15	1	FURIN
Respiratory syncytial virus genome replication R-HSA-9834752	1	0	0/2	1	
Respiratory syncytial virus genome transcription R-HSA-9828642	1	0	0/1	1	
Response of EIF2AK1 (HRI) to heme deficiency R-HSA-9648895	1	0	0/14	1	
Response of EIF2AK4 (GCN2) to amino acid deficiency R-HSA-9633012	1	0	0/92	1	
Response of Mtb to phagocytosis R-HSA-9637690	1	0	0/14	1	
Response to elevated platelet cytosolic Ca2+ R-HSA-76005	0.17380231547448	2.17603445835261	3/55	1	APP;VWF;TTN
Response to metal ions R-HSA-5660526	1	0	0/0	1	
Retinoid cycle disease events R-HSA-2453864	1	0	0/1	1	
Retinoid metabolism and transport R-HSA-975634	1	0	0/13	1	
Retinoid metabolism disease events R-HSA-6809583	1	0	0/0	1	
Retrograde neurotrophin signalling R-HSA-177504	1	0	0/8	1	
Retrograde transport at the Trans-Golgi-Network R-HSA-6811440	1	0	0/26	1	
Reuptake of GABA R-HSA-888593	1	0	0/2	1	
Rev-mediated nuclear export of HIV RNA R-HSA-165054	1	0	0/12	1	
Reversal of alkylation damage by DNA dioxygenases R-HSA-73943	1	0	0/0	1	
Reverse Transcription of HIV RNA R-HSA-162589	1	0	0/1	1	
Reversible hydration of carbon dioxide R-HSA-1475029	1	0	0/7	1	
Rhesus blood group biosynthesis R-HSA-9037628	1	0	0/0	1	
Rhesus glycoproteins mediate ammonium transport. R-HSA-444411	1	0	0/0	1	
Ribavirin ADME R-HSA-9755088	1	0	0/5	1	
Ribosomal scanning and start codon recognition R-HSA-72702	1	0	0/47	1	
Role of ABL in ROBO-SLIT signaling R-HSA-428890	1	0	0/6	1	
Role of LAT2/NTAL/LAB on calcium mobilization R-HSA-2730905	1	0	0/12	1	
Role of phospholipids in phagocytosis R-HSA-2029485	1	0	0/16	1	
S Phase R-HSA-69242	0.963775852581555	0.297946110943165	1/123	1	E2F5
SARS-CoV Infections R-HSA-9679506	0.686384784472839	0.870257179017773	6/260	1	EP300;FURIN;ATP1A1;FXYD2;SMAD3;JAK3
SARS-CoV-1 Genome Replication and Transcription R-HSA-9679514	1	0	0/4	1	
SARS-CoV-1 Infection R-HSA-9678108	0.786607801706756	0.688582131200177	2/109	1	EP300;SMAD3
SARS-CoV-1 activates/modulates innate immune responses R-HSA-9692916	1	0	0/35	1	
SARS-CoV-1 modulates host translation machinery R-HSA-9735869	1	0	0/33	1	
SARS-CoV-1 targets PDZ proteins in cell-cell junction R-HSA-9692912	1	0	0/0	1	
SARS-CoV-1-host interactions R-HSA-9692914	0.66554233535115	0.882350983528493	2/86	1	EP300;SMAD3
SARS-CoV-1-mediated effects on programmed cell death R-HSA-9692913	1	0	0/3	1	
SARS-CoV-2 Genome Replication and Transcription R-HSA-9694682	1	0	0/4	1	
SARS-CoV-2 Infection R-HSA-9694516	0.992490569465933	0.200041918217801	1/180	1	FURIN
SARS-CoV-2 activates/modulates innate and adaptive immune responses R-HSA-9705671	1	0	0/82	1	
SARS-CoV-2 modulates autophagy R-HSA-9754560	1	0	0/2	1	
SARS-CoV-2 modulates host translation machinery R-HSA-9754678	1	0	0/42	1	
SARS-CoV-2 targets PDZ proteins in cell-cell junction R-HSA-9705677	1	0	0/1	1	
SARS-CoV-2 targets host intracellular signalling and regulatory pathways R-HSA-9755779	1	0	0/12	1	
SARS-CoV-2-host interactions R-HSA-9705683	1	0	0/138	1	
SCF(Skp2)-mediated degradation of p27/p21 R-HSA-187577	1	0	0/58	1	
SCF-beta-TrCP mediated degradation of Emi1 R-HSA-174113	1	0	0/52	1	
SDK interactions R-HSA-373756	1	0	0/0	1	
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion R-HSA-399955	1	0	0/5	1	
SHC-mediated cascade:FGFR1 R-HSA-5654688	1	0	0/7	1	
SHC-mediated cascade:FGFR2 R-HSA-5654699	1	0	0/9	1	
SHC-mediated cascade:FGFR3 R-HSA-5654704	1	0	0/7	1	
SHC-mediated cascade:FGFR4 R-HSA-5654719	1	0	0/7	1	
SHC-related events triggered by IGF1R R-HSA-2428933	1	0	0/7	1	
SHC1 events in EGFR signaling R-HSA-180336	1	0	0/13	1	
SHC1 events in ERBB2 signaling R-HSA-1250196	1	0	0/15	1	
SHC1 events in ERBB4 signaling R-HSA-1250347	1	0	0/9	1	
SHOC2 M1731 mutant abolishes MRAS complex function R-HSA-9726840	1	0	0/5	1	
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs R-HSA-77588	1	0	0/8	1	
SLBP independent Processing of Histone Pre-mRNAs R-HSA-111367	1	0	0/7	1	
SLC transporter disorders R-HSA-5619102	1	0	0/37	1	
SLC-mediated transmembrane transport R-HSA-425407	0.866118859306527	0.497356129905137	1/75	1	SLC12A2
SLIT2:ROBO1 increases RHOA activity R-HSA-8985586	1	0	0/3	1	
SMAC (DIABLO) binds to IAPs  R-HSA-111463	1	0	0/2	1	
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes  R-HSA-111464	1	0	0/2	1	
SMAC, XIAP-regulated apoptotic response R-HSA-111469	1	0	0/2	1	
SOS-mediated signalling R-HSA-112412	1	0	0/7	1	
SRP-dependent cotranslational protein targeting to membrane R-HSA-1799339	1	0	0/94	1	
STAT3 nuclear events downstream of ALK signaling R-HSA-9701898	0.253635549571777	3.73892787264533	1/11	1	EP300
STAT5 Activation R-HSA-9645135	0.124423905593351	9.35086557215028	1/5	1	STAT5B
STAT5 activation downstream of FLT3 ITD mutants R-HSA-9702518	0.191582925100974	5.34296079232313	1/8	1	STAT5B
STING mediated induction of host immune responses R-HSA-1834941	0.191582925100974	5.34296079232313	1/8	1	STAT6
SUMO E3 ligases SUMOylate target proteins R-HSA-3108232	0.105242101785491	1.94195050750254	6/124	1	AURKB;H4C9;EP300;HIPK2;MDC1;NR5A2
SUMO is conjugated to E1 (UBA2:SAE1) R-HSA-3065676	1	0	0/4	1	
SUMO is proteolytically processed R-HSA-3065679	1	0	0/4	1	
SUMO is transferred from E1 to E2 (UBE2I, UBC9) R-HSA-3065678	1	0	0/5	1	
SUMOylation R-HSA-2990846	0.111425855370755	1.90861215613351	6/126	1	AURKB;H4C9;EP300;HIPK2;MDC1;NR5A2
SUMOylation of DNA damage response and repair proteins R-HSA-3108214	0.691193656669326	0.862708842774289	1/44	1	MDC1
SUMOylation of DNA methylation proteins R-HSA-4655427	1	0	0/14	1	
SUMOylation of DNA replication proteins R-HSA-4615885	0.380675025962704	2.19604331875759	1/18	1	AURKB
SUMOylation of RNA binding proteins R-HSA-4570464	1	0	0/24	1	
SUMOylation of SUMOylation proteins R-HSA-4085377	1	0	0/12	1	
SUMOylation of chromatin organization proteins R-HSA-4551638	0.699377024767589	0.842889378428536	1/45	1	H4C9
SUMOylation of immune response proteins R-HSA-4755510	1	0	0/9	1	
SUMOylation of intracellular receptors R-HSA-4090294	0.443390945354158	1.77608203944115	1/22	1	NR5A2
SUMOylation of nuclear envelope proteins R-HSA-9793242	1	0	0/2	1	
SUMOylation of transcription cofactors R-HSA-3899300	0.233286892067172	2.27484794144367	2/35	1	EP300;HIPK2
SUMOylation of transcription factors R-HSA-3232118	1	0	0/13	1	
SUMOylation of ubiquitinylation proteins R-HSA-3232142	1	0	0/15	1	
Scavenging by Class A Receptors R-HSA-3000480	1	0	0/11	1	
Scavenging by Class B Receptors R-HSA-3000471	1	0	0/5	1	
Scavenging by Class F Receptors R-HSA-3000484	1	0	0/3	1	
Scavenging by Class H Receptors R-HSA-3000497	1	0	0/2	1	
Scavenging of heme from plasma R-HSA-2168880	1	0	0/5	1	
Sealing of the nuclear envelope (NE) by ESCRT-III R-HSA-9668328	1	0	0/25	1	
Selective autophagy R-HSA-9663891	0.750947445829768	0.725911579475404	1/52	1	SRC
Selenoamino acid metabolism R-HSA-2408522	1	0	0/95	1	
Selenocysteine synthesis R-HSA-2408557	1	0	0/83	1	
Sema3A PAK dependent Axon repulsion R-HSA-399954	1	0	0/10	1	
Sema4D in semaphorin signaling R-HSA-400685	1	0	0/16	1	
Sema4D induced cell migration and growth-cone collapse R-HSA-416572	1	0	0/13	1	
Sema4D mediated inhibition of cell attachment and migration R-HSA-416550	1	0	0/6	1	
Semaphorin interactions R-HSA-373755	1	0	0/41	1	
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582	0.143876614006099	1.88033981404578	5/106	1	H2BC21;H2BC12;H4C9;H2AX;H2BC14
Sensory perception of sour taste R-HSA-9729555	1	0	0/0	1	
Sensory perception of sweet, bitter, and umami (glutamate) taste R-HSA-9717207	1	0	0/3	1	
Sensory processing of sound by outer hair cells of the cochlea R-HSA-9662361	0.412861892904292	1.96395982365259	1/20	1	GSN
Separation of Sister Chromatids R-HSA-2467813	0.967538357065304	0.288185899175067	1/127	1	AURKB
Serine biosynthesis R-HSA-977347	1	0	0/2	1	
Serotonin Neurotransmitter Release Cycle R-HSA-181429	0.124423905593351	9.35086557215028	1/5	1	TSPOAP1
Serotonin and melatonin biosynthesis R-HSA-209931	1	0	0/1	1	
Serotonin clearance from the synaptic cleft R-HSA-380615	1	0	0/1	1	
Serotonin receptors R-HSA-390666	1	0	0/0	1	
Severe congenital neutropenia type 4 (G6PC3) R-HSA-3282872	1	0	0/1	1	
Sialic acid metabolism R-HSA-4085001	1	0	0/11	1	
Signal Transduction R-HSA-162582	0.243906600113642	1.1766381720927	38/1306	1	SRC;AURKB;H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14;EP300;NCOR1;FURIN;LRRC7;ARHGEF7;CDC42;APP;SPHK1;FZD5;H3-4;SPATA13;KAT5;E2F5;WNT3A;SMAD3;STAT6;JUNB;JAK3;STAT5B;SRY;SOX9;VWF;SMAD2;TRIM33;NR5A2;PLAT;PMEPA1;DOCK5;PIP5K1A;PDGFD
Signal amplification R-HSA-392518	0.380675025962704	2.19604331875759	1/18	1	SRC
Signal attenuation R-HSA-74749	1	0	0/8	1	
Signal regulatory protein family interactions R-HSA-391160	0.233494350043928	4.15469625193707	1/10	1	SRC
Signal transduction by L1 R-HSA-445144	1	0	0/14	1	
Signaling by ALK fusions and activated point mutants R-HSA-9725370	0.47871516053899	1.26425779668532	2/61	1	JUNB;MECP2
Signaling by ALK in cancer R-HSA-9700206	0.47871516053899	1.26425779668532	2/61	1	JUNB;MECP2
Signaling by AMER1 mutants R-HSA-4839748	1	0	0/10	1	
Signaling by APC mutants R-HSA-4839744	1	0	0/10	1	
Signaling by AXIN mutants R-HSA-4839735	1	0	0/10	1	
Signaling by BMP R-HSA-201451	1	0	0/16	1	
Signaling by BRAF and RAF1 fusions R-HSA-6802952	0.233286892067172	2.27484794144367	2/35	1	SRC;VWF
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350	0.45806040328366	1.69494567015225	1/23	1	SRC
Signaling by CSF3 (G-CSF) R-HSA-9674555	0.538370942160232	1.32982264644569	1/29	1	STAT5B
Signaling by CTNNB1 phospho-site mutants R-HSA-4839743	1	0	0/11	1	
Signaling by EGFR in Cancer R-HSA-1643713	1	0	0/23	1	
Signaling by EGFRvIII in Cancer R-HSA-5637812	1	0	0/13	1	
Signaling by ERBB2 ECD mutants R-HSA-9665348	1	0	0/13	1	
Signaling by ERBB2 KD Mutants R-HSA-9664565	1	0	0/18	1	
Signaling by ERBB2 R-HSA-1227986	0.637249115747812	1.00411758787702	1/38	1	SRC
Signaling by ERBB2 TMD/JMD mutants R-HSA-9665686	1	0	0/15	1	
Signaling by ERBB2 in Cancer R-HSA-1227990	1	0	0/18	1	
Signaling by ERBB4 R-HSA-1236394	0.262688602605588	2.0838592247051	2/38	1	SRC;NCOR1
Signaling by Erythropoietin R-HSA-9006335	0.396981147981571	2.07367136211455	1/19	1	STAT5B
Signaling by FGFR R-HSA-190236	0.737180506582421	0.755924037913128	1/50	1	SRC
Signaling by FGFR in disease R-HSA-1226099	0.321418872254881	1.7835341296187	2/44	1	STAT5B;MYO18A
Signaling by FGFR1 R-HSA-5654736	0.525856190208566	1.3793942445188	1/28	1	SRC
Signaling by FGFR1 amplification mutants R-HSA-1839120	1	0	0/0	1	
Signaling by FGFR1 in disease R-HSA-5655302	0.147516353391238	3.13461810019507	2/26	1	STAT5B;MYO18A
Signaling by FGFR2 IIIa TM R-HSA-8851708	1	0	0/17	1	
Signaling by FGFR2 R-HSA-5654738	0.70734552573649	0.823950589376898	1/46	1	SRC
Signaling by FGFR2 amplification mutants R-HSA-2023837	1	0	0/1	1	
Signaling by FGFR2 fusions R-HSA-8853333	1	0	0/1	1	
Signaling by FGFR2 in disease R-HSA-5655253	1	0	0/28	1	
Signaling by FGFR3 R-HSA-5654741	0.486260042626989	1.55293979689739	1/25	1	SRC
Signaling by FGFR3 fusions in cancer R-HSA-8853334	1	0	0/0	1	
Signaling by FGFR3 in disease R-HSA-5655332	1	0	0/11	1	
Signaling by FGFR4 R-HSA-5654743	0.486260042626989	1.55293979689739	1/25	1	SRC
Signaling by FGFR4 in disease R-HSA-5655291	1	0	0/10	1	
Signaling by FLT3 ITD and TKD mutants R-HSA-9703648	0.310966623183603	2.87416395939725	1/14	1	STAT5B
Signaling by GPCR R-HSA-372790	0.612560267455865	0.945458366901553	6/241	1	SRC;ARHGEF7;CDC42;APP;FZD5;WNT3A
Signaling by GSK3beta mutants R-HSA-5339716	1	0	0/11	1	
Signaling by Hedgehog R-HSA-5358351	1	0	0/110	1	
Signaling by Hippo R-HSA-2028269	1	0	0/11	1	
Signaling by Insulin receptor R-HSA-74752	1	0	0/44	1	
Signaling by Interleukins R-HSA-449147	0.57948123237472	0.975588563621339	9/351	1	CDC42;APP;NANOG;SMAD3;STAT6;IL4R;JUNB;JAK3;STAT5B
Signaling by KIT in disease R-HSA-9669938	0.0952469944498643	4.18502489709519	2/20	1	SRC;STAT5B
Signaling by LRP5 mutants  R-HSA-5339717	1	0	0/2	1	
Signaling by LTK R-HSA-9842663	1	0	0/9	1	
Signaling by LTK in cancer R-HSA-9842640	1	0	0/7	1	
Signaling by Leptin R-HSA-2586552	0.212814889902584	4.67518817282894	1/9	1	STAT5B
Signaling by Ligand-Responsive EGFR Variants in Cancer R-HSA-5637815	1	0	0/17	1	
Signaling by MAP2K mutants R-HSA-9652169	1	0	0/2	1	
Signaling by MAPK mutants R-HSA-9652817	1	0	0/2	1	
Signaling by MET R-HSA-6806834	0.72266013961281	0.788490234056424	1/48	1	SRC
Signaling by MRAS-complex mutants R-HSA-9660537	1	0	0/5	1	
Signaling by MST1 R-HSA-8852405	1	0	0/1	1	
Signaling by NOTCH1 HD Domain Mutants in Cancer R-HSA-2691230	1	0	0/9	1	
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer R-HSA-2894858	0.379005316273045	1.55825939331202	2/50	1	EP300;NCOR1
Signaling by NOTCH1 PEST Domain Mutants in Cancer R-HSA-2644602	0.379005316273045	1.55825939331202	2/50	1	EP300;NCOR1
Signaling by NOTCH1 R-HSA-1980143	0.45243709882314	1.33299416308349	2/58	1	EP300;NCOR1
Signaling by NOTCH1 in Cancer R-HSA-2644603	0.379005316273045	1.55825939331202	2/50	1	EP300;NCOR1
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant R-HSA-2660825	1	0	0/4	1	
Signaling by NOTCH2 R-HSA-1980145	0.472346799019033	1.62085821553598	1/24	1	EP300
Signaling by NOTCH3 R-HSA-9012852	0.646847616429472	0.977449047960505	1/39	1	EP300
Signaling by NOTCH4 R-HSA-9013694	0.60514256745431	0.990515139343868	2/77	1	EP300;SMAD3
Signaling by NTRK1 (TRKA) R-HSA-187037	0.393331443757457	1.35265993666899	3/86	1	SRC;EP300;JUNB
Signaling by NTRK2 (TRKB) R-HSA-9006115	0.363932244211123	2.33377333495509	1/17	1	SRC
Signaling by NTRK3 (TRKC) R-HSA-9034015	0.253635549571777	3.73892787264533	1/11	1	SRC
Signaling by NTRKs R-HSA-166520	0.231765328354712	1.67640947587439	4/94	1	SRC;EP300;FURIN;JUNB
Signaling by Non-Receptor Tyrosine Kinases R-HSA-9006927	1	0	0/40	1	
Signaling by Overexpressed Wild-Type EGFR in Cancer R-HSA-5638302	1	0	0/8	1	
Signaling by PDGFR in disease R-HSA-9671555	1	0	0/14	1	
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770	1	0	0/12	1	
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767	1	0	0/12	1	
Signaling by PTK6 R-HSA-8848021	1	0	0/40	1	
Signaling by RAF1 mutants R-HSA-9656223	0.129473301370098	3.4211512686734	2/24	1	SRC;VWF
Signaling by RAS GAP mutants R-HSA-9753510	1	0	0/3	1	
Signaling by RAS GTPase mutants R-HSA-9753512	1	0	0/3	1	
Signaling by RAS mutants R-HSA-6802949	0.15672262787221	3.00855819333667	2/27	1	SRC;VWF
Signaling by ROBO receptors R-HSA-376176	0.831137710664036	0.657738724754911	3/170	1	SRC;CDC42;NTN1
Signaling by Receptor Tyrosine Kinases R-HSA-9006934	0.0835070128369545	1.61307359461093	13/327	1	SRC;EP300;NCOR1;FURIN;ARHGEF7;CDC42;SPHK1;STAT6;JUNB;JAK3;STAT5B;PLAT;PDGFD
Signaling by Retinoic Acid R-HSA-5362517	1	0	0/15	1	
Signaling by Rho GTPases R-HSA-194315	0.272379389408034	1.26099903407563	12/374	1	SRC;AURKB;H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14;ARHGEF7;CDC42;SPATA13;DOCK5
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 R-HSA-9716542	0.281588319172297	1.24958883458289	12/377	1	SRC;AURKB;H2BC21;H2BC12;H4C9;KDM4C;H2AX;H2BC14;ARHGEF7;CDC42;SPATA13;DOCK5
Signaling by SCF-KIT R-HSA-1433557	0.223528616933996	2.34659521093487	2/34	1	SRC;STAT5B
Signaling by TCF7L2 mutants R-HSA-5339700	1	0	0/3	1	
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192	1	0	0/27	1	
Signaling by VEGF R-HSA-194138	0.321040157487123	1.54186735133174	3/76	1	SRC;CDC42;SPHK1
Signaling by WNT in cancer R-HSA-4791275	0.10353465954373	3.9639924847644	2/21	1	FZD5;WNT3A
Signaling by activated point mutants of FGFR1 R-HSA-1839122	1	0	0/2	1	
Signaling by activated point mutants of FGFR3 R-HSA-1839130	1	0	0/2	1	
Signaling by cytosolic PDGFRA and PDGFRB fusion proteins R-HSA-9673766	1	0	0/0	1	
Signaling by extracellular domain mutants of KIT R-HSA-9680187	1	0	0/1	1	
Signaling by high-kinase activity BRAF mutants R-HSA-6802948	0.0871648296231222	4.43225988266371	2/19	1	SRC;VWF
Signaling by juxtamembrane domain KIT mutants R-HSA-9669935	1	0	0/1	1	
Signaling by kinase domain mutants of KIT R-HSA-9669933	1	0	0/1	1	
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB R-HSA-9673768	1	0	0/2	1	
Signaling by moderate kinase activity BRAF mutants R-HSA-6802946	0.15672262787221	3.00855819333667	2/27	1	SRC;VWF
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439	0.0952469944498643	4.18502489709519	2/20	1	SRC;STAT5B
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336	1	0	0/1	1	
Signaling by the B Cell Receptor (BCR) R-HSA-983705	1	0	0/95	1	
Signaling downstream of RAS mutants R-HSA-9649948	0.15672262787221	3.00855819333667	2/27	1	SRC;VWF
Signalling to ERK5 R-HSA-198765	1	0	0/2	1	
Signalling to ERKs R-HSA-187687	0.42832825457232	1.86538195580771	1/21	1	SRC
Signalling to RAS R-HSA-167044	0.292358333261937	3.11429423158507	1/13	1	SRC
Signalling to STAT3 R-HSA-198745	1	0	0/2	1	
Signalling to p38 via RIT and RIN R-HSA-187706	1	0	0/3	1	
Small interfering RNA (siRNA) biogenesis R-HSA-426486	1	0	0/3	1	
Smooth Muscle Contraction R-HSA-445355	1	0	0/23	1	
Sodium-coupled phosphate cotransporters R-HSA-427652	1	0	0/2	1	
Sodium-coupled sulphate, di- and tri-carboxylate transporters R-HSA-433137	1	0	0/2	1	
Sodium/Calcium exchangers R-HSA-425561	1	0	0/7	1	
Sodium/Proton exchangers R-HSA-425986	1	0	0/5	1	
Somitogenesis R-HSA-9824272	1	0	0/47	1	
Sorafenib-resistant KIT mutants R-HSA-9669936	1	0	0/1	1	
Sorafenib-resistant PDGFR mutants R-HSA-9674404	1	0	0/1	1	
Specification of primordial germ cells R-HSA-9827857	0.124423905593351	9.35086557215028	1/5	1	NANOG
Specification of the neural plate border R-HSA-9834899	0.212814889902584	4.67518817282894	1/9	1	WNT3A
Sperm Motility And Taxes R-HSA-1300642	1	0	0/0	1	
Sphingolipid catabolism R-HSA-9845614	0.14740262953668	7.48288775581792	1/6	1	ACER1
Spry regulation of FGF signaling R-HSA-1295596	0.329090081730138	2.668231298019	1/15	1	SRC
Stabilization of p53 R-HSA-69541	1	0	0/56	1	
Sterols are 12-hydroxylated by CYP8B1 R-HSA-211994	1	0	0/0	1	
Stimulation of the cell death response by PAK-2p34 R-HSA-211736	1	0	0/1	1	
Striated Muscle Contraction R-HSA-390522	0.166035472371445	2.89218521695033	2/28	1	TTN;NEB
Sulfide oxidation to sulfate R-HSA-1614517	1	0	0/3	1	
Sulfur amino acid metabolism R-HSA-1614635	1	0	0/14	1	
Sunitinib-resistant KIT mutants R-HSA-9669934	1	0	0/1	1	
Sunitinib-resistant PDGFR mutants R-HSA-9674401	1	0	0/1	1	
Suppression of apoptosis R-HSA-9635465	1	0	0/3	1	
Suppression of autophagy R-HSA-9636569	1	0	0/1	1	
Suppression of phagosomal maturation R-HSA-9637687	1	0	0/8	1	
Surfactant metabolism R-HSA-5683826	1	0	0/7	1	
Switching of origins to a post-replicative state R-HSA-69052	1	0	0/81	1	
Synaptic adhesion-like molecules R-HSA-8849932	1	0	0/4	1	
Syndecan interactions R-HSA-3000170	1	0	0/15	1	
Synthesis And Processing Of GAG, GAGPOL Polyproteins R-HSA-174495	1	0	0/7	1	
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) R-HSA-2142816	1	0	0/3	1	
Synthesis of 12-eicosatetraenoic acid derivatives R-HSA-2142712	1	0	0/3	1	
Synthesis of 15-eicosatetraenoic acid derivatives R-HSA-2142770	1	0	0/4	1	
Synthesis of 5-eicosatetraenoic acids R-HSA-2142688	1	0	0/5	1	
Synthesis of CL R-HSA-1483076	1	0	0/1	1	
Synthesis of DNA R-HSA-69239	1	0	0/92	1	
Synthesis of Dolichyl-phosphate R-HSA-446199	1	0	0/1	1	
Synthesis of GDP-mannose R-HSA-446205	1	0	0/2	1	
Synthesis of Hepoxilins (HX) and Trioxilins (TrX) R-HSA-2142696	1	0	0/0	1	
Synthesis of IP2, IP, and Ins in the cytosol R-HSA-1855183	1	0	0/6	1	
Synthesis of IP3 and IP4 in the cytosol R-HSA-1855204	1	0	0/8	1	
Synthesis of IPs in the ER lumen R-HSA-1855231	1	0	0/1	1	
Synthesis of IPs in the nucleus R-HSA-1855191	1	0	0/0	1	
Synthesis of Ketone Bodies R-HSA-77111	1	0	0/1	1	
Synthesis of Leukotrienes (LT) and Eoxins (EX) R-HSA-2142691	1	0	0/10	1	
Synthesis of Lipoxins (LX) R-HSA-2142700	1	0	0/2	1	
Synthesis of PA R-HSA-1483166	1	0	0/13	1	
Synthesis of PC R-HSA-1483191	1	0	0/9	1	
Synthesis of PE R-HSA-1483213	1	0	0/3	1	
Synthesis of PG R-HSA-1483148	1	0	0/3	1	
Synthesis of PI R-HSA-1483226	1	0	0/3	1	
Synthesis of PIPs at the ER membrane R-HSA-1483248	1	0	0/4	1	
Synthesis of PIPs at the Golgi membrane R-HSA-1660514	1	0	0/11	1	
Synthesis of PIPs at the early endosome membrane R-HSA-1660516	1	0	0/10	1	
Synthesis of PIPs at the late endosome membrane R-HSA-1660517	1	0	0/9	1	
Synthesis of PIPs at the plasma membrane R-HSA-1660499	0.513005450285811	1.43279072325922	1/27	1	PIP5K1A
Synthesis of PIPs in the nucleus R-HSA-8847453	1	0	0/2	1	
Synthesis of PS R-HSA-1483101	1	0	0/2	1	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) R-HSA-2162123	1	0	0/4	1	
Synthesis of UDP-N-acetyl-glucosamine R-HSA-446210	1	0	0/1	1	
Synthesis of active ubiquitin: roles of E1 and E2 enzymes R-HSA-8866652	1	0	0/19	1	
Synthesis of bile acids and bile salts R-HSA-192105	1	0	0/10	1	
Synthesis of bile acids and bile salts via 24-hydroxycholesterol R-HSA-193775	1	0	0/2	1	
Synthesis of bile acids and bile salts via 27-hydroxycholesterol R-HSA-193807	1	0	0/5	1	
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol R-HSA-193368	1	0	0/9	1	
Synthesis of diphthamide-EEF2 R-HSA-5358493	1	0	0/4	1	
Synthesis of dolichyl-phosphate mannose R-HSA-162699	1	0	0/2	1	
Synthesis of dolichyl-phosphate-glucose R-HSA-480985	1	0	0/1	1	
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) R-HSA-2142670	1	0	0/2	1	
Synthesis of glycosylphosphatidylinositol (GPI) R-HSA-162710	1	0	0/8	1	
Synthesis of pyrophosphates in the cytosol R-HSA-1855167	1	0	0/2	1	
Synthesis of substrates in N-glycan biosythesis R-HSA-446219	1	0	0/19	1	
Synthesis of wybutosine at G37 of tRNA(Phe) R-HSA-6782861	1	0	0/1	1	
Synthesis, secretion, and deacylation of Ghrelin R-HSA-422085	1	0	0/11	1	
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771	1	0	0/10	1	
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511	1	0	0/7	1	
TAK1-dependent IKK and NF-kappa-B activation   R-HSA-445989	0.637249115747812	1.00411758787702	1/38	1	APP
TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P R-HSA-6791462	1	0	0/1	1	
TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P R-HSA-6791055	1	0	0/1	1	
TBC/RABGAPs R-HSA-8854214	1	0	0/16	1	
TCR signaling R-HSA-202403	1	0	0/103	1	
TET1,2,3 and TDG demethylate DNA R-HSA-5221030	1	0	0/1	1	
TFAP2 (AP-2) family regulates transcription of cell cycle factors R-HSA-8866911	1	0	0/4	1	
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors R-HSA-8866910	1	0	0/9	1	
TFAP2 (AP-2) family regulates transcription of other transcription factors R-HSA-8866906	1	0	0/3	1	
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation R-HSA-8869496	0.100831870512745	12.4605401761496	1/4	1	MYBL2
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) R-HSA-2173791	1	0	0/15	1	
TGFBR1 LBD Mutants in Cancer R-HSA-3656535	1	0	0/4	1	
TGFBR2 Kinase Domain Mutants in Cancer R-HSA-3645790	1	0	0/3	1	
TGFBR2 MSI Frameshift Mutants in Cancer R-HSA-3642279	1	0	0/2	1	
TICAM1 deficiency - HSE R-HSA-5602566	1	0	0/2	1	
TICAM1, RIP1-mediated IKK complex recruitment R-HSA-168927	1	0	0/19	1	
TICAM1,TRAF6-dependent induction of TAK1 complex R-HSA-9014325	1	0	0/10	1	
TICAM1-dependent activation of IRF3/IRF7 R-HSA-9013973	1	0	0/12	1	
TLR3 deficiency - HSE R-HSA-5602410	1	0	0/1	1	
TLR3-mediated TICAM1-dependent programmed cell death R-HSA-9013957	1	0	0/6	1	
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway R-HSA-5676594	1	0	0/9	1	
TNF signaling R-HSA-75893	1	0	0/40	1	
TNFR1-induced NF-kappa-B signaling pathway R-HSA-5357956	1	0	0/22	1	
TNFR1-induced proapoptotic signaling R-HSA-5357786	1	0	0/14	1	
TNFR1-mediated ceramide production R-HSA-5626978	1	0	0/5	1	
TNFR2 non-canonical NF-kB pathway R-HSA-5668541	1	0	0/72	1	
TNFs bind their physiological receptors R-HSA-5669034	1	0	0/7	1	
TP53 Regulates Metabolic Genes R-HSA-5628897	1	0	0/59	1	
TP53 Regulates Transcription of Caspase Activators and Caspases R-HSA-6803207	1	0	0/9	1	
TP53 Regulates Transcription of Cell Cycle Genes R-HSA-6791312	0.627392260138806	1.03227788262778	1/37	1	EP300
TP53 Regulates Transcription of Cell Death Genes R-HSA-5633008	1	0	0/25	1	
TP53 Regulates Transcription of DNA Repair Genes R-HSA-6796648	0.637249115747812	1.00411758787702	1/38	1	MDC1
TP53 Regulates Transcription of Death Receptors and Ligands R-HSA-6803211	1	0	0/6	1	
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release R-HSA-6803204	1	0	0/13	1	
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest R-HSA-6804116	1	0	0/10	1	
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest R-HSA-6804114	0.329090081730138	2.668231298019	1/15	1	EP300
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain R-HSA-6804115	1	0	0/14	1	
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain R-HSA-6803205	1	0	0/6	1	
TRAF3 deficiency - HSE R-HSA-5602571	1	0	0/3	1	
TRAF3-dependent IRF activation pathway R-HSA-918233	0.292358333261937	3.11429423158507	1/13	1	EP300
TRAF6 mediated IRF7 activation R-HSA-933541	0.513005450285811	1.43279072325922	1/27	1	EP300
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling R-HSA-975110	1	0	0/12	1	
TRAF6 mediated NF-kB activation R-HSA-933542	0.45806040328366	1.69494567015225	1/23	1	APP
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation R-HSA-975138	0.88307499368284	0.465283065109332	1/80	1	APP
TRAF6-mediated induction of TAK1 complex within TLR4 complex R-HSA-937072	1	0	0/12	1	
TRAIL  signaling R-HSA-75158	1	0	0/5	1	
TRIF (TICAM1)-mediated TLR4 signaling  R-HSA-937061	0.910863105667819	0.411939646370659	1/90	1	APP
TRIF-mediated programmed cell death R-HSA-2562578	1	0	0/7	1	
TRKA activation by NGF R-HSA-187042	1	0	0/1	1	
TRP channels R-HSA-3295583	0.191582925100974	5.34296079232313	1/8	1	TRPM7
TWIK related potassium channel (TREK) R-HSA-1299503	1	0	0/0	1	
TWIK-related alkaline pH activated K+ channel (TALK) R-HSA-1299361	1	0	0/0	1	
TWIK-related spinal cord K+ channel (TRESK) R-HSA-1299344	1	0	0/0	1	
TWIK-releated acid-sensitive K+ channel (TASK) R-HSA-1299316	1	0	0/1	1	
TYSND1 cleaves peroxisomal proteins R-HSA-9033500	1	0	0/2	1	
Tachykinin receptors bind tachykinins R-HSA-380095	1	0	0/1	1	
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) R-HSA-1299308	1	0	0/1	1	
Tandem pore domain halothane-inhibited K+ channel (THIK) R-HSA-1299287	1	0	0/1	1	
Tandem pore domain potassium channels R-HSA-1296346	1	0	0/3	1	
Tat-mediated HIV elongation arrest and recovery R-HSA-167243	1	0	0/22	1	
Tat-mediated elongation of the HIV-1 transcript R-HSA-167246	1	0	0/26	1	
Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417	1	0	0/10	1	
Telomere C-strand synthesis initiation R-HSA-174430	1	0	0/2	1	
Telomere Extension By Telomerase R-HSA-171319	1	0	0/7	1	
Terminal pathway of complement R-HSA-166665	1	0	0/4	1	
Termination of O-glycan biosynthesis R-HSA-977068	1	0	0/11	1	
Termination of translesion DNA synthesis R-HSA-5656169	1	0	0/17	1	
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation R-HSA-1474151	1	0	0/5	1	
The AIM2 inflammasome R-HSA-844615	1	0	0/2	1	
The IPAF inflammasome R-HSA-844623	1	0	0/2	1	
The NLRP1 inflammasome R-HSA-844455	1	0	0/2	1	
The NLRP3 inflammasome R-HSA-844456	0.346741223784396	2.49010112143882	1/16	1	APP
The activation of arylsulfatases R-HSA-1663150	1	0	0/1	1	
The canonical retinoid cycle in rods (twilight vision) R-HSA-2453902	1	0	0/4	1	
The fatty acid cycling model R-HSA-167826	1	0	0/0	1	
The phototransduction cascade R-HSA-2514856	1	0	0/10	1	
The proton buffering model R-HSA-167827	1	0	0/0	1	
The retinoid cycle in cones (daylight vision) R-HSA-2187335	1	0	0/1	1	
The role of GTSE1 in G2/M progression after G2 checkpoint R-HSA-8852276	1	0	0/75	1	
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952	1	0	0/18	1	
Threonine catabolism R-HSA-8849175	1	0	0/3	1	
Thrombin signalling through proteinase activated receptors (PARs) R-HSA-456926	0.363932244211123	2.33377333495509	1/17	1	SRC
Thromboxane signalling through TP receptor R-HSA-428930	1	0	0/12	1	
Thyroxine biosynthesis R-HSA-209968	1	0	0/3	1	
Tie2 Signaling R-HSA-210993	1	0	0/15	1	
Tight junction interactions R-HSA-420029	1	0	0/6	1	
Toll Like Receptor 10 (TLR10) Cascade R-HSA-168142	0.866118859306527	0.497356129905137	1/75	1	APP
Toll Like Receptor 2 (TLR2) Cascade R-HSA-181438	0.908408309409255	0.41672848853144	1/89	1	APP
Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164	0.905886564161822	0.421627407170382	1/88	1	APP
Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016	0.948304984511304	0.334613633880228	1/110	1	APP
Toll Like Receptor 5 (TLR5) Cascade R-HSA-168176	0.866118859306527	0.497356129905137	1/75	1	APP
Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181	0.886201646223107	0.459348679850541	1/81	1	APP
Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138	0.892208603102462	0.447914083222512	1/83	1	APP
Toll Like Receptor TLR1:TLR2 Cascade R-HSA-168179	0.908408309409255	0.41672848853144	1/89	1	APP
Toll Like Receptor TLR6:TLR2 Cascade R-HSA-168188	0.908408309409255	0.41672848853144	1/89	1	APP
Toll-like Receptor Cascades R-HSA-168898	0.958460281057115	0.311084781759856	1/118	1	APP
Toxicity of botulinum toxin type A (botA) R-HSA-5250968	1	0	0/0	1	
Toxicity of botulinum toxin type B (botB) R-HSA-5250958	1	0	0/3	1	
Toxicity of botulinum toxin type C (botC) R-HSA-5250971	1	0	0/0	1	
Toxicity of botulinum toxin type D (botD) R-HSA-5250955	1	0	0/1	1	
Toxicity of botulinum toxin type E (botE) R-HSA-5250992	1	0	0/0	1	
Toxicity of botulinum toxin type F (botF) R-HSA-5250981	1	0	0/1	1	
Toxicity of botulinum toxin type G (botG) R-HSA-5250989	1	0	0/2	1	
Toxicity of tetanus toxin (tetX) R-HSA-5250982	1	0	0/1	1	
Trafficking and processing of endosomal TLR R-HSA-1679131	1	0	0/4	1	
Trafficking of AMPA receptors R-HSA-399719	1	0	0/14	1	
Trafficking of GluR2-containing AMPA receptors R-HSA-416993	1	0	0/7	1	
Trafficking of myristoylated proteins to the cilium R-HSA-5624138	1	0	0/0	1	
Transcription from mitochondrial promoters R-HSA-75944	1	0	0/2	1	
Transcription of E2F targets under negative control by DREAM complex R-HSA-1362277	0.310966623183603	2.87416395939725	1/14	1	E2F5
Transcription of the HIV genome R-HSA-167172	1	0	0/41	1	
Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827	1	0	0/42	1	
Transcriptional  activation of  cell cycle inhibitor p21  R-HSA-69895	1	0	0/2	1	
Transcriptional Regulation by E2F6 R-HSA-8953750	1	0	0/26	1	
Transcriptional Regulation by TP53 R-HSA-3700989	0.389541030796551	1.18916662580776	7/228	1	AURKB;EP300;HIPK2;KAT5;NBN;MDC1;NOC2L
Transcriptional Regulation by VENTX R-HSA-8853884	1	0	0/32	1	
Transcriptional activation of mitochondrial biogenesis R-HSA-2151201	0.606875758685348	1.09352564185209	1/35	1	NCOR1
Transcriptional activation of p53 responsive genes   R-HSA-69560	1	0	0/2	1	
Transcriptional and post-translational regulation of MITF-M expression and activity R-HSA-9856649	0.42832825457232	1.86538195580771	1/21	1	WNT3A
Transcriptional regulation by RUNX2 R-HSA-8878166	0.754498374046508	0.738121578641787	2/102	1	SRC;SOX9
Transcriptional regulation by RUNX3 R-HSA-8878159	0.435876338548822	1.25954515205695	3/92	1	SRC;EP300;SMAD3
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors R-HSA-8864260	0.10353465954373	3.9639924847644	2/21	1	EP300;MYBL2
Transcriptional regulation of brown and beige adipocyte differentiation R-HSA-9843743	1	0	0/19	1	
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 R-HSA-9844594	1	0	0/19	1	
Transcriptional regulation of white adipocyte differentiation R-HSA-381340	0.416286511328687	1.43695399372548	2/54	1	EP300;NCOR1
Transfer of LPS from LBP carrier to CD14 R-HSA-166020	1	0	0/0	1	
Transferrin endocytosis and recycling R-HSA-917977	1	0	0/15	1	
Translation R-HSA-72766	0.95540984105237	0.403908264020573	2/181	1	CARS2;AARS2
Translation initiation complex formation R-HSA-72649	1	0	0/48	1	
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9679504	1	0	0/5	1	
Translation of Replicase and Assembly of the Replication Transcription Complex R-HSA-9694676	1	0	0/5	1	
Translation of Structural Proteins R-HSA-9683701	1	0	0/18	1	
Translation of Structural Proteins R-HSA-9694635	1	0	0/29	1	
Translesion Synthesis by POLH R-HSA-110320	1	0	0/10	1	
Translesion synthesis by POLI R-HSA-5656121	1	0	0/10	1	
Translesion synthesis by POLK R-HSA-5655862	1	0	0/10	1	
Translesion synthesis by REV1 R-HSA-110312	1	0	0/10	1	
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template R-HSA-110313	1	0	0/21	1	
Translocation of SLC2A4 (GLUT4) to the plasma membrane R-HSA-1445148	1	0	0/47	1	
Translocation of ZAP-70 to Immunological synapse R-HSA-202430	1	0	0/16	1	
Transmission across Chemical Synapses R-HSA-112315	0.337856567599442	1.3905567018196	4/112	1	SRC;TSPOAP1;LRRC7;ARHGEF7
Transmission across Electrical Synapses  R-HSA-112307	1	0	0/1	1	
Transport and synthesis of PAPS R-HSA-174362	1	0	0/5	1	
Transport of Mature Transcript to Cytoplasm R-HSA-72202	1	0	0/32	1	
Transport of Mature mRNA Derived from an Intronless Transcript R-HSA-159231	1	0	0/15	1	
Transport of Mature mRNA derived from an Intron-Containing Transcript R-HSA-159236	1	0	0/27	1	
Transport of Mature mRNAs Derived from Intronless Transcripts R-HSA-159234	1	0	0/16	1	
Transport of RCbl within the body R-HSA-9758890	1	0	0/3	1	
Transport of Ribonucleoproteins into the Host Nucleus R-HSA-168271	1	0	0/11	1	
Transport of bile salts and organic acids, metal ions and amine compounds R-HSA-425366	1	0	0/15	1	
Transport of connexins along the secretory pathway R-HSA-190827	1	0	0/2	1	
Transport of connexons to the plasma membrane R-HSA-190872	1	0	0/20	1	
Transport of fatty acids R-HSA-804914	1	0	0/4	1	
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus R-HSA-159763	1	0	0/2	1	
Transport of glycerol from adipocytes to the liver by Aquaporins R-HSA-432030	1	0	0/1	1	
Transport of inorganic cations/anions and amino acids/oligopeptides R-HSA-425393	0.656194471025846	0.952147964858822	1/40	1	SLC12A2
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane R-HSA-83936	1	0	0/3	1	
Transport of nucleotide sugars R-HSA-727802	1	0	0/4	1	
Transport of organic anions R-HSA-879518	1	0	0/5	1	
Transport of small molecules R-HSA-382551	0.289435080902778	1.26768458608334	10/309	1	FURIN;ATP1A1;FXYD2;SLC12A2;SCNN1A;SCNN1B;TRPM7;SCNN1G;SCNN1D;WNK2
Transport of the SLBP Dependant Mature mRNA R-HSA-159230	1	0	0/13	1	
Transport of the SLBP independent Mature mRNA R-HSA-159227	1	0	0/12	1	
Transport of vitamins, nucleosides, and related molecules R-HSA-425397	1	0	0/17	1	
Transport to the Golgi and subsequent modification R-HSA-948021	1	0	0/99	1	
Triglyceride biosynthesis R-HSA-75109	1	0	0/6	1	
Triglyceride catabolism R-HSA-163560	1	0	0/14	1	
Triglyceride metabolism R-HSA-8979227	1	0	0/20	1	
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA R-HSA-450513	1	0	0/14	1	
Truncations of AMER1 destabilize the destruction complex R-HSA-5467348	1	0	0/10	1	
Tryptophan catabolism R-HSA-71240	1	0	0/5	1	
Type I hemidesmosome assembly R-HSA-446107	1	0	0/6	1	
Type II Na+/Pi cotransporters R-HSA-427589	1	0	0/1	1	
Tyrosine catabolism R-HSA-8963684	1	0	0/1	1	
UCH proteinases R-HSA-5689603	1	0	0/80	1	
UNC93B1 deficiency - HSE R-HSA-5602415	1	0	0/1	1	
Ub-specific processing proteases R-HSA-5689880	0.336175817684293	1.33301344715361	5/146	1	H2BC21;H2BC12;H2BC14;SMAD3;SMAD2
Ubiquinol biosynthesis R-HSA-2142789	1	0	0/1	1	
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A R-HSA-69601	1	0	0/50	1	
Ubiquitin-dependent degradation of Cyclin D R-HSA-75815	1	0	0/51	1	
Unblocking of NMDA receptors, glutamate binding and activation R-HSA-438066	0.253635549571777	3.73892787264533	1/11	1	LRRC7
Uncoating of the HIV Virion R-HSA-162585	1	0	0/1	1	
Unfolded Protein Response (UPR) R-HSA-381119	1	0	0/57	1	
Unwinding of DNA R-HSA-176974	1	0	0/6	1	
Uptake and actions of bacterial toxins R-HSA-5339562	0.346741223784396	2.49010112143882	1/16	1	FURIN
Uptake and function of anthrax toxins R-HSA-5210891	0.191582925100974	5.34296079232313	1/8	1	FURIN
Uptake and function of diphtheria toxin R-HSA-5336415	1	0	0/5	1	
Uptake of dietary cobalamins into enterocytes R-HSA-9758881	1	0	0/2	1	
Urea cycle R-HSA-70635	0.100831870512745	12.4605401761496	1/4	1	ASS1
Utilization of Ketone Bodies R-HSA-77108	1	0	0/0	1	
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399	1	0	0/4	1	
VEGF ligand-receptor interactions R-HSA-194313	1	0	0/4	1	
VEGFA-VEGFR2 Pathway R-HSA-4420097	0.299293584451177	1.60918008384367	3/73	1	SRC;CDC42;SPHK1
VEGFR2 mediated vascular permeability R-HSA-5218920	1	0	0/21	1	
VLDL assembly R-HSA-8866423	1	0	0/3	1	
VLDL clearance R-HSA-8964046	1	0	0/4	1	
VLDLR internalisation and degradation R-HSA-8866427	1	0	0/12	1	
Variant SLC6A14 may confer susceptibility towards obesity R-HSA-5619094	1	0	0/0	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5619101	1	0	0/1	1	
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) R-HSA-5660686	1	0	0/1	1	
Vasopressin regulates renal water homeostasis via Aquaporins R-HSA-432040	1	0	0/19	1	
Vasopressin-like receptors R-HSA-388479	1	0	0/1	1	
Vesicle-mediated transport R-HSA-5653656	0.997832649983919	0.230753311666249	2/305	1	SRC;APP
Vif-mediated degradation of APOBEC3G R-HSA-180585	1	0	0/53	1	
Viral Infection Pathways R-HSA-9824446	0.895855792377528	0.704371769209178	11/567	1	H2BC21;H2BC12;H4C9;H2BC14;EP300;NCOR1;FURIN;ATP1A1;FXYD2;SMAD3;JAK3
Viral Messenger RNA Synthesis R-HSA-168325	1	0	0/23	1	
Viral RNP Complexes in the Host Cell Nucleus R-HSA-168330	1	0	0/1	1	
Viral mRNA Translation R-HSA-192823	1	0	0/81	1	
Virus Assembly and Release R-HSA-168268	1	0	0/2	1	
Visual phototransduction R-HSA-2187338	1	0	0/26	1	
Vitamin B1 (thiamin) metabolism R-HSA-196819	1	0	0/0	1	
Vitamin B2 (riboflavin) metabolism R-HSA-196843	1	0	0/3	1	
Vitamin B5 (pantothenate) metabolism R-HSA-199220	1	0	0/5	1	
Vitamin B6 activation to pyridoxal phosphate R-HSA-964975	1	0	0/0	1	
Vitamin C (ascorbate) metabolism R-HSA-196836	1	0	0/2	1	
Vitamin D (calciferol) metabolism R-HSA-196791	1	0	0/3	1	
Vitamin E R-HSA-8877627	1	0	0/0	1	
Vitamins R-HSA-211916	1	0	0/0	1	
Voltage gated Potassium channels R-HSA-1296072	1	0	0/7	1	
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization R-HSA-180897	1	0	0/1	1	
Vpr-mediated nuclear import of PICs R-HSA-180910	1	0	0/13	1	
Vpu mediated degradation of CD4 R-HSA-180534	1	0	0/51	1	
VxPx cargo-targeting to cilium R-HSA-5620916	1	0	0/10	1	
WNT ligand biogenesis and trafficking R-HSA-3238698	0.212814889902584	4.67518817282894	1/9	1	WNT3A
WNT mediated activation of DVL R-HSA-201688	1	0	0/5	1	
WNT5:FZD7-mediated leishmania damping R-HSA-9673324	1	0	0/6	1	
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 R-HSA-5140745	0.212814889902584	4.67518817282894	1/9	1	FZD5
WNT5A-dependent internalization of FZD4 R-HSA-5099900	1	0	0/8	1	
Wax and plasmalogen biosynthesis R-HSA-8848584	1	0	0/1	1	
Wax biosynthesis R-HSA-9640463	1	0	0/1	1	
XAV939 stabilizes AXIN R-HSA-5545619	1	0	0/1	1	
XBP1(S) activates chaperone genes R-HSA-381038	1	0	0/22	1	
Xenobiotics R-HSA-211981	0.169783838370041	6.23416731470989	1/7	1	ARNT
YAP1- and WWTR1 (TAZ)-stimulated gene expression R-HSA-2032785	0.233494350043928	4.15469625193707	1/10	1	HIPK2
Z-decay: degradation of maternal mRNAs by zygotically expressed factors R-HSA-9820865	1	0	0/9	1	
ZBP1(DAI) mediated induction of type I IFNs R-HSA-1606322	1	0	0/19	1	
Zinc efflux and compartmentalization by the SLC30 family R-HSA-435368	1	0	0/0	1	
Zinc influx into cells by the SLC39 gene family R-HSA-442380	1	0	0/0	1	
Zinc transporters R-HSA-435354	1	0	0/0	1	
Zygotic genome activation (ZGA) R-HSA-9819196	0.191582925100974	5.34296079232313	1/8	1	EP300
activated TAK1 mediates p38 MAPK activation R-HSA-450302	1	0	0/22	1	
alectinib-resistant ALK mutants R-HSA-9717316	1	0	0/0	1	
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism R-HSA-2046104	1	0	0/5	1	
alpha-linolenic acid (ALA) metabolism R-HSA-2046106	1	0	0/5	1	
betaKlotho-mediated ligand binding R-HSA-1307965	1	0	0/1	1	
brigatinib-resistant ALK mutants R-HSA-9717319	1	0	0/0	1	
cGMP effects R-HSA-418457	1	0	0/5	1	
ceritinib-resistant ALK mutants R-HSA-9717323	1	0	0/0	1	
crenolanib-resistant FLT3 mutants R-HSA-9702581	1	0	0/0	1	
crizotinib-resistant ALK mutants R-HSA-9717326	1	0	0/0	1	
eNOS activation R-HSA-203615	1	0	0/6	1	
gilteritinib-resistant FLT3 mutants R-HSA-9702590	1	0	0/0	1	
lestaurtinib-resistant FLT3 mutants R-HSA-9702596	1	0	0/0	1	
linifanib-resistant FLT3 mutants R-HSA-9702998	1	0	0/0	1	
lorlatinib-resistant ALK mutants R-HSA-9717329	1	0	0/0	1	
mRNA 3'-end processing R-HSA-72187	1	0	0/23	1	
mRNA Capping R-HSA-72086	1	0	0/20	1	
mRNA Editing R-HSA-75072	1	0	0/0	1	
mRNA Editing: A to I Conversion R-HSA-75064	1	0	0/0	1	
mRNA Editing: C to U Conversion R-HSA-72200	1	0	0/0	1	
mRNA Splicing - Major Pathway R-HSA-72163	1	0	0/108	1	
mRNA Splicing - Minor Pathway R-HSA-72165	1	0	0/37	1	
mRNA Splicing R-HSA-72172	1	0	0/114	1	
mRNA decay by 3' to 5' exoribonuclease R-HSA-429958	1	0	0/10	1	
mRNA decay by 5' to 3' exoribonuclease R-HSA-430039	1	0	0/11	1	
mTORC1-mediated signalling R-HSA-166208	1	0	0/22	1	
midostaurin-resistant FLT3 mutants R-HSA-9702600	1	0	0/0	1	
mitochondrial fatty acid beta-oxidation of saturated fatty acids R-HSA-77286	1	0	0/6	1	
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids R-HSA-77288	1	0	0/3	1	
p38MAPK events R-HSA-171007	0.233494350043928	4.15469625193707	1/10	1	SRC
p53-Dependent G1 DNA Damage Response R-HSA-69563	1	0	0/63	1	
p53-Dependent G1/S DNA damage checkpoint R-HSA-69580	1	0	0/63	1	
p53-Independent DNA Damage Response R-HSA-69610	1	0	0/50	1	
p53-Independent G1/S DNA damage checkpoint R-HSA-69613	1	0	0/50	1	
p75 NTR receptor-mediated signalling R-HSA-193704	0.770269380049468	0.685060564559151	1/55	1	ARHGEF7
p75NTR negatively regulates cell cycle via SC1 R-HSA-193670	1	0	0/4	1	
p75NTR recruits signalling complexes R-HSA-209543	1	0	0/12	1	
p75NTR regulates axonogenesis R-HSA-193697	1	0	0/2	1	
p75NTR signals via NF-kB R-HSA-193639	1	0	0/15	1	
pexidartinib-resistant FLT3 mutants R-HSA-9702605	1	0	0/0	1	
phospho-PLA2 pathway R-HSA-111995	1	0	0/2	1	
ponatinib-resistant FLT3 mutants R-HSA-9702614	1	0	0/0	1	
quizartinib-resistant FLT3 mutants R-HSA-9702620	1	0	0/0	1	
rRNA modification in the mitochondrion R-HSA-6793080	1	0	0/0	1	
rRNA modification in the nucleus and cytosol R-HSA-6790901	1	0	0/22	1	
rRNA processing R-HSA-72312	0.965708183249352	0.292987299674818	1/125	1	DDX21
rRNA processing in the mitochondrion R-HSA-8868766	1	0	0/1	1	
rRNA processing in the nucleus and cytosol R-HSA-8868773	0.964755133281977	0.29544654908863	1/124	1	DDX21
semaxanib-resistant FLT3 mutants R-HSA-9702577	1	0	0/0	1	
snRNP Assembly R-HSA-191859	1	0	0/21	1	
sorafenib-resistant FLT3 mutants R-HSA-9702624	1	0	0/0	1	
sunitinib-resistant FLT3 mutants R-HSA-9702632	1	0	0/0	1	
t(4;14) translocations of FGFR3 R-HSA-2033515	1	0	0/0	1	
tRNA modification in the mitochondrion R-HSA-6787450	1	0	0/2	1	
tRNA modification in the nucleus and cytosol R-HSA-6782315	1	0	0/10	1	
tRNA processing R-HSA-72306	1	0	0/33	1	
tRNA processing in the mitochondrion R-HSA-6785470	1	0	0/1	1	
tRNA processing in the nucleus R-HSA-6784531	1	0	0/21	1	
tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis R-HSA-9708296	1	0	0/0	1	
tamatinib-resistant FLT3 mutants R-HSA-9703009	1	0	0/0	1	
tandutinib-resistant FLT3 mutants R-HSA-9702636	1	0	0/0	1	
trans-Golgi Network Vesicle Budding R-HSA-199992	0.646847616429472	0.977449047960505	1/39	1	APP
vRNA Synthesis R-HSA-192814	1	0	0/1	1	
vRNP Assembly R-HSA-192905	1	0	0/1	1	
